OWENS & MINOR INC/VA/ VA false 0000075252 0000075252 2024-07-22 2024-07-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 22, 2024
OWENS & MINOR, INC.
(Exact name of Registrant as specified in charter)
|
|
|
|
|
Virginia |
|
001-09810 |
|
54-1701843 |
(State or other jurisdiction of incorporation) |
|
(Commission file number) |
|
(I.R.S. employer identification no.) |
|
|
|
9120 Lockwood Blvd., Mechanicsville, Virginia |
|
23116 |
(Address of principal executive offices) |
|
(Zip code) |
|
|
|
Post Office Box 27626, Richmond, Virginia |
|
23261-7626 |
(Mailing address of principal executive offices) |
|
(Zip code) |
Registrant’s telephone number, including area code (804) 723-7000
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, $2 par value per share |
|
OMI |
|
New York Stock Exchange |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. |
Entry Into a Material Definitive Agreement. |
Merger Agreement
On July 22, 2024, Owens & Minor, Inc., a Virginia corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Rotech Healthcare Holdings Inc., a Delaware corporation (“Rotech”), Hitchcock Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”) and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the representative of the equity holders of Rotech (“Representative”). The Merger Agreement provides, among other things, that, upon the terms and subject to the conditions set forth therein, Merger Sub will be merged with and into Rotech (the “Merger”) with Rotech surviving the Merger as an indirect, wholly owned subsidiary of the Company, in exchange for an aggregate purchase price of $1.36 billion in cash, subject to customary adjustments for cash, debt, net working capital and transaction expenses, as set forth in the Merger Agreement. The cash consideration is expected to be funded through debt financing commitments.
The closing of the Merger is subject to the satisfaction or waiver of certain customary closing conditions, including, among others, (i) the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), (ii) the absence of any order, judgment or injunction that enjoins, makes illegal or otherwise prohibits the consummation of the Merger, (iii) completion of all filings and notices and the expiration or termination of all applicable notice or waiting periods under applicable healthcare regulatory notification laws, (iv) the accuracy of representations and warranties made by the Company, Merger Sub and Rotech, subject to certain specified materiality standards and certain exceptions, (v) performance and compliance by the parties of their respective covenants and obligations under the Merger Agreement in all material respects, and (vi) the absence of any Material Adverse Effect (as defined in the Merger Agreement) since the date of the Merger Agreement. Following the execution of the Merger Agreement, Rotech delivered to the Company an executed irrevocable written consent of stockholders of Rotech who collectively own a majority of the outstanding shares of common stock of Rotech (the “Rotech Majority Stockholders”), pursuant to which the Rotech Majority Stockholders adopted the Merger Agreement and approved and consented to the Merger and the consummation of the transactions contemplated thereby. No further approval by holders of shares of Rotech’s common stock is required to adopt the Merger Agreement or approve the Merger, or the other transactions contemplated by the Merger Agreement.
Rotech made customary representations, warranties and covenants in the Merger Agreement, including, among others, and subject to certain exceptions, covenants to conduct its and its’ subsidiaries businesses and operations in the ordinary course of business during the period between the date of the Merger Agreement to the earlier of the closing date of the Merger and the termination of the Merger Agreement, not to engage in specified types of actions during this period.
The Merger Agreement contains certain termination rights, including that either the Company or Rotech may terminate the Merger Agreement if, subject to certain limitations, the Merger has not closed by July 22, 2025 (the “Termination Date”).
The Merger Agreement provides that the Company will be required to pay Rotech a termination fee of $70 million under certain specified circumstances if the expiration or termination of the applicable period under the HSR Act has not occurred or if any governmental authority issues a final and nonappealable injunction or order permanently enjoining or otherwise permanently preventing the consummation of the Merger and relating to an antitrust law, subject to the additional terms and conditions set forth in the Merger Agreement.
The Company has obtained debt financing commitments to finance the transactions contemplated by the Merger Agreement and pay related fees and expenses pursuant to that certain commitment letter, dated as of July 22, 2024 (the “Commitment Letter”), between Citigroup Global Markets Inc. and the Company. Pursuant to the Commitment Letter, Citigroup Global Markets Inc., Citibank, N.A., Citicorp North America, Inc. and/or any of their affiliates (“Citi”) have agreed to provide committed acquisition debt financing in the form of (i) a term loan B facility under the Company’s existing Credit Agreement, dated as of March 29, 2022 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof) among the Company, the other
borrowers party thereto, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A. (“JPM”), as collateral agent and administrative agent in an aggregate principal amount of $775 million and (ii) a senior unsecured bridge loan in an aggregate principal amount of $625 million (the “Bridge Facility”). The Bridge Facility availability is subject to reduction in equivalent amounts upon any incurrence by the Company of loans or notes prior to the consummation of the Merger and upon other specified events, subject to certain exceptions set forth in the Commitment Letter. The obligations of Citi to provide debt financing under the Commitment Letter are subject to a number of customary conditions.
The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement, which is filed as Exhibit 2.01 to this Current Report on Form 8-K and incorporated herein by reference. The Merger Agreement has been included to provide investors with information regarding its terms. It is not intended to provide any other factual information about the Company, Rotech or any of their respective affiliates. In particular, the representations and warranties contained in the Merger Agreement were made only for the purposes of the Merger Agreement as of the specific dates therein, and were solely for the benefit of the parties to the Merger Agreement. The representations and warranties contained in the Merger Agreement may be subject to limitations agreed upon by the parties to the Merger Agreement and are qualified by information in confidential disclosure schedules provided in connection with the signing of the Merger Agreement. These confidential disclosure schedules contain information that modifies, qualifies and creates exceptions to the representations and warranties set forth in the Merger Agreement. Moreover, certain representations and warranties in the Merger Agreement may be subject to a standard of materiality provided for in the Merger Agreement and have been used for the purpose of allocating risk among the parties, rather than establishing matters of fact. Investors are not third-party beneficiaries under the Merger Agreement and should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Rotech or any of their subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures. The Merger Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the parties that is or will be contained in, or incorporated by reference into, the Company’s Annual Report on Form 10-K for the period ended December 31, 2023, Quarterly Report on Form 10-Q for the period ended March 31, 2024 and other documents that the Company has filed or will file with the Securities and Exchange Commission (the “SEC”).
Item 7.01. |
Regulation FD Disclosure. |
On July 23, 2024, the Company and Rotech issued a joint press release announcing the transactions contemplated by the Merger Agreement. The Company has prepared an investor presentation, dated July 23, 2024, in connection with the announcement of the transactions contemplated by the Merger Agreement. On July 23, 2024 at 8:30 am Eastern time, the Company will hold a conference call to discuss the transactions contemplated by the Merger Agreement. The Company is furnishing the press release attached hereto as Exhibit 99.1 and the investor presentation attached hereto as Exhibit 99.2 pursuant to Item 7.01 of Form 8-K and each is incorporated by reference herein.
In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01, including Exhibit 99.1 and Exhibit 99.2, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Forward Looking Statements
This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding our expectations regarding the proposed Merger and the future performance and financial results of the Company’s business and other non-historical statements. Some of these statements can be identified by terms and phrases such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “predicts,” “intends,” “trends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. The Company cautions readers of this communication that such “forward looking statements,” wherever they occur in this communication or in other statements attributable to the Company, are necessarily estimates reflecting the judgment of the Company’s senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the “forward-looking statements.”
Factors that could cause the Company’s actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; the inability to complete the proposed Merger due to the failure to obtain approval of Rotech’s stockholders for the proposed Merger or the failure to satisfy other conditions to completion of the proposed Merger, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the proposed Merger; risks related to disruption of management’s attention from the Company’s ongoing business operations due to the proposed Merger; the effect of the announcement of the proposed Merger on the Company’s relationships with its customers, suppliers and other third parties, as well as it operating results and business generally; the risk that the proposed Merger will not be consummated in a timely manner; exceeding the expected costs of the Merger; the risk that problems may arise in successfully integrating the businesses of the companies, which may result in the combined company not operating as effectively and efficiently as expected; the risk that the combined company may be unable to achieve synergies or it may take longer than expected to achieve those synergies.
Additional factors that could cause the Company’s actual outcomes or results to differ materially from those described in the forward-looking statements can be found in the “Risk Factors” sections of our most recent Annual Report on Form 10-K for the period ended December 31, 2023 and Quarterly Report on Form 10-Q for the period ended March 31, 2024, as such factors may be further updated from time to time in the Company’s other filings with the SEC. These reports are or will be accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the Company’s filings with the SEC. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
Item 9.01. |
Financial Statements and Exhibits. |
(d) Exhibits.
The following exhibits are filed herewith:
* |
Schedules and Exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant hereby agrees to supplementally furnish to the SEC upon request any omitted schedule or exhibit to the Agreement and Plan of Merger. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
OWENS & MINOR, INC. |
|
|
|
|
Date: July 23, 2024 |
|
|
|
By: |
|
/s/ Heath H. Galloway |
|
|
|
|
Name: |
|
Heath H. Galloway |
|
|
|
|
Title: |
|
Executive Vice President, General Counsel & Corporate Secretary |
Exhibit 2.1
AGREEMENT AND PLAN OF MERGER
BY
AND AMONG
OWENS & MINOR, INC.,
HITCHCOCK MERGER SUB INC.,
ROTECH HEALTHCARE HOLDINGS INC.,
AND
SHAREHOLDER REPRESENTATIVE
SERVICES LLC, IN ITS CAPACITY AS THE REPRESENTATIVE,
DATED AS OF July 22, 2024
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page |
|
ARTICLE 1 DEFINITIONS |
|
|
1 |
|
1.1 |
|
Definitions |
|
|
1 |
|
1.2 |
|
Other Capitalized Terms |
|
|
20 |
|
1.3 |
|
Interpretive Provisions |
|
|
21 |
|
|
|
ARTICLE 2 THE MERGER |
|
|
22 |
|
2.1 |
|
The Merger |
|
|
22 |
|
2.2 |
|
Closing; Certificate of Merger |
|
|
22 |
|
2.3 |
|
Paying Agent |
|
|
23 |
|
2.4 |
|
Effect of the Merger |
|
|
23 |
|
2.5 |
|
Organizational Documents |
|
|
23 |
|
2.6 |
|
Directors and Officers |
|
|
23 |
|
2.7 |
|
Withholding Rights |
|
|
24 |
|
|
|
ARTICLE 3 CALCULATION OF MERGER CONSIDERATION; EFFECT ON CAPITAL STOCK; AND PAYMENT |
|
|
24 |
|
3.1 |
|
Calculation of the Closing Merger Consideration |
|
|
24 |
|
3.2 |
|
Effect on Capital Stock; Restricted Shares; Options; Restricted Stock Units |
|
|
25 |
|
3.3 |
|
Pre-Closing Deliveries |
|
|
26 |
|
3.4 |
|
Transactions to be Effected at the Closing |
|
|
27 |
|
3.5 |
|
Post-Closing Adjustment to Aggregate Closing Merger Consideration |
|
|
29 |
|
3.6 |
|
Final Adjustment Payment |
|
|
31 |
|
3.7 |
|
Dissenting Shares |
|
|
32 |
|
3.8 |
|
No Adverse Actions; Access |
|
|
32 |
|
3.9 |
|
Company Actions |
|
|
33 |
|
|
|
ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF THE COMPANY |
|
|
33 |
|
4.1 |
|
Organization and Qualification |
|
|
33 |
|
4.2 |
|
Capitalization of the Company |
|
|
34 |
|
4.3 |
|
Subsidiaries |
|
|
35 |
|
4.4 |
|
Authority; Binding Obligation |
|
|
36 |
|
4.5 |
|
No Defaults or Conflicts |
|
|
36 |
|
4.6 |
|
No Governmental Authorization Required |
|
|
37 |
|
4.7 |
|
Financial Statements |
|
|
37 |
|
4.8 |
|
Intellectual Property, Data Privacy, and Data Security |
|
|
38 |
|
4.9 |
|
Compliance with the Laws |
|
|
40 |
|
4.10 |
|
Contracts |
|
|
40 |
|
4.11 |
|
Litigation |
|
|
44 |
|
4.12 |
|
Taxes |
|
|
44 |
|
4.13 |
|
Permits |
|
|
46 |
|
4.14 |
|
Employee Benefit Plans |
|
|
47 |
|
ii
|
|
|
|
|
|
|
4.15 |
|
Labor Relations |
|
|
49 |
|
4.16 |
|
Environmental Compliance |
|
|
50 |
|
4.17 |
|
Insurance |
|
|
50 |
|
4.18 |
|
Real Property; Title to Assets |
|
|
50 |
|
4.19 |
|
Affiliate Transactions |
|
|
51 |
|
4.20 |
|
Absence of Certain Changes or Events |
|
|
52 |
|
4.21 |
|
Suppliers and Customers |
|
|
52 |
|
4.22 |
|
Healthcare Regulatory Matters |
|
|
52 |
|
4.23 |
|
FDA Regulatory Matters |
|
|
53 |
|
4.24 |
|
Brokers |
|
|
54 |
|
4.25 |
|
Exclusivity of Representations |
|
|
55 |
|
|
|
ARTICLE 5 REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB |
|
|
55 |
|
5.1 |
|
Organization |
|
|
55 |
|
5.2 |
|
Ownership of Merger Sub; No Prior Activities |
|
|
55 |
|
5.3 |
|
Authority; Binding Obligation |
|
|
56 |
|
5.4 |
|
No Defaults or Conflicts |
|
|
56 |
|
5.5 |
|
No Authorization or Consents Required |
|
|
56 |
|
5.6 |
|
Brokers |
|
|
56 |
|
5.7 |
|
Financing |
|
|
57 |
|
5.8 |
|
Litigation |
|
|
59 |
|
5.9 |
|
Solvency |
|
|
59 |
|
5.10 |
|
Parents Reliance |
|
|
59 |
|
5.11 |
|
Investment Purpose |
|
|
60 |
|
|
|
ARTICLE 6 COVENANTS |
|
|
60 |
|
6.1 |
|
Conduct of Business of the Company |
|
|
60 |
|
6.2 |
|
Access to Information; Confidentiality; Public Announcements |
|
|
64 |
|
6.3 |
|
Filings and Authorizations; Consummation |
|
|
65 |
|
6.4 |
|
Resignations |
|
|
67 |
|
6.5 |
|
Employee Matters |
|
|
67 |
|
6.6 |
|
Further Assurances |
|
|
68 |
|
6.7 |
|
Officer and Director Indemnification and Insurance |
|
|
68 |
|
6.8 |
|
Exclusivity |
|
|
70 |
|
6.9 |
|
FIRPTA Certificate |
|
|
70 |
|
6.10 |
|
Payoff Letters |
|
|
70 |
|
6.11 |
|
Written Consent |
|
|
71 |
|
6.12 |
|
Company Obligations in Respect of the Financing |
|
|
71 |
|
6.13 |
|
Parent Obligations in Respect of Financing |
|
|
75 |
|
6.14 |
|
Frustration of Closing Conditions |
|
|
77 |
|
6.15 |
|
280G |
|
|
77 |
|
6.16 |
|
Tax Matters |
|
|
78 |
|
6.17 |
|
R&W Insurance Policy |
|
|
79 |
|
6.18 |
|
Termination of Certain Agreements |
|
|
79 |
|
6.19 |
|
Termination of Derivative Contract |
|
|
80 |
|
iii
|
|
|
|
|
|
|
|
|
ARTICLE 7 CONDITIONS PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB |
|
|
80 |
|
7.1 |
|
Representations and Warranties |
|
|
80 |
|
7.2 |
|
Performance |
|
|
80 |
|
7.3 |
|
No MAE |
|
|
81 |
|
7.4 |
|
Officers Certificate |
|
|
81 |
|
7.5 |
|
Legal Prohibition |
|
|
81 |
|
7.6 |
|
HSR Act |
|
|
81 |
|
7.7 |
|
Healthcare Notification Laws |
|
|
81 |
|
|
|
ARTICLE 8 CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY |
|
|
81 |
|
8.1 |
|
Representations and Warranties |
|
|
81 |
|
8.2 |
|
Performance |
|
|
82 |
|
8.3 |
|
Officer Certificate |
|
|
82 |
|
8.4 |
|
Legal Prohibition |
|
|
82 |
|
8.5 |
|
HSR Act |
|
|
82 |
|
8.6 |
|
Healthcare Notification Laws |
|
|
82 |
|
|
|
ARTICLE 9 TERMINATION |
|
|
82 |
|
9.1 |
|
Termination |
|
|
82 |
|
9.2 |
|
Effect of Termination |
|
|
84 |
|
9.3 |
|
Reverse Termination Fee |
|
|
84 |
|
|
|
ARTICLE 10 MISCELLANEOUS |
|
|
86 |
|
10.1 |
|
No Survival |
|
|
86 |
|
10.2 |
|
Reserved |
|
|
86 |
|
10.3 |
|
Expenses |
|
|
86 |
|
10.4 |
|
Amendment |
|
|
86 |
|
10.5 |
|
Entire Agreement |
|
|
86 |
|
10.6 |
|
Headings |
|
|
86 |
|
10.7 |
|
Notices |
|
|
86 |
|
10.8 |
|
Exhibits and Schedules |
|
|
88 |
|
10.9 |
|
Waiver |
|
|
89 |
|
10.10 |
|
Binding Effect; Assignment |
|
|
89 |
|
10.11 |
|
No Third Party Beneficiary |
|
|
89 |
|
10.12 |
|
Counterparts |
|
|
89 |
|
10.13 |
|
Non-Recourse |
|
|
89 |
|
10.14 |
|
Release |
|
|
90 |
|
10.15 |
|
Governing Law and Jurisdiction |
|
|
90 |
|
10.16 |
|
Consent to Jurisdiction and Service of Process |
|
|
90 |
|
10.17 |
|
WAIVER OF JURY TRIAL |
|
|
91 |
|
10.18 |
|
Transfer Taxes |
|
|
91 |
|
10.19 |
|
Specific Performance |
|
|
91 |
|
10.20 |
|
Representative |
|
|
92 |
|
10.21 |
|
Waiver of Conflicts Regarding Representation |
|
|
94 |
|
10.22 |
|
Severability |
|
|
95 |
|
10.23 |
|
Financing Sources |
|
|
95 |
|
10.24 |
|
Currency |
|
|
96 |
|
10.25 |
|
Time of the Essence |
|
|
96 |
|
iv
EXHIBITS
|
|
|
Exhibit A |
|
Balance Sheet Rules |
Exhibit B |
|
Form of Escrow Agreement |
Exhibit C |
|
Form of Letter of Transmittal |
Exhibit D |
|
FIRPTA Certificate |
v
AGREEMENT AND PLAN OF MERGER
AGREEMENT AND PLAN OF MERGER (the Agreement), dated as of July 22, 2024, by and among Rotech Healthcare Holdings Inc., a
Delaware corporation (the Company), Shareholder Representative Services LLC, a Colorado limited liability company solely in its capacity as the representative of the Equityholders (the Representative),
Owens & Minor, Inc., a Virginia corporation (Parent), and Hitchcock Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of Parent (Merger Sub).
RECITALS
WHEREAS,
the Board of Directors of each of Parent, Merger Sub and the Company has approved and declared advisable to their respective stockholder(s), the merger of Merger Sub with and into the Company (the Merger), pursuant to which the
Company shall continue as the surviving corporation and as a wholly-owned subsidiary of Parent, upon the terms and subject to the conditions of this Agreement and in accordance with the General Corporation Law of the State of Delaware (the
DGCL);
WHEREAS, the Board of Directors of each of Parent and the Company has determined that the Merger is in
furtherance of and consistent with their respective business strategies and is in the best interest of their respective stockholder(s), and Parent has approved this Agreement and the Merger as the sole stockholder of Merger Sub; and
WHEREAS, promptly following the execution and delivery of this Agreement, the Company will deliver to Parent a true and correct copy of an
irrevocable written consent of the stockholders of the Company (including the Specified Stockholders (as defined below)) who collectively own a majority of the outstanding shares of Common Stock entitled to vote on the matter, adopting this
Agreement and approving and consenting to the Merger and the consummation of the transactions contemplated hereby (the Written Consent), in accordance with the DGCL and the Companys Organizational Documents, in each case as
in effect as of the date hereof.
NOW THEREFORE, in consideration of the foregoing and the respective representations, warranties,
covenants and agreements contained herein, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Parties agree as follows:
ARTICLE 1
DEFINITIONS
1.1 Definitions. The following terms, whenever used herein, shall have the following meanings for all purposes of this
Agreement.
1
Accounting Methodology means the accounting principles, methods and
practices utilized in preparing the Audited Financial Statements, applied on a consistent basis.
Action means any
action, claim, complaint, suit, arbitration, mediation or other proceeding, in each case before any Governmental Authority, whether civil, criminal, administrative or otherwise, in law or in equity.
Affiliate means, as to any Person, (a) any Person which directly or indirectly controls, is controlled by, or is under
common control with such Person, and (b) any Person who is a director, officer, partner or principal of such Person or of any Person which directly or indirectly controls, is controlled by, or is under common control with such Person. For
purposes of this definition, control of a Person shall mean the power, direct or indirect, to direct or cause the direction of the management and policies of such Person whether by ownership of voting stock, by contract or otherwise.
Affiliated Group means an affiliated group as defined in Section 1504 of the Code (or any analogous combined,
consolidated, unitary or similar group under state, local or non-U.S. Law).
Agents means, with respect to any Person, any director, officer, agent, employee, general partner, member, stockholder,
advisor or representative of such Person.
Antitrust Laws means the HSR Act, the Sherman Act, the Clayton Act, the
Federal Trade Commission Act, and any other United States federal or state or foreign Laws that are designed to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade.
Audited Balance Sheet has the meaning as set forth in the definition of Financial Statements.
Audited Financial Statements has the meaning as set forth in the definition of Financial Statements.
Balance Sheet Rules means, collectively, the Accounting Methodology and the rules set forth on Exhibit A attached
hereto; provided, that in the event of any conflict between the Accounting Methodology and the rules set forth on Exhibit A, the rules set forth on Exhibit A shall apply.
Bankruptcy Code means Title 11 of the United States Code entitled Bankruptcy, as now and hereafter in effect,
or any successor statute.
Business Day means any day that is not a Saturday, Sunday or other day on which banking
institutions in New York, New York are authorized or required by Law or executive order to close.
2
Cash and Cash Equivalents means, with respect to any Person as of any
time, the aggregate amount of such Persons cash and cash equivalents (including marketable securities, bank deposits, and short term investments, in each case, to the extent convertible to cash within ninety (90) days) as of such time,
including the amounts of any received but uncleared checks and drafts and wires issued to a member of the Company Group prior to such time and deposits in transit, net of issued but uncleared checks or transfers as of such time. Cash and
Cash Equivalents shall also include (a) any accrued interest on any Cash and Cash Equivalents, and (b) amounts paid, if any, by any member of the Company Group in connection with the purchase of any tail policies pursuant
to Section 6.7. Notwithstanding anything to the contrary herein, Cash and Cash Equivalents shall not include any deposits or other cash collateral held by non-bank third parties or
Restricted Cash.
Closing Date Cash means all Cash and Cash Equivalents of the Company Group existing as of the
Reference Time, giving effect to any cash dividends, distributions or any other payments of any kind in respect of any capital stock of the Company and uses of cash to pay Indebtedness or Company Expenses, in each case, after the Reference Time and
prior to the Closing, determined in accordance with the Balance Sheet Rules and without giving effect to the transactions contemplated by this Agreement.
Closing Date Indebtedness means all Indebtedness of the Company Group existing as of immediately prior to the Closing,
determined in accordance with the Balance Sheet Rules and without giving effect to the transactions contemplated by this Agreement.
Closing Working Capital means the Working Capital as of the Reference Time without giving effect to the transactions
contemplated by this Agreement.
Code means the Internal Revenue Code of 1986.
Common Stock means the common stock of the Company, $0.001 par value.
Company Expenses means, without duplication and solely to the extent that the following obligations have been incurred on
or prior to the Closing Date and remain unpaid immediately prior to the Closing, the aggregate amount due and payable by the Company or a Company Subsidiary for (a) third-party, out of pocket costs and expenses incurred by or on behalf of the
Company or any Company Subsidiary (solely to the extent, in each case, such amounts are a liability of and are due and payable by the Company or a Company Subsidiary) in connection with the transactions contemplated by this Agreement, including
legal, accounting, financial advisory, and other advisory, transaction or consulting fees and expenses; (b) any transaction-related bonuses, severance, retention awards, change in control payments, incentive or deferred compensation payments,
or other similar payments or obligations to any current or former director, manager, officer or employee of, or consultant or independent contractor to the Company or a Company Subsidiary payable solely in connection with the consummation of the
transactions contemplated by this Agreement (including in combination with any other event, together with the employer portion of any applicable FICA, state, local or foreign withholding, payroll, employment, social security, unemployment or similar
Taxes due with respect to
3
any such payments and calculated as if all such amounts were paid on the Closing Date, but excluding (i) any regular performance or discretionary bonuses and (ii) any
transaction-related bonuses, severance, retention awards, change in control payments, incentive or deferred compensation payments or other similar payments or obligations resulting from the termination of employment of any recipient arising, in each
case, at or after Closing or due to any other action taken at the direction, or with the approval, of Parent or any of its Affiliates) and (c) the employer portion of any applicable FICA, state, local or foreign withholding, payroll,
employment, social security, unemployment or similar Taxes associated with the payments to the holders of Equity Awards contemplated by this Agreement, calculated as if all such amounts were paid on the Closing Date. Notwithstanding anything to the
contrary contained herein, in no event shall Company Expenses include (i) any costs, fees or expenses related to the purchase of the tail policy pursuant to Section 6.7(b), (ii) HSR Act filing
fees or any other filing or similar fees in respect of any other Antitrust Laws, (iii) Transfer Taxes, recording fees and other similar Taxes, (iv) any fees of the Escrow Agent and the Paying Agent, and (v) any amounts to the extent
taken into account in the calculation of Closing Date Indebtedness or Closing Working Capital.
Company Fundamental
Representations means the representations and warranties of the Company contained in Section 4.1(a) (Organization and Qualification), Section 4.2 (Capitalization of the Company),
Section 4.4 (Authority; Binding Obligation), Section 4.20(b) (Absence of Certain Changes or Events) and Section 4.24 (Brokers).
Company Group means the Company and the Company Subsidiaries.
Company IT Systems means all Information Systems owned or used by or on behalf of the Company Group.
Company Owned Intellectual Property means any Intellectual Property owned or purported to be owned by any member of the
Company Group, including the Registered Intellectual Property.
Company Products means any product manufactured,
distributed, sold, or offered for sale by the Company or any Company Subsidiary.
Contract means any legally binding
contract, agreement, license, sublicense, lease, sublease, conditional sales contract, mortgage, sales or purchase order, commitment, arrangement, undertaking or understanding.
Credit Facilities means the Third Amended and Restated Credit Agreement, dated as of March 31, 2022, by and among
Rotech Healthcare Inc., Rotech Intermediate Holdings LLC, the other guarantors named therein, the lenders named therein and Truist Bank.
Credit Facilities Payoff Amount means the amount of outstanding principal and accrued but unpaid interest, fees and other
amounts payable (including any prepayment penalties, if any) as of the close of business on the Closing Date under the Credit Facilities.
4
Current Assets means, as of any date, the consolidated current assets of
the Company Group determined in accordance with the Balance Sheet Rules. Current Assets shall exclude any assets with respect to Cash and Cash Equivalents, Income Tax assets and deferred non-Income Tax assets.
Current Liabilities means, as of any date, the consolidated current liabilities of the Company Group determined in
accordance with the Balance Sheet Rules. Current Liabilities shall exclude any liabilities with respect to Indebtedness, Company Expenses, Income Tax liabilities and deferred non-Income Tax liabilities.
date hereof and date of this Agreement means the date first written above.
Debt Commitment Letter means the debt commitment letter, addressed to Parent, from the Debt Financing Sources, dated as of
the date hereof (together with all exhibits, schedules and annexes attached thereto).
Debt Financing Related Parties
means the Debt Financing Sources, their respective Affiliates, and their successors and permitted assigns.
Debt Financing
Sources has the meaning set forth in Section 5.7(a) hereof.
Emergency means any
(a) natural disaster (including any epidemic, pandemic or disease outbreak, act of God, casualty, earthquake, storm, hurricane, tornado, severe weather, fire, accident, flood or other natural or man-made
catastrophe), or (b) outbreak, escalation or worsening of hostilities, war (whether or not declared), military actions, acts of terrorism, political instability or other national or international calamity, crisis or emergency.
Emergency Measures means (a) any quarantine, shelter in place, stay at home, workforce
reduction, social distancing, shut down, closure, sequester, safety or similar Law, directive, guidelines or recommendations promulgated by any Governmental Authority, including the Centers for Disease Control and Prevention and the World Health
Organization, in each case, in connection with or in response to an Emergency and any other Emergency relief measure adopted by any Governmental Authority and (b) the taking of or failing to take any action, whether proactive or reactive,
reasonably in response to an Emergency or any of the measures described in the foregoing clause (a), including (i) the establishment of any policy, procedure or protocol in response to an Emergency and (ii) any action or omission intended
to protect the health and safety of the business employees and other individuals having business dealings with the business.
Encumbrance means any and all liens, charges, mortgages, options, pledges, restrictions on transfer, security interests,
hypothecations, easements, rights-of-way or other restrictions or encumbrances of any kind.
5
Environment means any environmental medium or natural resource, including
ambient air, indoor air, surface water, groundwater, drinking water, sediment, surface and subsurface strata.
Environmental
Claims means any written claims, notice of noncompliance or violation or other written notice, orders and legal proceedings by any Governmental Authority or other Person alleging any actual or potential violation of or liability arising
under any Environmental Law.
Environmental Laws means any Law relating to public or worker health or safety (with
respect to Hazardous Substances), pollution or protection of the Environment, including any Law relating to the use, transportation, storage, disposal, release or threatened release of any Hazardous Substance.
Equity Awards means the Options, the Restricted Shares and the Restricted Stock Units.
Equity Incentive Plan means the Rotech Healthcare Holdings Inc. 2022 Equity Incentive Plan, as amended and in effect as of
the date of this Agreement.
Equityholders means, collectively, the Stockholders, the Optionholders and the RSU
Holders.
ERISA means the Employee Retirement Income Security Act of 1974.
ERISA Affiliate means any Person that, together with the Company or any of the Companys Subsidiaries, is (or at any
relevant time has been or would be) treated as a single employer under Section 414 of the Code.
Escrow Agent
means Citibank N.A.
Escrow Agreement means the escrow agreement in substantially the form attached hereto as
Exhibit B.
Excluded Benefits has the meaning set forth in Section 6.5(a) hereof.
Excluded Information means (a) any description of post-Closing capital structure, including descriptions of
indebtedness or equity or ownership of Parent or any of its affiliates (including the Company and its Subsidiaries on or after the Closing Date), (b) any description of the Debt Financing (including any such descriptions to be included in liquidity
and capital resources disclosure and any description of notes) or any information customarily provided by a lead arranger, underwriter or initial purchaser in a customary information memorandum or offering memorandum for a secured bank
financing or high yield debt securities issued pursuant to Rule 144A promulgated under the Securities Act, as applicable, including sections customarily drafted by a lead arranger or an initial purchaser or underwriter, such as those regarding
confidentiality, timelines, syndication process, limitations of liability and plan of distribution, (c) any information regarding any post-Closing or pro forma cost savings, synergies or other pro forma
6
adjustments or any pro forma or projected information or pro forma financial statements, (d) risk factors relating to all or any component of the Debt Financing, (e) financial
statements or information required by Rule 3-09, 3-10 or 3-16, 13-01 or 13-02 of Regulation S-X, any compensation discussion and analysis or other information required by Item 402 and Item 601 of Regulation
S-K under the Securities Act, XBRL exhibits or any information regarding executive compensation or related persons related to SEC Release Nos. 33-8732A, 34-54302A and IC-27444A, (f) separate subsidiary financial statements, (g) projections, (h) segment financial information, (i) any information or
materials that relate to the proposed sale of the business of the Company or the negotiation, execution and delivery of this Agreement and (j) other information customarily excluded from an offering memorandum for private placements of non-convertible high-yield debt securities under Rule 144A promulgated under the Securities Act.
FDA means the U.S. Food and Drug Administration.
FDA Regulatory Laws means any Laws governing the design, development, testing, manufacture, labeling, promotion, sale,
holding, or distribution of any Company Products that apply to the Company or any Company Subsidiary, including requirements for establishment registration and product listing, compliance with current good manufacturing practices, and procedures
governing complaint handling and recalls; including the Federal Food, Drug, and Cosmetic Act (21 U.S.C. §§ 301 et. seq.), and its implementing regulations, and all equivalent or similar Laws in any jurisdiction applicable to the Company or
any Company Subsidiary.
Financial Statements means (a) the
audited consolidated balance sheet of Rotech Healthcare Inc. and its consolidated Subsidiaries (the Audited Balance Sheet), and the related consolidated statements of operations, changes in stockholders equity and cash flows
of Rotech Healthcare Inc. and its consolidated Subsidiaries for the year ended December 31, 2021, December 31, 2022 and December 31, 2023, together with the notes and schedules thereto (the Audited Financial
Statements), and (b) the unaudited consolidated balance sheet of Rotech Healthcare Inc. and its consolidated Subsidiaries as of March 31, 2024 (the Interim Balance Sheet) and the related consolidated statements
of income, changes in stockholders equity and cash flows of Rotech Healthcare Inc. and its consolidated Subsidiaries for the three months then ended, prepared in accordance with GAAP applied on a basis consistent with the Audited Financial
Statements (the Unaudited Financial Statements).
Fraud means actual and intentional common law
fraud under Delaware law (which, for the avoidance of doubt, shall not include any fraud based on constructive knowledge, or negligent or reckless misrepresentation) committed by a Party to this Agreement in making the representations and warranties
set forth in Article 4 or Article 5 of this Agreement or any certificate delivered pursuant hereto; provided, that, for the avoidance of doubt, a claim of Fraud hereunder may be asserted
only against the Party to this Agreement committing such actual and intentional fraud.
7
Fully Diluted Shares means, as of the time of determination, the sum of
(a) the aggregate number of shares of Common Stock outstanding as of such time, plus (b) the aggregate number of shares of Common Stock into which the
In-the-Money Options are exercisable as of such time, plus (c) the aggregate number of shares of Common Stock subject to Restricted Stock Units that are
vested and unsettled as of such time (including, for purposes of any determination at the Effective Time, any such Restricted Stock Units that vest automatically pursuant to its terms upon the Closing).
GAAP means United States generally accepted accounting principles, as consistently applied by the Company and its
Subsidiaries.
Government Contract means any Contract between the Company or one of its Subsidiaries, on the one hand,
and (a) a Governmental Authority, or (b) any prime contractor of a Governmental Authority that, to the knowledge of the Company, is acting in its capacity as a prime contractor; provided, that, other than for purposes of
Section 4.10(m), a task, purchase, work or delivery order under a Government Contract shall not constitute a separate Government Contract, for purposes of this definition, but shall be part of the Government Contract to
which it relates.
Governmental Authority means any nation or government, any federal, state, province, or other
political subdivision thereof, exercising executive, legislative, judicial, regulatory, taxing or administration functions of or pertaining to government, or any government authority, commission or instrumentality of any jurisdiction, including the
United States of America, any foreign government, any state of the United States of America, or any municipality or other political subdivision thereof, and any court, tribunal or other body of competent jurisdiction.
Governmental Health Program means any federal health program as defined in 42 U.S.C. §
1320a-7b(f), including Medicare, Medicaid, TRICARE, CHAMPVA, and state health care programs (as defined therein), and any health insurance program for the benefit of federal employees, including those under
chapter 89 of title 5, United States Code.
Hazardous Substance means petroleum and petroleum byproducts, asbestos, per- and polyfluoroalkyl substances, radiation, polychlorinated biphenyls and mold and any substance, material or waste defined by or regulated under, or for which liability or standards of conduct may be imposed
pursuant to, Environmental Laws, including the Comprehensive Environmental Response, Compensation and Liability Act, 42 U.S.C. §9601 et seq., the Resource Conservation and Recovery Act, 42 U.S.C. §6901 et seq., the Clean Water
Act, 33 U.S.C. §1251 et seq., the Clean Air Act, 42 U.S.C. §7401 et seq., the Toxic Substances Control Act, 15 U.S.C. §2601 et seq., the Safe Drinking Water Act, 42 U.S.C. §300f et seq., the Hazardous
Materials Transportation Act, 49 U.S.C. §1801 et seq., the Emergency Planning and Community Right to Know Act, 42 U.S.C. §11001 et seq., the Oil Pollution Act, 33 U.S.C. §2701 et seq., and any state or local equivalents
thereof.
8
Healthcare Laws means any healthcare Law of any Governmental Authority,
Governmental Health Program, or Payor applicable to the design, manufacture, marketing, sale or reimbursement of the healthcare products or services offered by the Company Group, including: (a) Medicare (Title XVIII of the Social Security Act),
including, the Ethics in Patient Referrals Act, 42 U.S.C. § 1395nn, Medicaid (Title XIX of the Social Security Act), and any other foreign, federal or state governmental healthcare programs; (b) all Laws related to healthcare fraud and
abuse, false claims and kickbacks, including the Federal False Claims Act (31 U.S.C. §§ 3729 3733), the Federal Anti-Kickback Statute (42 U.S.C. §1320a 7b); the Federal physician self-referral law
(42 U.S.C. § 1395nn); the Federal Civil Monetary Penalties Law (42 U.S.C. §1320a-7a), the Federal Program Fraud Civil Remedies Act (31 U.S.C. § 3801 et seq.), the Travel Act (18
U.S.C. § 1952) and the Federal Health Care Fraud Law (18 U.S.C. § 1347); (c) the Physician Payment Sunshine Act (42 U.S.C. § 1320a-7h); (d) the Deficit Reduction Act of 2005; (e) the Exclusion
Laws (42 U.S.C. § 1320a-7); (f) Laws governing the privacy, security, transmission or protection of health care information belonging to individuals or entities, including HIPAA; (g) the Patient
Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010; and (h) all other Laws that regulate the design, manufacture, marketing, sale, or reimbursement of medical devices, and durable medical equipment.
Healthcare Notification Laws means any Law that requires any Party or their respective Affiliates to notify, or obtain
the consent of, a Governmental Authority with respect to the transactions contemplated by this Agreement, by reason of the fact, in whole or in part, that any Party or their respective Affiliates provide, bill or receive payment for healthcare
products or services related thereto.
HIPAA means the following: (a) the Health Insurance Portability and
Accountability Act of 1996; (b) the Health Information Technology for Economic and Clinical Health Act (Title XIII of the American Recovery and Reinvestment Act of 2009); and (c) applicable state Laws regarding patient privacy and the security,
use or disclosure of health care records.
HSR Act means the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
Income Tax means Taxes imposed on, or determined by reference to, (a) net income or profits or gross receipts, or
(b) multiple bases (including, but not limited to, corporate franchise, doing business, or occupation taxes) if one or more of the bases upon which such tax may be based, by which it may be measured, or with respect to which it may be
calculated is described in clause (a) of this definition.
Income Tax Amount means any unpaid Income Taxes arising in respect of the Pre-Closing Tax Period (or portion thereof) ending on the Closing Date or the immediately prior Pre-Closing Tax Period (but with respect to an immediately prior Pre-Closing Tax Period and an Income Tax, only if (x) the final Tax Return for such immediately prior Pre-Closing Tax Period and Income Tax has not yet been filed as of the Closing Date, or (y) the final Tax Return for such immediately prior Pre-Closing Tax Period and
Income Tax has been filed as of the Closing Date but amounts reflected as due and owing on such Tax Return remain unpaid), from all jurisdictions in which there is a liability for Income Taxes (which amount shall equal the sum of such amounts
separately calculated for each jurisdiction, Income Tax, and tax period, and shall not be less than zero
9
for any Income Tax or in any such jurisdiction or tax period, and which shall not include any offsets or reductions with respect to Income Tax refunds or overpayments of Income Tax (except to the
extent that such refunds or overpayments of Income Tax may actually be utilized in the applicable jurisdiction in the applicable Pre-Closing Tax Period to reduce (but not below zero) amounts that would
otherwise be unpaid Income Taxes with respect to such jurisdiction and tax period)) determined by (a) applying the applicable member of the Company Groups historic (i) Income Tax return filing practices, including the jurisdictions
in which the Company Group files (and, if a member of the Company Group began operations in a jurisdiction on or after January 1, 2023 in a fashion that created nexus for an Income Tax in such jurisdiction at a more likely than not
(or higher) level of confidence, including such jurisdiction for such Income Tax), (ii) applicable elections and (iii) accounting methods, except in each case to the extent that such filing practice, elections or accounting methods are not
supported at a more likely than not (or higher) level of confidence, (b) ignoring, for the avoidance of doubt, any Income Taxes attributable to transactions taken at the direction of Parent, not contemplated by this Agreement, and
occurring outside the ordinary course of business on the Closing Date after the Closing, (c) taking into account (but not below zero) in the Pre-Closing Tax Period all Transaction Tax Deductions that are
properly allocable to the Pre-Closing Tax Period at a more likely than not (or higher) level of confidence and (d) assuming that the Company Group makes an election pursuant to
Section 7.03(3)(d) of Rev. Proc. 2015-13 to apply a one-year adjustment period with respect to that certain Form 3115 filed by the Company Group in January 2024
described on Schedule 4.12(f).
Indebtedness means, of any
Person, without duplication, (a) indebtedness for borrowed money, (b) obligations for deferred purchase price for the acquisition of a business, property, assets, securities or services including all seller notes, indemnities, purchase
price adjustments, or earn-out payments, other than as set forth on Schedule 1.1(a), (c) indebtedness evidenced by any note, bond, debenture, mortgage or other debt instrument or debt
security, (d) obligations under any performance bond or letter of credit, but only to the extent drawn or called as of the Reference Time, (e) all financing lease obligations as determined under GAAP (for the avoidance of doubt, such
obligations shall include any outstanding obligations for payments owed to patient equipment vendors finance companies (e.g., Phillips Medical Capital) but shall exclude any trade payables payable to any patient equipment vendor), (f) any
outstanding and unpaid severance or retention obligations, or any deferred compensation obligations (other than any deferred compensation that may be payable in shares of Common Stock as of immediately prior to the Closing), in each case, as of
immediately prior to the Closing in respect of any current or former employee or other individual service provider of the Company or any Company Subsidiary, together with the employer portion of any applicable payroll Taxes due with respect to any
such payments and calculated as if all such amounts were paid on the Closing Date (excluding, for the avoidance of doubt, any unpaid severance or retention obligations incurred at the direction, or with the approval, of Parent or any of its
Affiliates), (g) all obligations under any interest rate or currency swaps, collars, caps, hedges or similar protection or hedging agreements, (h) guarantees with respect to any indebtedness of any other Person of a type described in
clauses (a) through (g) above, (i) the Credit Facilities, (j) for clauses (a) through (i) above, all accrued interest thereon, if any, and any termination fees associated with the repayment of such Indebtedness on the
Closing Date to the extent
10
paid on the Closing Date, (k) the Income Tax Amount and (l) the purchase price for any acquisition contemplated by Section 6.1(l) for which the consummation of
such acquisition has not occurred as of immediately prior to the Closing (for the avoidance of doubt, the foregoing shall not include any such acquisitions which have closed or been consummated prior to the Closing). For the avoidance of doubt,
Indebtedness shall not include (i) any Indebtedness included in the determination of Closing Working Capital, (ii) any intercompany Indebtedness between the Company and the Company Subsidiaries, (iii) any Indebtedness incurred by
Parent and its Affiliates (and subsequently assumed by the Company or any Company Subsidiary), (iv) any endorsement of negotiable instruments for collection in the ordinary course of business, (v) any deferred revenue (but shall, for the
avoidance of doubt, include Taxes on deferred revenue to the extent such Taxes are included in Income Tax Amount), (vi) any trade payables or accrued expenses arising in the ordinary course of the business, (vii) all liabilities under any
agreement between the Company or any Company Subsidiary, on the one hand, and Parent or any of its Affiliates, on the other hand, and (viii) any amounts included as Company Expenses.
Information Systems means computer systems, servers, workstations, routers, hubs, switches, data communications
networks (other than the Internet) and other information technology equipment.
Intellectual Property means all of the
following, in any jurisdiction throughout the world: (a) patents, patent applications and any reissue, continuation, continuation-in-part, divisional, or extension
thereof; (b) trademarks and service marks, trade names, logos, social media accounts and handles, and other indicia of source or origin (together with the goodwill associated therewith); (c) URLs and Internet domain names, (d) works of
authorship, copyrights and copyrightable works; (e) rights in software, databases and data collections, (f) industrial designs, inventions, proprietary know-how, confidential business information,
business methods, electronic databases and trade secrets; and (g) all other intellectual property or proprietary rights, and any applications or registrations for the foregoing.
Interim Balance Sheet shall have the meaning as set forth in the definition of Financial Statements.
IRS means the United States Internal Revenue Service.
knowledge of the Company or any similar phrase means, as of the applicable date, the actual knowledge without independent
investigation (and in no event shall encompass constructive, imputed or similar concepts of knowledge) of Robin Menchen, Dan Phan, Steve Burres and Joni Moss, and in each case, assuming due inquiry of his or her direct reports (none of whom shall
have, for avoidance of doubt, any personal liability or obligations regarding such knowledge).
Law(s) shall mean any
law (including common law), statute, regulation, act, code, ordinance, policy, rule, judgement, order, injunction, ruling, award, directive, decree, writ or other requirement of any Governmental Authority.
11
Lease has the meaning set forth in
Section 4.18(b) hereof.
Marketing Period means the first period of fifteen
(15) consecutive Business Days commencing on the date Parent shall have received the Required Information and at the end of which nothing has occurred and no condition exists that would cause any of the conditions set forth in
Article 7 to fail to be satisfied, assuming the Closing were to be scheduled at the end of such fifteen (15) Business Day period; provided, that under no circumstance will the Marketing Period commence before
November 12, 2024, provided, further, that (i) the Marketing Period shall not be required to be consecutive to the extent it would include November 28, 2024, November 29, 2024, January 20, 2025, February 17,
2025, May 26, 2025 and June 19, 2025 (any such day to be excluded for purposes of, but shall not reset, the Marketing Period), (ii) if the Marketing Period has not ended on or prior to December 23, 2024, the Marketing Period will not
commence earlier than January 2, 2025, (iii) if the Marketing Period has not ended on or prior to February 11, 2025, such Marketing Period will not commence prior to (A) the delivery of the audited financial statements of the Company
and its subsidiaries for the fiscal year ended December 31, 2024 required to be delivered pursuant to paragraph 9 of Exhibit D to the Commitment Letter and (B) 10 days after the delivery by the Company of the relevant Required Information
regarding the Company and its subsidiaries necessary to assist Parent in preparing related pro forma financial statements required to be delivered pursuant to paragraph 11 of Exhibit D to the Commitment Letter, (iv) the Marketing Period shall
be deemed to have been complied with and automatically end on any earlier date on which the Debt Financing is consummated or the applicable proceeds have been deposited into escrow and Parent shall have obtained the net proceeds contemplated by the
Debt Financing (it being understood that any such net proceeds deposited into escrow shall be deemed to have been obtained by Parent) and (v) the Marketing Period shall be deemed not to have commenced if, after the date of this Agreement and
prior to the completion of such 15 consecutive Business Day period, (A) the Companys auditor shall have withdrawn its audit opinion with respect to any annual audited financial statements constituting Required Information, in which case
the Marketing Period shall not commence unless and until a new unqualified audit opinion is issued with respect to such financial statements (or portion thereof) for the applicable periods by such auditor or another independent public accounting
firm of recognized national standing, (B) the Company shall have announced, or the board of directors of the Company shall have determined, that a restatement of any historical financial information constituting Required Information is
required, in which case the Marketing Period shall be deemed not to commence unless and until such restatement has been completed and the Required Information has been amended to reflect such restatement or the Company subsequently determines in
writing or issues a public statement that no restatement is required in accordance with GAAP or (C) in the case of a Debt Financing involving the issuance of debt securities, the financial statements and other financial information included in
such Required Information are, throughout the Marketing Period, not sufficient to permit the Companys independent auditors to issue a customary comfort letter to the Debt Financing Sources (including placement agents or initial purchasers) on
the historical financial statements and historical financial information of the Company Group contained in offering documents pertaining to the Debt Financing, including as to customary negative assurances and change period, in order to consummate
any offering of non-convertible, high yield debt securities throughout the Marketing Period
12
(it being understood that such issuance of the comfort letter shall not occur until the pricing of such debt securities), in which case the Marketing Period shall be deemed not to
commence unless and until such Required Information is updated or supplemented to permit the issuance of such comfort letter. If at any time the Company shall in good faith believe that it has provided the Required Information, the Company may
deliver to Parent a written notice to that effect (stating when it believes it completed delivery of the Required Information ), in which case, subject to clauses (A), (B) and (C) above, the Marketing Period will be deemed to have commenced on
the date of such notice, unless Parent in good faith reasonably believes the Required Information has not been provided and, within two (2) Business Days after the delivery of such notice by the Company, delivers a written notice to the Company
to that effect (stating with specificity why Parent believes the Required Information has not been provided) and, following delivery of such Required Information specified in such notice, the Marketing Period will commence (provided that, it is
understood that the delivery of such written notice from the Parent or the Companys failure to deliver a notice that the Company delivered the Required Information, in each case, will not prejudice the Companys right to assert that the
Required Information has been delivered). For the avoidance of doubt, after the initial commencement of the Marketing Period, the required delivery of any Required Information in accordance with paragraphs 9 (solely with respect to the Company) and
11 of Exhibit D to the Commitment Letter for any fiscal period shall result in the restart of the Marketing Period, notwithstanding that a period of fifteen (15) consecutive Business Days shall have passed throughout which Parent
has had what would otherwise have constituted the Required Information throughout such period (were the Closing to have occurred prior to such required delivery of financial information for such subsequent period).
Material Adverse Effect means any change, event, circumstance, effect, development, condition, fact or occurrence (each, an
Effect) which, individually or together with any other Effects, has had, or would reasonably be expected to have, a material adverse effect on the business, assets, liabilities, results of operations or condition (financial or
otherwise) of the Company Group, taken as a whole; provided, however, that none of the following, nor any Effect resulting from or arising out of any of the following, either alone or in combination, shall be deemed to constitute, or
be taken into account in determining whether a Material Adverse Effect has occurred or would reasonably be expected to occur: (a) Effects that generally affect the industries or segments in which the Company or the Company
Subsidiaries operate (including legal and regulatory changes); (b) Effects arising from any national, international or any foreign or domestic regional economic, financial, social or political conditions (including changes therein) or events in
general, including the results of any primary or general elections, or any statements or other proclamations of public officials, or changes in policy related thereto; (c) Effects affecting financial, credit or capital markets in the United
States or in any other country or region in the world, including changes in interest rates or foreign exchange rates; (d) Effects relating to any Emergency or any Emergency Measures or any change in Emergency Measures following the date of this
Agreement or any material worsening of such conditions threatened or existing as of the date of this Agreement; (e) Effects arising from changes in Laws or accounting principles (including, for the avoidance of doubt, GAAP) or the
interpretation or enforcement thereof, in each case, occurring after the date hereof; (f) Effects relating to the announcement of the execution of this Agreement or the
13
transactions contemplated hereby or the Parties hereto, including any impact on the relationships after the date hereof with any customer, supplier, landlord, partner, employee or other business
relationship (it being understood that the exception described in this clause (f) shall not apply with respect to any representations and warranties (in whole or relevant part) made by the Company in this Agreement, the purpose of which is to
address the consequence resulting from, relating to or arising out of the execution of this Agreement or any Ancillary Document to which the Company is a party, the consummation of the transactions contemplated hereby or any conditions to Closing
related to such representations and warranties); (g) Effects resulting from compliance with the express terms and conditions of this Agreement by the Equityholders, the Representative, the Company or the Company Subsidiaries or any actions by
the Equityholders, the Representative, the Company or the Company Subsidiaries expressly consented to or requested in writing by Parent; (h) the failure of the Company to meet any internal or industry business plans, estimates, expectations,
forecasts, projections or budgets for any period (but, in each case, the Effects underlying such failure, to the extent such Effects are not otherwise expressly excluded in this definition, may be taken into account for the purposes of determining
whether a Material Adverse Effect has occurred or would reasonably be expected to occur and shall not be excluded pursuant to this clause (h)); (i) any action taken by Parent, Merger Sub or any of their respective Affiliates or Agents
(including, for the avoidance of doubt, any breach of this Agreement or any other agreements entered into in connection with the transactions contemplated hereby) or (j) Effects arising or resulting from the matters set forth on Schedule
1.1(b); provided, that Material Adverse Effect shall include any Effects arising out of or attributable to the matters described in clauses (a) through (e) above to the extent the Company Group, taken as a whole, is
disproportionately affected relative to other participants in the industries in which the Company Group, taken as a whole, operates. For the avoidance of doubt, a Material Adverse Effect shall be measured only against past performance of the Company
Group, taken as a whole, and not against forward-looking statements, budgets, pro forma amounts, financial projections or forecasts of the Company Group.
Open Source Software means any software that is licensed pursuant to a license (i) that is, or is substantially
similar to, a license approved by the Open Source Initiative and listed at http://www.opensource.org/licenses/alphabetical, or (ii) under which such software or other materials are distributed or licensed as free software,
open source software or under similar terms or models.
Option means each outstanding option to purchase
Common Stock, granted under the Equity Incentive Plan.
Option Exercise Amount means the aggregate exercise price due
in respect of all the vested In-the-Money Options (assuming, for the avoidance of doubt, payment of the exercise price for each such vested In-the-Money Option in cash and not by way of net exercise or other cashless exercise feature).
Optionholder means a holder of one or more Options.
14
Organizational Documents means: (a) the articles or certificate of
incorporation and the bylaws of a corporation; (b) the partnership agreement and any statement of partnership of a general partnership; (c) the limited partnership agreement and the certificate of limited partnership of a limited
partnership; (d) the articles or certificate of formation and limited liability company agreement of a limited liability company; and/or (e) any charter or similar document adopted or filed in connection with the creation, formation, or
organization of a Person.
Parent Fundamental Representations means the representations and warranties of Parent
contained in Section 5.1 (Organization), Section 5.3 (Binding Obligation) and Section 5.6 (Brokers).
Party or Parties means the Company, the Representative, Merger Sub and Parent.
Payment Schedule means the schedule described in Section 3.3, which shall be initially prepared and delivered
to Parent by the Company. The Payment Schedule shall be updated from time to time after Closing (in connection with future distributions of funds) by the Representative (with the cooperation of Parent and the Company as reasonably
requested) to reflect the allocation and distribution of any amounts payable to, or any liabilities or obligations of, the Stockholders, the Optionholders and the RSU Holders. Such allocation and distribution shall be determined by the
Representative in good faith and in accordance with the Companys Organizational Documents and the Equity Incentive Plan, as applicable. For the avoidance of doubt, the allocation and distribution to the Common Stock, the Options and the
Restricted Stock Units may vary depending on the designation and participation threshold of the Common Stock in the Companys Organizational Documents or the exercise prices of the applicable Equity Awards. Any determination of the Payment
Schedule by the Representative shall be final and binding on all Stockholders, Optionholders and RSU Holders absent fraud or manifest error.
Payoff Letter means one or more payoff letters in customary form received from Truist Bank specifying the
aggregate amount of the Company Groups obligations (including unpaid principal, accrued and unpaid interest, prepayment penalties, breakage costs and premiums in connection with the repayment thereof) that will be outstanding as of the Closing
under the Credit Facilities to be repaid at Closing pursuant to the terms of this Agreement and which will include customary lien and security interest releases.
Payor means any Governmental Health Program and all other health care service plans, health maintenance organizations,
health insurers and/or other private, commercial, or governmental third-party payors.
Per Share Amount means an amount
equal to (a) the Aggregate Closing Merger Consideration plus the Option Exercise Amount, divided by (b) the number of Fully Diluted Shares as of the Closing Date.
15
Permitted Encumbrances means (a) Encumbrances securing the
obligations of the Company and Company Subsidiaries under the Credit Facilities; (b) Encumbrances disclosed in the Audited Financial Statements or any schedules to this Agreement; (c) Encumbrances for taxes, assessments and other
government charges not yet due and payable or which are being contested in good faith by appropriate proceedings and for which appropriate reserves have been established in accordance with GAAP; (d) mechanics, workmens,
repairmens, warehousemens, carriers or other like Encumbrances incurred in the ordinary course of business for amounts which are not yet due and payable or which are being contested in good faith by appropriate proceedings for
which appropriate reserves have been established in accordance with GAAP; (e) Encumbrances relating to the transferability of securities under applicable securities Laws; (f) Encumbrances securing rental payments under capitalized leases;
(g) with respect to real property leased or subleased by the Company or any of the Company Subsidiaries (as lessee or sublessee), (i) Encumbrances in favor of the lessors or sublessors under the leases or subleases thereof and (ii) any
right, title or interest of a lessor or sublessor under any of the leases or subleases thereof; (h) with respect to any real property, (i) easements, covenants, conditions, restrictions and other
non-monetary matters or records affecting title to such real property which do not or would not reasonably be expected to materially impair the use or occupancy of such real property in the operation of the
business currently conducted thereon and (ii) Encumbrances imposed or promulgated by Laws with respect to such real property and improvements, including zoning, entitlement, building and other land use regulations and codes regulating the use
or occupancy of such real property or the activities conducted thereon which are imposed by any Governmental Authority having jurisdiction over such real property which are not violated in any material respect by the current use or occupancy of such
real property or the operation of the business conducted thereon; (i) non-exclusive licenses of Intellectual Property rights granted in the ordinary course of business; and (j) the Encumbrances set
forth on Schedule 1.1(c).
Person means any individual, corporation (including any not for
profit corporation), general or limited partnership, limited liability partnership, joint venture, estate, trust, firm, company (including any limited liability company or joint stock company), association, organization, entity or Governmental
Authority.
Personal Data means any information defined as personal data, personally identifying
information, personal information, or similar term by any applicable Privacy Law.
Post-Closing
Payment means any payment made from time to time following the Closing Date to a Stockholder, Optionholder or RSU Holder, in their capacities as such, including pursuant to Section 3.6 or pursuant to any release
by the Representative of any portion of the Reserve Amount in accordance with Section 10.20(c).
Pre-Closing Tax Period means any taxable period ending on or before the Closing Date and, for any Straddle Period, the portion through the end of the Closing Date.
Privacy Law(s) shall mean any applicable Law concerning the collection, storage, use, or processing of Personal Data.
16
R&W Insurance Policy means that certain representations and
warranties insurance policy procured by Parent in connection with this Agreement and the transactions contemplated hereby.
Reference Time means 11:59pm on the date immediately prior to the Closing Date.
Registered Intellectual Property has the meaning specified in Section 4.8(a).
Reserve Amount means $250,000.
Restricted Cash means, without duplication, any Cash and Cash Equivalents of the Company Group that (a) are not freely
usable by the Company Group or, after the Closing, Parent or any of its Affiliates because it is subject to restrictions or limitations on use or distribution by Law, Contract or otherwise (including, for the avoidance of doubt, any deposits with
third-parties or amounts held in escrow), (b) are insurance proceeds in respect of a condemnation, casualty, loss or other material damage to any of the assets of the Company or any Company Subsidiary or that are received prior to the Closing that
have not been used to repair or replace such condemned or damaged property or (c) are held by the Company Group outside of the United States, to the extent of the withholding or other Taxes that would be imposed on the repatriation of such Cash
and Cash Equivalents.
Restricted Shares means each award of Common Stock that is subject to restrictions under the
applicable award agreement or under the Equity Incentive Plan.
Restricted Stock Units means each outstanding
restricted stock unit award in respect of Common Stock (together with any accrued and unpaid dividends or dividend equivalents corresponding to such restricted stock unit award), granted under the Equity Incentive Plan.
RSU Holder means a holder of one or more Restricted Stock Units.
Security Incident means any (a) breach of security, phishing incident, network intrusion, ransomware, or malware
attack affecting any Company IT System, or (b) incident in which confidential information or Personal Data was or may have been accessed, disclosed, destroyed, processed, used, or exfiltrated in an unauthorized manner (whether any of the
foregoing was possessed or controlled by a member of the Company Group or by another Person on behalf of a member of the Company Group).
Solvent means, with respect to any Person and its Subsidiaries, on a consolidated basis, that as of the date of
determination, both (a) (i) the sum of such Persons debts (including contingent liabilities) does not exceed the present fair saleable value of such Persons present assets (when taken as a whole), (ii) such Persons
capital is not unreasonably small in relation to its business as contemplated on the Closing Date or with respect to any transaction contemplated to be undertaken after the Closing Date (when taken as a whole), and (iii) such Person has not
incurred and does not intend to incur, or
17
believe (nor should it reasonably believe) that it shall incur, debts beyond its ability to pay such debts as they become due (whether at maturity or otherwise) (when taken as a whole); and
(b) such Person is solvent within the meaning given that term and similar terms under the Bankruptcy Code and Laws relating to fraudulent transfers and conveyances. For purposes of this definition, the amount of any contingent
liability at any time shall be computed as the amount that, in light of all of the facts and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability (irrespective of whether
such contingent liabilities meet the criteria for accrual under Statement of Financial Accounting Standard No. 5).
Specified Stockholders has the meaning set forth on Schedule 1.1(d).
Stockholders means the holders of Common Stock at or prior to the Effective Time.
Stockholders Agreement means the Stockholders Agreement, dated as of September 27, 2013, by and among the Company and
the Stockholders (as defined therein), as amended by the Amendment to Stockholders Agreement, dated as of April 6, 2018, by and among the Company, Rotech Healthcare Holdings Inc. and the Stockholders (as defined therein).
Subsidiary means, with respect to a specified Person, any corporation, partnership, limited liability company, limited
liability partnership, joint venture, or other legal entity of which the specified Person (either alone and/or through and/or together with any other Subsidiary) owns, directly or indirectly, more than 50% of the voting stock or other equity or
partnership interests the holders of which are generally entitled to vote for the election of the board of directors or other governing body, of such legal entity or of which the specified Person controls the management. For clarity, none of the
mentor-protégé arrangements, joint ventures or any other entities in which ownership interests are disclosed on Schedule 4.3(c) shall constitute a Company Subsidiary for any purpose hereunder.
Tax or Taxes means all federal, state, county, local, municipal,
non-U.S. and other taxes of any kind, and any assessments, duties or similar charges, including all interest, penalties and additions imposed with respect to such amounts, imposed by any Governmental
Authority, however denominated, whether disputed or not.
Tax Returns means any report, declaration, return,
information return, claim for refund, election, disclosure, estimate or statement supplied or required to be supplied to a Governmental Authority in connection with Taxes, including any schedule or attachment thereto or amendment thereof.
Transaction Percentage means, the pro rata amount set forth on the Payment Schedule, which shall be, with respect to each
Equityholder, the percentage equal to (a) the number of (i) shares of Common Stock owned and held by such Equityholder as of the Closing Date plus (ii) shares of Common Stock into which such Equityholders
In-the-Money Options are exercisable as of the Closing Date and (b) divided by the number of Fully Diluted Shares as of the Closing Date.
18
Transaction Tax Deductions means, without duplication, any loss or
deduction, which is deductible for income Tax purposes by a member of the Company Group at a more likely than not (or higher) level of confidence, resulting from or attributable to (a) Company Expenses; (b) other transaction
costs of the Company and the Company Subsidiaries arising from, incurred in connection with or incident to this Agreement and the transactions contemplated hereby that are paid on or prior to the Closing Date and included in the computation of
Working Capital; (c) fees, expenses and interest (including amounts treated as interest for Tax purposes and any breakage fees) incurred by the Company and the Company Subsidiaries, and any unamortized deferred financing costs, in each case
with respect to the repayment of Indebtedness in connection with the transactions contemplated by this Agreement; or (d) payments by the Company and the Company Subsidiaries to, or the vesting of any stock (restricted, incentive or otherwise),
stock options, other incentive equity or payment right held by, any current or former employee, service provider or member of the board of directors (or similar governing body) of the Company or any of the Company Subsidiaries resulting from or
related to the transactions contemplated by this Agreement and included in Company Expenses or Indebtedness; provided that, in connection with the foregoing, it shall be assumed that the Company and the Company Subsidiaries make an election
under Revenue Procedure 2011-29, 2011-18 I.R.B. 746 to treat 70% of any success-based fees that were paid by or on behalf of the Company and the Company Subsidiaries as
an amount that did not facilitate the transactions contemplated under this Agreement.
Treasury Regulations means the
Treasury regulations promulgated under the Code.
Unaudited Financial Statements has the meaning as set forth in the
definition of Financial Statements.
Willful Breach means a material breach that is a consequence of an act or omission
knowingly undertaken or omitted by the breaching Party with the intent of causing a breach of this Agreement.
Working
Capital means, at any date, all Current Assets minus all Current Liabilities as of such date, calculated in accordance with the Balance Sheet Rules.
Working Capital Excess shall exist when, and shall be equal to the amount by which, the Closing Working Capital exceeds the
Working Capital Target.
Working Capital Shortfall shall exist when, and shall be equal to the amount by which, the
Working Capital Target exceeds the Closing Working Capital.
Working Capital Target means $24,600,000.
19
1.2 Other Capitalized Terms. The following terms shall have the meanings specified in
the indicated section of this Agreement.
|
|
|
Term |
|
Section |
Accounting Firm |
|
3.5(b) |
Aggregate Closing Merger Consideration |
|
3.1(a)(vi) |
Agreement |
|
Preamble |
Alternative Financing |
|
6.13(a) |
Alternative Financing Commitment Letter |
|
6.13(a) |
Alternative Financing Fee Letter |
|
6.13(a) |
Certificate |
|
3.2(a)(i) |
Certificate of Merger |
|
2.2(b) |
Closing |
|
2.2(a) |
Closing Date |
|
2.2(a) |
Closing Merger Consideration |
|
3.1(a) |
Company |
|
Preamble |
Company D&O Tail Policy |
|
6.7(b) |
Company Plan |
|
4.14(a) |
Company Subsidiaries |
|
4.3(a) |
Company Subsidiary |
|
4.3(a) |
Confidential Information |
|
6.2(b) |
Confidentiality Agreement |
|
6.2(b) |
Continuing Employee |
|
6.5(a) |
D&O Indemnified Parties |
|
6.7(a) |
D&O Indemnified Party |
|
6.7(a) |
D&O Tail Policy |
|
6.7(b) |
Debt Financing |
|
5.7(a) |
DGCL |
|
Recitals |
Disclosure Schedules |
|
4 |
Dissenting Shares |
|
3.7(a) |
Effective Time |
|
2.2(b) |
Equitable Exceptions |
|
4.4 |
Escrow Account |
|
3.4(a)(v) |
Escrow Amount |
|
3.4(a)(v) |
Estimated Aggregate Closing Merger Consideration |
|
3.3 |
Estimated Closing Date Cash |
|
3.3 |
Estimated Closing Date Indebtedness |
|
3.3 |
Estimated Closing Statement |
|
3.3 |
Estimated Company Expenses |
|
3.3 |
Estimated Working Capital Excess |
|
3.3 |
Estimated Working Capital Shortfall |
|
3.3 |
Excluded Shares |
|
3.2(a)(iii) |
Fee Letter |
|
5.7(b) |
Final Aggregate Merger Consideration |
|
3.1(a)(vi) |
20
|
|
|
Term |
|
Section |
Insurance Policies |
|
4.17 |
Interim Balance Sheet |
|
1.1 |
In-the-Money
Option |
|
3.2(b) |
In-the-Money
Option Payment |
|
3.2(b) |
Labor Agreement |
|
4.10(p) |
Leased Real Property |
|
4.18(b) |
Leases |
|
4.18(b) |
Letter of Transmittal |
|
3.4(a)(i) |
Material Contracts |
|
4.10 |
Merger |
|
Recitals |
Merger Sub |
|
Preamble |
Notice of Disagreement |
|
3.5(b) |
Owned Real Property |
|
4.18(a) |
Parent |
|
Preamble |
Paul, Weiss |
|
10.21 |
Paying Agent |
|
2.3 |
Payment Schedule |
|
3.3 |
Permits |
|
4.13 |
Real Property |
|
4.18(b) |
Registered Intellectual Property |
|
4.8(a) |
Related Parties |
|
10.13 |
Representative |
|
Preamble |
Required Amount |
|
5.8 |
SBA |
|
4.10 |
Securities Act |
|
5.11 |
Statement |
|
3.5(a) |
Surviving Corporation |
|
2.1 |
Termination Date |
|
9.1(d) |
Top Customers |
|
4.21(b) |
Top Suppliers |
|
4.21(a) |
Transfer Taxes |
|
10.18 |
Unresolved Matters |
|
3.5(b) |
VA |
|
4.10 |
Waived Benefit |
|
6.15 |
Working Capital Estimate |
|
3.3 |
Written Consent |
|
Recitals |
1.3 Interpretive Provisions. Unless the express context otherwise requires: (a) the words
hereof, herein, and hereunder and words of similar import, when used in this Agreement, shall refer to this Agreement as a whole and not to any particular provision of this Agreement; (b) terms defined in the
singular shall have a comparable meaning when used in the plural, and vice versa; (c) the terms Dollars and $ mean United States Dollars; (d) references herein to a specific Section, Subsection, Recital, Schedule or
Exhibit shall refer, respectively, to Sections, Subsections, Recitals, Schedules or Exhibits of this Agreement; (e) wherever the word include, includes, or
21
including is used in this Agreement, it shall be deemed to be followed by the words without limitation; (f) references herein to any gender shall include each other
gender; (g) references herein to any Person shall include such Persons heirs, executors, personal representatives, administrators, successors and assigns; provided, however, that nothing contained in this clause (g) is
intended to authorize any assignment or transfer not otherwise permitted by this Agreement; (h) references herein to a Person in a particular capacity or capacities shall exclude such Person in any other capacity; (i) with respect to the
determination of any period of time, the word from means from and including and the words to and until each means to but excluding; (j) references herein to any Law or any Permit mean
such Law or Permit as amended, modified, codified, reenacted, supplemented or superseded in whole or in part, and in effect from time to time; (k) references herein to any Law shall be deemed also to refer to all rules and regulations
promulgated thereunder; (l) any reference to days shall mean calendar days unless Business Days are expressly specified; (m) if the last day for the giving of any notice or the performance of any act required or permitted under
this Agreement is a day that is not a Business Day, then the time for the giving of such notice or the performance of such action shall be extended to the next succeeding Business Day; and (n) any reference to ordinary course of
business shall mean, with respect to a Person, the ordinary course of business of such Person, consistent with past practice. The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event of an ambiguity
or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the
provisions of this Agreement.
ARTICLE 2
THE MERGER
2.1 The
Merger. Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company. As a result of the Merger, the separate corporate
existence of Merger Sub shall cease, and the Company shall continue as the surviving corporation and as a wholly-owned subsidiary of Parent (the Surviving Corporation).
2.2 Closing; Certificate of Merger.
(a) Unless this Agreement is earlier terminated pursuant to, and in accordance with, Article 9, the closing of the
transactions contemplated by this Agreement, including the Merger (the Closing) will take place as promptly as practicable, and in any event no later than five (5) Business Days after the satisfaction or waiver of the
conditions set forth in Article 7 and Article 8 (other than those conditions that by their nature are to be satisfied on the Closing Date, but subject to the satisfaction or waiver of those
conditions at the Closing) remotely by exchange of documents and signatures (or their electronic counterparts) at 10:00 a.m. (New York time); provided that such place, date and time may be changed to another place, date and/or time as
agreed to in writing by Parent and the Company; provided further that if the Marketing Period has
22
not ended, the Closing will occur on the earlier of (i) a date during the Marketing Period specified by Parent in writing on no fewer than two (2) Business Days notice to the
Company and (ii) the second (2nd) Business Day immediately following the last day of the Marketing Period (subject in each case to the satisfaction or waiver of the conditions set forth in Articles 7 and 8 (other than those conditions that by
their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of those conditions at the Closing)). The date upon which the Closing actually occurs is herein referred to as the Closing Date.
(b) At the Closing, the Parties shall cause the Merger to be consummated by filing a certificate of merger (the Certificate of
Merger) with the Secretary of State of the State of Delaware, in such form as required by, and executed in accordance with, the relevant provisions of the DGCL, and make all other filings or recordings required by Delaware Law in order to
effect the Merger (the date and time of acceptance by the Secretary of State of Delaware of such filing, or, if another date and time is specified in such filing, such specified date and time, being the Effective Time).
2.3 Paying Agent. Prior to the Effective Time, Parent shall (a) select a bank or trust company, satisfactory to the Representative
in its reasonable discretion, to act as the paying agent in the Merger (the Paying Agent) and (b) enter into a paying agent agreement with the Paying Agent, the terms and conditions of which are satisfactory to the
Representative in its reasonable discretion.
2.4 Effect of the Merger. At the Effective Time, the effect of the Merger shall be as
provided in this Agreement and the applicable provisions of the DGCL. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time, except as otherwise provided herein, all the property, assets, rights, privileges,
immunities, powers and franchises of the Company and Merger Sub shall vest in the Surviving Corporation, and all claims, obligations, restrictions, disabilities, liabilities, debts and duties of the Company and Merger Sub shall become the claims,
obligations, restrictions, disabilities, liabilities, debts and duties of the Surviving Corporation.
2.5 Organizational Documents.
At the Effective Time, the Organizational Documents of the Company shall survive and shall be amended and restated in the form of the Organizational Documents of Merger Sub, as in effect immediately prior to the Effective Time, and as so amended and
restated shall be, from and after the Effective Time, the Organizational Documents of the Surviving Corporation until, subject to Section 6.7, duly amended or repealed in accordance with the provisions thereof and of
applicable Law.
2.6 Directors and Officers. The directors of Merger Sub immediately prior to the Effective Time shall be the
initial directors of the Surviving Corporation, each to serve in accordance with the Organizational Documents of the Surviving Corporation. The officers of the Company immediately prior to the Effective Time shall be the initial officers of the
Surviving Corporation, each to hold office in accordance with the Organizational Documents of the Surviving Corporation.
23
2.7 Withholding Rights. Notwithstanding anything in this Agreement to the contrary,
Parent, Merger Sub, the Company, any Company Subsidiary, and their respective Affiliates, the Paying Agent, and any other applicable withholding agent shall be entitled to deduct and withhold (or cause to be deducted and withheld) from any amounts
payable to any Person pursuant to this Agreement or otherwise in connection with or by virtue of the transactions contemplated hereby such amounts as are required to be deducted and withheld under the Code or any other applicable Tax Law;
provided, that if Parent determines that any amounts are required to be withheld in respect of the Closing Merger Consideration (other than by reason of the Companys failure to deliver the certificate required to be delivered pursuant
to Section 6.9, or withholding in respect of compensatory amounts), Parent shall use commercially reasonable efforts to (i) provide advance written notice of such determination to the Company at least five
(5) Business Days prior to the date on which payment is to be made to the applicable payee and (ii) cooperate with the Company, upon the Companys reasonable request, to mitigate and reduce such withholding to the extent permitted by
applicable Tax Law. Any such withheld amounts shall be reasonably promptly remitted to the applicable Governmental Authority and shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction
and withholding was made.
ARTICLE 3
CALCULATION OF MERGER CONSIDERATION; EFFECT ON CAPITAL STOCK; AND PAYMENT
3.1 Calculation of the Closing Merger Consideration.
(a) The Closing Merger Consideration shall be equal to:
(i) $1,357,000,000 (one billion, three hundred fifty seven million dollars);
(ii) plus the Estimated Closing Date Cash;
(iii) plus the Estimated Working Capital Excess, if any;
(iv) minus the Estimated Company Expenses;
(v) minus the Estimated Closing Date Indebtedness; and
(vi) minus the Estimated Working Capital Shortfall, if any.
The Aggregate Closing Merger Consideration shall be equal to the Closing Merger Consideration less (a) the
Escrow Amount less (b) the Reserve Amount. The Aggregate Closing Merger Consideration shall be subject to adjustment following the Closing pursuant to Section 3.5 (the Aggregate Closing Merger Consideration, as
adjusted and finally determined, the Final Aggregate Merger Consideration).
24
3.2 Effect on Capital Stock; Restricted Shares; Options; Restricted Stock
Units.
(a) At the Effective Time, by virtue of the Merger and without any action on the part of any Party or the holders of any
equity securities of Merger Sub or the Company:
(i) each share of Common Stock issued and outstanding immediately prior to the Effective
Time (other than the Excluded Shares (as defined below) and any Dissenting Shares, but including any Restricted Shares) shall be converted into the right to receive at such time and in the manner provided in Sections 3.4
and 3.6, (A) the Per Share Amount and (B) the portion of any Post-Closing Payment allocable to a share of Common Stock, in each case, determined in accordance with the Payment Schedule, subject to the surrender of the certificate
formerly representing such share of Common Stock or such share of Common Stock that is in non-certificated book-entry form (either case being referred to in this Agreement, to the extent applicable, as a
Certificate) by the holder of such share in accordance with this Section 3.2(a);
(ii) each
share of common stock of Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into and exchanged for one validly issued, fully paid and nonassessable share of common stock of the Surviving Corporation;
(iii) each share of Common Stock held by the Company or any of its Subsidiaries immediately prior to the Effective Time (collectively, the
Excluded Shares) shall be automatically cancelled without any conversion thereof and no payment or consideration shall be delivered in exchange therefor; and
(iv) each holder of a Certificate representing shares of Common Stock (other than the Excluded Shares and the Dissenting Shares) shall cease
to have any rights as a stockholder of the Company, except for the right to surrender its Certificate in exchange for the right to receive at such time and in the manner provided in Sections 3.4 and 3.6, (A) the Per
Share Amount and (B) the portion of any Post-Closing Payment allocable to a share of Common Stock, in each case, determined in accordance with the Payment Schedule. No transfer of shares of Common Stock shall be made on the stock transfer books
of the Surviving Corporation. At the close of business on the day of the Effective Time, the stock ledger of the Company with respect to the Common Stock shall be closed.
(b) At the Effective Time, by virtue of the Merger and without any action on the part of any Party or the holders of any equity securities of
Merger Sub or the Company, each Option issued and outstanding immediately prior to the Effective Time (i) that is vested as of immediately prior to the Effective Time or that vests automatically pursuant to its terms (and without any further
action by any Person) upon the Closing, and (ii) that has an exercise price that is less than the Per Share Amount (each such Option, as applicable, an
In-the-Money Option), if any, shall be cancelled, extinguished and converted as of the Effective Time, solely into the right to receive from the
Company at
25
such time and in the manner provided in Sections 3.4 and 3.6, without interest, (A) an amount equal to (1)(x) the Per Share Amount multiplied
by (y) the total number of shares of Common Stock subject to such In-the-Money Option less (2) the aggregate exercise price in respect of the
Common Stock subject to such In-the-Money Option (such amount, as set forth on the Payment Schedule, an In-the-Money Option Payment), and (B) the portion of any Post-Closing Payment allocable to each Option determined in accordance with the Payment Schedule, in each case, subject to any
applicable tax withholding. All Options other than In-the-Money Options shall, immediately prior to the Effective Time, to the extent not exercised by the holder thereof
prior to the Effective Time in accordance with the terms thereof, automatically be extinguished and cancelled without the right to receive any consideration (with no payment being made hereunder with respect thereto). Immediately upon the Effective
Time, each Option shall no longer be outstanding and shall automatically be cancelled and extinguished and shall cease to exist and no longer represent the right to purchase shares of Common Stock but, in lieu thereof, shall only represent the right
to receive payments of cash to the extent provided in this Agreement, to the extent applicable. Notwithstanding anything to the contrary in this Agreement, no Post-Closing Payments shall be allocated or paid in respect of any In-the-Money Option except to the extent permissible under Treasury Regulation Section 1.409A-3(i)(5)(iv)(A); provided,
that no such Post-Closing Payments shall be allocated or paid in respect of any In-the-Money Option following the fifth (5th) anniversary of the Closing Date.
(c) At the Effective Time, by virtue of the Merger and without any action on the part of any Party or the holders of any equity securities of
Merger Sub or the Company, each Restricted Stock Unit issued and outstanding immediately prior to the Effective Time that is vested as of immediately prior to the Effective Time or that vests automatically pursuant to its terms (and without any
further action by any Person) upon the Closing, if any, shall be cancelled, extinguished and converted as of the Effective Time, solely into the right to receive from the Company at such time and in the manner provided in
Sections 3.4 and 3.6, without interest, (A) an amount equal to (1) the Per Share Amount multiplied by (2) the total number of shares of Common Stock subject to such Restricted Stock Unit (such
amount, as set forth on the Payment Schedule, a Restricted Stock Unit Payment) and (B) the portion of any Post-Closing Payment allocable to a share of Common Stock, in each case, determined in accordance with the Payment
Schedule, in each case, subject to any applicable tax withholding. Immediately upon the Effective Time, each Restricted Stock Unit shall no longer be outstanding and shall automatically be cancelled and extinguished and shall cease to exist and no
longer represent the right to receive shares of Common Stock but, in lieu thereof, shall only represent the right to receive payments of cash to the extent provided in this Agreement, to the extent applicable. Notwithstanding anything to the
contrary in this Agreement, no Post-Closing Payments shall be allocated or paid in respect of any Restricted Stock Unit except to the extent permissible under Treasury Regulation
Section 1.409A-3(i)(5)(iv)(A).
3.3 Pre-Closing
Deliveries. At least four (4) Business Days prior to the Closing Date, the Company shall deliver to Parent a statement (the Estimated Closing Statement) setting forth a good faith estimate of (a) Closing Working
Capital and the resulting Working Capital Excess (the Estimated Working Capital Excess) or Working Capital Shortfall (the Estimated Working Capital Shortfall), (b) the amount of the
26
Company Expenses (the Estimated Company Expenses), (c) the amount of Closing Date Indebtedness (the Estimated Closing Date Indebtedness), (d) the amount of
Closing Date Cash (the Estimated Closing Date Cash), in each case prepared in accordance with the Balance Sheet Rules and (e) the resulting Aggregate Closing Merger Consideration (the Estimated Aggregate Closing
Merger Consideration), the Per Share Amount and a schedule of (A) the portion of the Aggregate Closing Merger Consideration payable to each Stockholder (assuming for the purposes of such schedule that all Stockholders have timely
delivered Letters of Transmittal), (B) the In-the-Money Option Payment payable to each Optionholder as determined in accordance with Section 3.2(b) and
(C) the Restricted Stock Unit Payment payable to each RSU Holder as determined in accordance with Section 3.2(c) (the Payment Schedule), together with such reasonable supporting documentation with
respect to the determination thereof as may be reasonably appropriate in the Companys reasonable discretion to support the calculations set forth in the Estimated Closing Statement. Parent (and its Agents) shall be afforded an opportunity to
review and comment on the Estimated Closing Statement and such accompanying estimates or reasonable supporting documentation, and the Company will use commercially reasonable efforts to consider any good faith comments of Parent and its Agents which
are delivered to the Company at least two (2) Business Days prior to the Closing Date, provided, for the avoidance of doubt, neither Parent nor the Company shall delay the Closing because of such comments.
3.4 Transactions to be Effected at the Closing. At the Closing, the following transactions shall be effected by the Parties:
(a) Parent shall:
(i) (x)
deliver to the Paying Agent, by wire transfer of immediately available funds to a bank account(s) designated in writing by the Paying Agent, an amount equal to the Aggregate Closing Merger Consideration allocable to the shares of Common Stock
covered by a completed letter of transmittal, substantially in the form of Exhibit C hereto (a Letter of Transmittal) delivered by the applicable Stockholders to the Paying Agent at least two (2) Business Days prior to
the Closing Date and (y) cause the Paying Agent to pay to each Stockholder, who shall have delivered a completed Letter of Transmittal to the Paying Agent at least two (2) Business Days prior to the Closing Date, an amount equal to the product
obtained by multiplying (A) the number of the shares of Common Stock covered by such Stockholders Letter of Transmittal by (B) the Per Share Amount, which amount shall be payable by wire transfer of immediately
available funds to the account designated in such Stockholders Letter of Transmittal or otherwise provided to the Paying Agent; provided, however, that if a Stockholder shall deliver a Letter of Transmittal to the
Paying Agent after the Closing Date, (x) Parent shall pay to the Paying Agent for further distribution to such Stockholder, an amount equal to the product obtained by multiplying (A) the number of the shares of Common Stock covered
by such Stockholders Letter of Transmittal by (B) the Per Share Amount, which amount shall be payable by wire transfer of immediately available funds to the account designated in such Stockholders Letter of Transmittal no
more than three (3) Business Days after receipt by the Paying Agent of such Letter of Transmittal; provided, further, that, with respect to any shares of Common Stock that constitute Restricted Shares immediately prior to the
Closing and identified on the Payment Schedule, any payment in respect of such Restricted Shares shall be paid by the Company through its ordinary payroll processes (including with respect to any applicable tax withholding);
27
(ii) (x) deliver to the Company, by wire transfer of immediately available funds to a
bank account(s) designated in writing by the Company, an aggregate amount equal to the In-The-Money Option Payment allocable to all In-the-Money Options and (y) cause the Company to pay to each Optionholder an amount equal to the In-The-Money Option
Payment allocable to such Optionholders In-the-Money Options as set forth on the Payment Schedule, which amount shall be payable by the Company through its
ordinary payroll processes (including with respect to any applicable tax withholding);
(iii) (x) deliver to the Company, by wire
transfer of immediately available funds to a bank account(s) designated in writing by the Company, an aggregate amount equal to the Restricted Stock Unit Payment allocable to all Restricted Stock Units and (y) cause the Company to pay to each
RSU Holder an amount equal to the Restricted Stock Unit Payment allocable to such RSU Holders Restricted Stock Units as set forth on the Payment Schedule, which amount shall be payable by the Company in accordance with its ordinary payroll
processes (including with respect to any applicable tax withholding);
(iv) deliver to the Representative, by wire transfer of
immediately available funds to a bank account(s) designated in writing by the Representative (such designation to be made at least two (2) Business Days prior to the Closing Date), an amount in cash equal to the Reserve Amount;
(v) deliver to the Escrow Agent, by wire transfer of immediately available funds to a bank account(s) designated in writing by the Escrow
Agent (such designation to be made at least two (2) Business Days prior to the Closing Date) as an escrow account(s) (the Escrow Account), $2,500,000 (the Escrow Amount) to be held by the Escrow Agent and
distributed by the Escrow Agent in accordance with the terms of the Escrow Agreement;
(vi) (a) deliver, by wire transfer of
immediately available funds to a bank account(s) designated in the Payoff Letter or in writing by each Person to whom any portion of the Credit Facilities Payoff Amount is owed (such designation to be made at least two (2) Business Days prior
to the Closing Date), an amount in cash equal to the portion of the Credit Facilities Payoff Amount owing to such Person, on behalf of the Company and the Company Subsidiaries and (b) deliver, by wire transfer of immediately available funds to
a bank account(s) designated in any additional payoff letter required to be delivered to Parent under Section 6.10(ii), an amount in cash equal to the portion required to be paid pursuant to any such payoff letter, on
behalf of the Company and the Company Subsidiaries;
28
(vii) deliver, by wire transfer of immediately available funds to a bank account(s)
designated in writing by each Person to whom any portion of the Company Expenses is owed (such designation to be made at least two (2) Business Days prior to the Closing Date), an amount in cash equal to the portion of the Company Expenses
owing to such Person, on behalf of the Company and the Company Subsidiaries;
(viii) deliver to the Representative and the Escrow Agent,
a copy of the Escrow Agreement, duly executed by Parent; and
(ix) deliver to the Representative, a copy of the paying agent agreement,
duly executed by Parent and the Paying Agent.
(b) The Company shall deliver to Parent and the Escrow Agent, a copy of the Escrow
Agreement, duly executed by the Representative and the Escrow Agent.
3.5 Post-Closing Adjustment to Aggregate Closing Merger
Consideration.
(a) Within sixty (60) days after the Closing Date, Parent shall deliver to the Representative a statement (the
Statement) setting forth Parents good faith determination of the (i) Closing Working Capital and the resulting Working Capital Excess or Working Capital Shortfall, if any, (ii) Closing Date Indebtedness,
(iii) Closing Date Cash, (iv) Company Expenses and (v) the resulting Aggregate Closing Merger Consideration, in each case prepared in accordance with the Balance Sheet Rules. Parent shall not amend, supplement or modify the Statement
following its delivery to the Representative.
(b) The Statement shall become final and binding upon the Parties on the thirtieth (30th) day following the date on which the Statement was delivered to the Representative, unless the Representative delivers written notice of its disagreement with the Statement (a Notice of
Disagreement) to Parent prior to such date; provided, however, that if Parent has not provided the access or information to the Representative pursuant to Section 3.8, the deadline for delivery of a Notice of
Disagreement shall be tolled until Parent provides such access or information pursuant to Section 3.8. Any Notice of Disagreement shall specify in reasonable detail the nature of any disagreement so asserted; provided,
however, that, the Representative may provide a Notice of Disagreement on the basis that it has not been provided with adequate information to understand and evaluate the differences between the calculations contained in the statement
delivered by the Company in accordance with Section 3.3, on the one hand, and the calculation contained in the Statement, on the other hand (and/or, in each case, components thereof, including the Closing Working Capital,
the amount of the Closing Date Cash, the amount of the Closing Date Indebtedness and/or the amount of Company Expenses). If a Notice of Disagreement is received by Parent in a timely manner, then the Statement (as revised in accordance with this
sentence) shall become final and binding upon the Parties on the earlier of (i) the date the Representative and Parent resolve in writing any differences they have with respect to the matters specified in the Notice of Disagreement and
(ii) the date any disputed matters are finally resolved in writing by the Accounting Firm. During the fourteen (14)-day period following the delivery of a Notice of Disagreement, the
29
Representative and Parent shall seek in good faith to resolve in writing any differences that they may have with respect to the matters specified in the Notice of Disagreement. The Parties
acknowledge and agree that the Federal Rules of Evidence Rule 408 and any similar state rules shall apply to the Representative (and any of its Agents) and Parent (and any of its Agents) during such negotiations and any subsequent dispute arising
therefrom. If at the end of such fourteen (14)-day period the Representative and Parent have not resolved in writing the matters specified in the Notice of Disagreement, the Representative and Parent shall
submit to an independent accounting firm (the Accounting Firm) to resolve such disputes (acting as an expert and not an arbitrator), in accordance with the standards set forth in this Section 3.5, only matters that remain
in dispute (the Unresolved Matters). The Accounting Firm shall be PricewaterhouseCoopers or, if such firm is unable or unwilling to act, such other nationally recognized independent public accounting firm as shall be reasonably
agreed upon by the Representative and Parent in writing. The Representative and Parent shall use reasonable efforts to cause the Accounting Firm to render a written decision resolving the matters submitted to the Accounting Firm within thirty
(30) days of the receipt of such submission. The scope of the disputes to be resolved by the Accounting Firm shall be limited to fixing mathematical errors and determining whether the Unresolved Matters were determined in accordance with the
Balance Sheet Rules and this Agreement and the Accounting Firm is not to make any other determination, including any determination as to whether the calculations contained in the statement delivered by the Company in accordance with
Section 3.3, on the one hand, and the calculation contained in the Statement (and/or components thereof, including the Closing Working Capital, the amount of the Closing Date Cash, the amount of the Closing Date Indebtedness and/or the
amount of Company Expenses) are correct. The Accounting Firms decision shall be based solely on written submissions by the Representative and Parent and their respective representatives and not by independent review. The Accounting Firm may
not assign a value greater than the greatest value for such item claimed by either Party or smaller than the smallest value for such item claimed by either Party. The Accounting Firms final determination in accordance with the requirements of
this Agreement shall be final, binding and non-appealable on the Parties, absent showing of fraud or manifest error and such final determination. The fees and expenses of the Accounting Firm incurred pursuant
to this Section 3.5 shall be borne by the Representative, on the one hand (solely from the Reserve Amount), and Parent, on the other hand, in proportion to the final allocation made by such Accounting Firm of the Unresolved Matters
weighted in relation to the claims made by the Representative and Parent, such that the prevailing party pays the lesser proportion of such fees, costs and expenses. For example, if the Representative claims that the appropriate adjustments with
respect to the Unresolved Matters are $1,000 greater than the amount determined by Parent (and such amount is the aggregate amount of the Unresolved Matters) and if the Accounting Firm ultimately resolves the Unresolved Matters by awarding to
Representative $300 of the $1,000 contested, then the fees, costs and expenses of the Accounting Firm will be allocated 30% (i.e., 300 ÷ 1,000) to Parent and 70% (i.e., 700 ÷ 1,000) to Representative.
30
3.6 Final Adjustment Payment. No later than the second (2nd) Business Day following the date on which the Statement becomes final:
(a) If the
Final Aggregate Merger Consideration exceeds the Estimated Aggregate Closing Merger Consideration:
(i) Parent shall pay (or cause the
Paying Agent or the Company, as applicable, to pay) to (a) each Stockholder such Stockholders Transaction Percentage of such excess, which amount shall be payable by wire transfer of immediately available funds to the account designated
in such Stockholders Letter of Transmittal (provided, that, with respect to any shares of Common Stock that constitute Restricted Shares immediately prior to the Closing and identified on the Payment Schedule, any payment in respect of
such Restricted Shares shall be paid by the Company through its ordinary payroll processes (including with respect to any applicable tax withholding)), (b) each Optionholder such Optionholders Transaction Percentage of such excess, which
amount shall be payable by the Company in accordance with its ordinary payroll practices (including with respect to any applicable tax withholding) and (c) each RSU Holder such RSU Holders Transaction Percentage of such excess, which
amount shall be payable by the Company in accordance with its ordinary payroll practices (including with respect to any applicable tax withholding); provided, that notwithstanding the foregoing, Parents aggregate payment obligation
pursuant to this Section 3.6(a)(i) shall not exceed the Escrow Amount; and
(ii) Parent and the Representative
shall provide a joint written instruction to the Escrow Agent to release the Escrow Amount to the Paying Agent, for further distribution to the Equityholders, in each case, as if such amounts were being distributed pursuant to
Section 3.6(a)(i).
(b) If the Final Aggregate Merger Consideration is less than the Estimated Aggregate
Closing Merger Consideration, then Parent and the Representative shall provide a joint written instruction to the Escrow Agent to release such shortfall to the Surviving Corporation solely and exclusively from the Escrow Account (up to a maximum
amount equal to the then-remaining Escrow Amount) and Parent and the Representative shall provide a joint written instruction to the Escrow Agent to release any portion of the Escrow Amount remaining following the payment of such shortfall to the
Paying Agent, for further distribution to the Equityholders as if such amounts were being distributed pursuant to Section 3.6(a)(i). Notwithstanding anything to the contrary in this Agreement, the sole and exclusive source
of recourse for payment of any amount owed to Parent, Merger Sub or any other Person under this Section 3.6(b) shall be to the Escrow Account and none of Parent, the Surviving Corporation, any of the Company Subsidiaries or
any other Person shall have any claim against any Equityholder or the Representative or any of their respective Affiliates in respect thereof.
(c) If the Final Aggregate Merger Consideration is equal to the Estimated Aggregate Closing Merger Consideration, then Parent and the
Representative shall provide a joint written instruction to the Escrow Agent to release the Escrow Amount to the Paying Agent, for further distribution to the Equityholders as if such amounts were being distributed pursuant to
Section 3.6(a)(i).
31
(d) The Parties shall treat all payments made pursuant to this
Section 3.6 as adjustments to the Closing Merger Consideration for all U.S. federal income and applicable state and local income tax purposes, except to the extent otherwise required by applicable Law.
3.7 Dissenting Shares.
(a) Notwithstanding any provision of this Agreement to the contrary (but subject to the other provisions of this
Section 3.7), any shares of Common Stock outstanding immediately prior to the Effective Time for which the holder thereof (i) has not voted in favor of the Merger or consented to it in writing and (ii) has
properly exercised and perfected the appraisal of such shares in accordance with, and has complied in all respects with, Section 262 of the DGCL (collectively, the Dissenting Shares), shall not be converted into, or represent
the right to receive, the consideration in accordance with Section 3.2(a), but shall instead entitle the holder thereof only to such rights as are provided to a holder of Dissenting Shares pursuant to Section 262 of
the DGCL. At the Effective Time, (A) all Dissenting Shares shall be canceled and cease to exist and (B) the holders of Dissenting Shares shall be entitled only to such rights as may be granted to them under
Section 262 of the DGCL. The Surviving Corporation shall provide to those Stockholders who did not execute the Written Consent all information with respect to appraisal rights required by Section 262(d)(2) of the DGCL.
(b) Notwithstanding the provisions of Section 3.7(a), if any holder of Dissenting Shares effectively withdraws
or loses such appraisal rights (through failure to perfect such appraisal rights or otherwise), then that holders shares of Common Stock (i) shall be deemed no longer to be Dissenting Shares and (ii) shall be treated as if they had
been converted automatically at the Effective Time into the right to receive the consideration in accordance with Section 3.2(a) upon surrender of a Certificate.
(c) The Company shall give Parent (i) prompt written notice of any written demands for appraisal of any shares of Common Stock,
including copies thereof, the withdrawals of such demands and any other instrument served on the Company under the DGCL and (ii) the right to participate in all negotiations and proceedings with respect to such demands for appraisal. Prior to
the Effective Time, the Company shall not, without the prior written consent of Parent, make any payment with respect to, or settle or offer to settle, any such demands, or agree to do any of the foregoing.
3.8 No Adverse Actions; Access. Following the Closing, Parent shall not take any action, directly or
indirectly, with respect to the accounting books and records of the Company, or the items reflected thereon, on which the Statement is to be based, that is inconsistent with the Companys past accounting practices, solely to the extent such
action would affect the final determination of the Final Aggregate Merger Consideration. No actions taken by Parent, directly or indirectly, on its own behalf or on behalf of the Surviving Corporation or the Company Subsidiaries, on or following the
Closing Date shall
32
be given effect for purposes of determining the Closing Working Capital, Closing Date Cash, Closing Date Indebtedness or Company Expenses. During the period of time from and after the Closing
Date through the final determination, and payment, of the Final Aggregate Merger Consideration, Parent shall afford, and shall cause the Surviving Corporation and the Company Subsidiaries to afford, to the Representative and any Agents (including
accountants, counsel or financial advisers) retained by the Representative in connection with the review of the Statement (and/or any components thereof), reasonable access during normal business hours upon reasonable advance notice to all the
properties, books, contracts, personnel, Agents (including the Companys accountants) and records of the Surviving Corporation, the Company Subsidiaries and such Agents (including the work papers of the Surviving Corporations accountants)
relevant to the review of the Statement and Parents determination of Closing Working Capital, Company Expenses, Closing Date Cash and Closing Date Indebtedness in accordance with Section 3.5; provided, that
(i) the Representative and such Agents have executed customary access and confidentiality agreements, (ii) information that is subject to attorney-client privilege is not required to be made available (provided, that Parent, the
Surviving Corporation and the Company Subsidiaries shall use their commercially reasonable efforts to disclose such information (or portions thereof) in a manner that would not violate the foregoing), (iii) work papers of the Surviving
Corporations and the Company Subsidiaries accountants shall be made available only if permitted by such accountants (it being agreed that Parent shall use reasonable best efforts to cause such accountants to permit such access to their
work papers) and (iv) any such access shall be conducted in a manner not to unreasonably interfere with the business or operations of the Surviving Corporation and the Company Subsidiaries.
3.9 Company Actions. If requested by Parent at least five (5) days prior to the Effective Time, the board of directors of the
Company (or, if appropriate, any committee thereof administering the Equity Incentive Plan) shall adopt such resolutions and take such other actions as may be required to cause the Equity Incentive Plan to terminate at the Effective Time.
ARTICLE 4
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
Except as set forth in the disclosure schedules (the Disclosure Schedules), the
Company represents and warrants to Parent on and as of the date of this Agreement and as of the Closing Date (except for such representations and warranties expressly stated to relate to an earlier date, in which case, as of such earlier date) as
follows:
4.1 Organization and Qualification.
(a) The Company is a corporation duly incorporated and validly existing under the Laws of the State of Delaware.
33
(b) Each Company Subsidiary is duly organized, validly existing and in good standing under
the Laws of the state of its incorporation or organization, except where the failure to be so organized, validly existing and in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect or
materially impair or delay the Companys ability to effect the transactions contemplated hereby.
(c) The Company Group has all
requisite organizational power and authority to own, lease and operate their respective properties and carry on their business as presently owned or conducted, except where the failure to have such power or authority would not, individually or in
the aggregate, reasonably be expected to have a Material Adverse Effect or materially impair or delay the Companys ability to effect the transactions contemplated hereby. Except as set forth on Schedule 4.1, the
Company and each Company Subsidiary have been qualified, licensed or registered to transact business as a foreign company and each is in good standing (or the equivalent thereof) in each jurisdiction in which the ownership or lease of property or
the conduct of its business requires such qualification, license or registration, except where the failure to be so qualified, licensed or registered or in good standing (or the equivalent thereof) would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect or materially impair or delay the Companys ability to effect the transactions contemplated hereby.
(d) The Company has made available to Parent complete and accurate copies of the Organizational Documents of each material member of the
Company Group and the Stockholders Agreement, as applicable, all as amended and in full force and effect as of the date of this Agreement. No material member of the Company Group is in violation of any terms of its Organizational Documents or the
Stockholders Agreement.
4.2 Capitalization of the Company.
(a) Schedule 4.2(a) sets forth (i) a complete and accurate list of the authorized, issued and outstanding equity securities of
the Company as of the date of this Agreement and (ii) as of the date hereof, for each Equity Award that is issued and outstanding, (A) the holders name, (B) the number of shares of Common Stock subject to such Equity Award,
(C) the grant date and vesting commencement date for such Equity Award, (D) the exercise price per share of Common Stock purchasable under any such Equity Award that is an Option, (E) the vesting schedule and whether the vesting of
such Equity Award is subject to any acceleration in connection with the Merger, and (F) whether any such Equity Award that is an Option is intended to be an incentive stock option as defined in Section 422 of the Code or
subject to Section 409A of the Code.
(b) Except as set forth on Schedule 4.2(a), there are no other equity securities of the
Company authorized, issued, reserved for issuance or outstanding, and no outstanding or authorized options, warrants, convertible or exchangeable securities, subscriptions, rights (including any preemptive rights, conversion rights and exchange
rights), calls, puts or commitments of any character whatsoever, relating to the equity securities of, or other equity or voting interest in, the Company, to which the Company or any of the Company Subsidiaries is a party or is bound requiring the
issuance, delivery or sale of equity securities of the Company. There are no outstanding or authorized stock
34
appreciation, phantom stock, profit participation or similar rights with respect to the equity securities of, or other equity or voting interest in, the Company to which the Company is a party or
is bound. The Company has no authorized or outstanding bonds, debentures, notes or other indebtedness the holders of which have the right to vote (or convertible into, exchangeable for, or evidencing the right to subscribe for or acquire securities
having the right to vote) with the Equityholders of the Company on any matter. Other than the Stockholders Agreement, there are (i) no contracts to which the Company is a party or by which it is bound to (x) repurchase, redeem or otherwise
acquire any equity securities of, or other equity or voting interest in, the Company or (y) vote or dispose of any equity securities of, or other equity or voting interest in, the Company and (ii) no irrevocable proxies and no voting
agreements with respect to any equity securities of, or other equity or voting interest in, the Company.
(c) All of the issued and
outstanding Common Stock of the Company is duly authorized, validly issued and, except as provided in the Stockholders Agreement, free of any preemptive rights in respect thereto.
(d) All grants of Equity Awards were validly issued and properly approved by the board of directors of the Company (or a duly constituted and
authorized committee thereof) in accordance with the Equity Incentive Plan and applicable Law. All Options have been granted with an exercise price per share at least equal to the fair market value of the underlying share of Common Stock within the
meaning of Section 409A of the Code and the Treasury Regulations promulgated thereunder, as applicable, on the date each Option was granted.
4.3 Subsidiaries.
(a)
Schedule 4.3(a) sets forth a complete and accurate list of the name and jurisdiction of each of the Companys Subsidiaries (each a Company Subsidiary, and collectively, the Company
Subsidiaries) and the authorized, issued and outstanding capital stock of each Company Subsidiary.
(b) All of the outstanding
capital stock of each Company Subsidiary is duly authorized, validly issued and is directly owned of record by the Company or a Company Subsidiary, free and clear of any Encumbrances, other than (i) Permitted Encumbrances and
(ii) Encumbrances created by Parents, Merger Subs or their respective Affiliates acts, and there are (A) no other equity securities of any Company Subsidiary authorized, issued, reserved for issuance or outstanding and
(B) no outstanding or authorized options, warrants, convertible or exchangeable securities, subscriptions, rights (including any preemptive rights, conversion rights and exchange rights), stock appreciation rights, calls, puts or commitments of
any character whatsoever to which any Company Subsidiary is a party or is bound requiring the issuance, delivery or sale of equity securities of any Company Subsidiary. There are no outstanding or authorized stock appreciation, phantom stock, profit
participation or similar rights with respect to the equity securities of, or other equity or voting interest in, any Company Subsidiary to which the Company or a Company Subsidiary is bound. No Company Subsidiary has any authorized or outstanding
bonds, debentures, notes or other indebtedness, the holders of which have
35
the right to vote (or convertible into, exchangeable for, or evidencing the right to subscribe for or acquire securities having the right to vote) with the equity holders of such Company
Subsidiary on any matter. There are no contracts to which the Company or any Company Subsidiary is a party or by which the Company or any Company Subsidiary is bound to (x) repurchase, redeem or otherwise acquire any limited liability company
interests, or other equity or voting interest in, any Company Subsidiary or (y) vote or dispose of any limited liability company interests, or other equity or voting interest in, any Company Subsidiary. There are no irrevocable proxies and no
voting agreements with respect to any limited liability company interests, or other equity or voting interest in, any Company Subsidiary.
(c) Except as set forth on Schedule 4.3(c), neither the Company nor any Company Subsidiary owns, directly or indirectly, any capital
stock of, or equity ownership or voting interest in, any Person (other than a Company Subsidiary).
4.4 Authority; Binding
Obligation. The Company has all requisite corporate authority and power to execute, deliver and perform this Agreement and each other agreement, document or certificate contemplated by this Agreement (the Ancillary Documents)
to which the Company is a party and to consummate the transactions contemplated hereby. This Agreement and the Ancillary Documents to which the Company is a party and the consummation of the transactions contemplated hereby have been duly and
validly authorized by all required corporate action on the part of the Company and no other corporate proceedings on the part of the Company are necessary to authorize this Agreement, the Ancillary Documents to which the Company is a party and the
consummation of the transactions contemplated hereby. This Agreement and the Ancillary Documents to which the Company is a party have been duly executed and delivered by the Company and, assuming that this Agreement constitutes the legal, valid and
binding obligation of Parent and Merger Sub, constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that the enforceability thereof may be limited by
(a) applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or similar laws from time to time in effect affecting generally the enforcement of creditors rights and remedies; and (b) general principles of
equity (collectively, the Equitable Exceptions). The adoption of this Agreement by the affirmative vote of the holders of a majority of the outstanding shares of Common Stock entitled to vote is the only vote or approval of the
holders of any of the Companys capital stock necessary under applicable Law, the Organizational Documents of the Company or the Stockholders Agreement to adopt this Agreement and consummate the transactions contemplated hereby.
4.5 No Defaults or Conflicts. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby
by the Company and performance by the Company of its obligations hereunder (a) does not conflict with or result in any violation of the applicable Organizational Documents of the Company or the Stockholders Agreement; (b) except as set
forth on Schedule 4.5(b), does not conflict with, or result in a breach of any of the terms or provisions of, or constitute a default or an event that, with or without notice or lapse of time or both, would become a default
under any Material Contract or Lease or result in or permit the termination of any provision of, or result in or permit the acceleration of the maturity, cancellation of performance of any obligation under, or result in the loss of a right or
benefit under, or result in the creation or imposition of any
36
Encumbrance (other than Permitted Encumbrances) of any nature whatsoever upon any assets or property of the Company Group, or give to others any interests or rights therein under, any Material
Contract or Lease; and (c) does not conflict with or violate in any respect any existing applicable Law, judgment, order or decree of any Governmental Authority having jurisdiction over the Company, the Company Subsidiaries or any of their
respective properties, except in the case of clauses (b) or (c) for such conflicts, breaches, defaults, terminations, accelerations, cancellations, loss of rights or benefits and Encumbrances that would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect or materially impair or delay the Companys ability to effect the transactions contemplated hereby.
4.6 No Governmental Authorization Required. Except for the filing of the Certificate of Merger with the Office of the Secretary of
State of Delaware, applicable requirements of Antitrust Laws or as otherwise set forth on Schedule 4.6, no authorization or approval, consent, licenses, orders, permits, or registrations, declarations or other action by,
and no notice to or filing with, any Governmental Authority will be required to be obtained or made by the Company in connection with the due execution, delivery and performance by the Company of this Agreement and the consummation by the Company of
the transactions contemplated hereby, except with respect to such authorizations, approvals, notices or filings with any Governmental Authority that, (a) if not obtained or made, would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect or materially impair or delay the Companys ability to effect the transactions contemplated hereby or (b) become applicable as a result of the business or activities in which Parent or Merger Sub
is or proposes to be engaged or as a result of any acts or omissions by, or the status of or any facts pertaining to, Parent or Merger Sub.
4.7 Financial Statements.
(a) Schedule 4.7(a) sets forth complete and accurate copies of the Financial Statements. The consolidated balance sheets included in
the Financial Statements fairly present, in all material respects, the consolidated financial position of Rotech Healthcare Inc. and its consolidated Subsidiaries as of their respective dates, and the other related statements included in the
Financial Statements, in all material respects, fairly present the results of their consolidated operations and cash flows for the periods indicated, in each case in accordance with GAAP applied on a consistent basis, with only such deviations from
such accounting principles and/or their consistent application as are referred to in the notes to the Financial Statements and subject, in the case of the Unaudited Financial Statements, to year-end and/or
audit adjustments, none of which are expected to be material, individually or in the aggregate, to the Company Group, taken as a whole, and the absence of footnotes. The Financial Statements, including the footnotes thereto, have been prepared from
the books and records of Rotech Healthcare Inc. and its consolidated Subsidiaries, and have been prepared in accordance with GAAP consistently applied.
37
(b) Except (i) as set forth on Schedule 4.7(b) or as
reserved against on the face of the Financial Statements, (ii) for liabilities incurred in the ordinary course of business since the date of the Interim Balance Sheet (none of which is a liability for breach of contract, tort, misappropriation,
or infringement or a claim or lawsuit or an environmental liability), (iii) those incurred in connection with, or arising out of, (A) the negotiation, preparation or execution of this Agreement, (B) the performance by the Company of its
covenants or agreements set forth in this Agreement and/or (C) the consummation by the Company of the transactions contemplated by this Agreement and (iv) as would not, individually or in the aggregate, have or reasonably be expected to
have a Material Adverse Effect, the Company Group does not have any liabilities of any kind whatsoever, whether accrued, contingent, absolutely determined or determinable.
(c) Except as set forth in the Audited Financial Statements, neither the Company nor any Company Subsidiary maintains any off-balance sheet arrangement within the meaning of Item 303 of Regulation S-K of the Securities and Exchange Commission.
(d) The Company Group maintains a system of accounting and internal controls sufficient to provide reasonable assurances that (i) all
transactions are executed in accordance with managements general or specific authorization and (ii) transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP. Except as set forth on
Schedule 4.7(d), for the period covering the Financial Statements, there has not been (i) any significant deficiency or material weakness in any system of internal accounting controls used by the Company Group, (ii) any fraud or
material wrongdoing that involves any of the management or other employees of the Company Group who have a role in the preparation of the Financial Statements or the internal accounting controls used by the Company Group or (iii) any claim or
allegation regarding any of the foregoing.
4.8 Intellectual Property, Data Privacy, and Data Security.
(a) Schedule 4.8(a) sets forth a list of all of the following Intellectual Property as of the date hereof:
(i) all registered trademarks and pending trademark applications owned by the Company Group; (ii) all registered copyrights owned by the Company Group; (iii) all registered patents and pending applications owned by the Company Group,
and (iv) domain names owned by the Company Group (collectively, the Registered Intellectual Property). Each material item of the Registered Intellectual Property is valid (or in the case of applications, applied for),
subsisting and in effect, and enforceable.
(b) Except as set forth on Schedule 4.8(b), the Company or a
Company Subsidiary, as applicable, exclusively owns all material Company Owned Intellectual Property and, is licensed to use or otherwise has the right to use all other material Intellectual Property used in the operation of the business of the
Company Group, in each case free and clear of any Encumbrances, other than Permitted Encumbrances. No Actions are pending or, to the knowledge of the Company, threatened challenging the ownership, enforceability or validity of any Company Owned
Intellectual Property, except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
38
(c) Except as set forth on Schedule 4.8(c), (i) to the knowledge of the Company, no
Person is infringing upon, misappropriating or otherwise violating, and has not, in the past three (3) years, infringed upon, misappropriated or otherwise violated, any of the Intellectual Property owned by the Company or any Company
Subsidiary, and (ii) the conduct of the business of the Company and the Company Subsidiaries does not infringe upon, misappropriate or otherwise violate, and has not, in the past three (3) years, infringed upon, misappropriated or
otherwise violated, any Intellectual Property right of any third party and for the past three (3) years, there has been no Action against, and there is no Action that is currently pending against, the Company or any Company Subsidiary alleging
that the conduct of the business of the Company and the Company Subsidiaries infringes upon, misappropriates or otherwise violates any Intellectual Property rights of a third party except, in the case of clauses (i) or (ii) above, as would not,
individually or in the aggregate, reasonably be expected to be material to the operation of the business of the Company Group, taken as a whole.
(d) No Person (other than the Company or any Company Subsidiary) has access or possession of, or any current or contingent right to access or
possess, any source code included in the material Company Owned Intellectual Property, and no material software included in the Company Owned Intellectual Property has been used, modified, distributed, licensed, conveyed or made available to third
parties by the Company or any Company Subsidiary other than to employees and independent contractors in the ordinary course of business pursuant to a written confidentiality agreement. No material software included in the Company Owned Intellectual
Property incorporates or interacts with any Open Source Software in a manner that would require the Company or any Company Subsidiaries to (i) make any proprietary source code available to any Person, including for the purpose of making
modifications or derivative works, (ii) grant, or purport to grant, to any third party any rights or immunities under any Company Owned Intellectual Property, or (iii) restrict the Company or any Company Subsidiary from charging a fee for
such software owned by the Company or a Company Subsidiary.
(e) The Company and each Company Subsidiary take and have taken commercially
reasonable actions to maintain and preserve the confidentiality of the trade secrets that comprise material Company Owned Intellectual Property. All Persons who have participated in the creation, development, or reduction to practice of any material
Company Owned Intellectual Property for or on behalf of the Company Group have executed and delivered a valid and enforceable agreement providing for (i) the non-disclosure by such Person of any material
trade secrets or other confidential information of the Company Group, and (ii) the assignment by such Person to the Company group of any such material Intellectual Property rights arising out of such Persons employment by, engagement by
or contract with the Company Group (or ownership of such Intellectual Property rights has automatically vested in the Company Group as a matter of Law). To the knowledge of the Company, no Person is in violation of any agreement referenced in this
Section 4.8(e), except for such violations that would not, individually or in the aggregate, material to the operation of the business of the Company Group, taken as a whole.
39
(f) In the last three (3) years, the Company and each Company Subsidiary is, and has
been, in compliance in all material respects with (i) their respective internal and external privacy and security policies, (ii) all applicable Privacy Laws, (iii) all industry and self-regulatory standards to which the Company or any
Company Subsidiary is bound or to which it purports to adhere (including, if applicable, the Payment Card Industry Data Security Standard), and (iv) all Contracts to which the Company or any Company Subsidiary is a party to, or is otherwise
bound, to the extent relating to the collection, use, storage, processing, transfer or disclosure of Personal Data (collectively, Privacy Requirements).
(g) Except as set forth on Schedule 4.8(g) or as would not, individually or in the aggregate, reasonably be expected to be material to
the operation of the business of the Company Group, taken as a whole, in the last three (3) years, there have been (i) no Security Incidents that the Company Group has been subjected to or experienced and (ii) no Actions, complaints,
investigations, or lawsuits related to the Company Groups collection, storage, use, or processing of Personal Data, any Security Incident or Privacy Requirement.
(h) Except as set forth on Schedule 4.8(h) or as would not, individually or in the aggregate, reasonably be expected to be material to
the operation of the business of the Company Group, taken as a whole, in the last three (3) years, there have been (i) no failures, outages, or disruptions of the Company IT Systems and (ii) no incidents of unauthorized access, loss,
or breach of security with respect to the Company IT Systems or any material confidential or proprietary information of the Company Group. For the past three (3) years, the Company and the Company Subsidiaries have implemented and maintained
commercially reasonable safeguards designed to protect the Company IT Systems and the Personal Data transmitted thereby, and the Company IT Systems are sufficient in all material respects for the conduct of the business of the Company Group.
4.9 Compliance with the Laws. For the past three (3) years, the business of the Company Group, taken as a whole, has not been
conducted in material violation of any applicable Laws. For the past three (3) years, no member of the Company Group has received written notice from a Governmental Authority asserting any noncompliance with any applicable Law by any member of
the Company Group that has not been cured as of the date of this Agreement, except for such noncompliance that has not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or materially
impair or delay the Companys ability to effect the transactions contemplated hereby.
4.10 Contracts.
Schedule 4.10 (collectively, the Contracts listed on Schedule 4.10 are referred to herein as the Material Contracts) lists a complete and accurate list of, as of the date of this
Agreement, and copies have been made available to Parent of, all Contracts (other than Company Plans, Leases and purchase orders) to which the Company or any Company Subsidiary is a party or to which their respective assets, property or business are
bound or subject as of the date of this Agreement, which:
(a) are contracts, agreements or instruments relating to Indebtedness for
borrowed money in excess of $5,000,000 (other than any Indebtedness to be paid at Closing under Section 3.4) or creating or granting a material Encumbrance on any assets of the Company Group other than Permitted
Encumbrances;
40
(b) are leases or agreements under which any member of the Company Group (i) is lessee
of or holds or operates, in each case, any tangible property (other than real property), owned by any other Person, except for any lease or agreement under which the aggregate annual rental payments do not exceed $1,000,000 or (ii) is lessor of
or permits any third party to hold or operate, in each case, any tangible property (other than real property), owned or controlled by any member of the Company Group, except for any lease or agreement under which the aggregate annual rental payments
do not exceed $1,000,000;
(c) are contracts, agreements or instruments (i) prohibiting any member of the Company Group from freely
engaging in any current line of business of the Company Group or (ii) restricting in any material respect any member of the Company Group from freely competing with any Person or in any geographic area or offering or selling any product or
service to any Person;
(d) provide for the acquisition or disposition by the Company Group of any capital stock, business, product line
or a material amount of stock or assets of any other Person (whether by merger, sale of stock, sale of assets or otherwise) (A) entered into at any time during the two (2) year period prior to the date of this Agreement, (B) pursuant
to which any member of the Company Group has material remaining obligations (other than customary confidentiality and non-disclosure obligations or customary covenants to provide reasonable access to books and
records), or (C) relating to the grant to any Person of any preferential rights to purchase any of its asserts or property;
(e) are
contracts, agreements or instruments relating to the future disposition or acquisition of material assets or properties by any member of the Company Group, or any merger or business combination with respect to any member of the Company Group;
(f) any Contract (A) under which any member of the Company Group licenses or has rights to any Intellectual Property owned by third
parties or under which any member of the Company Group grants any third party a license or rights to any Company Owned Intellectual Property, in each case, other than (x) any non-exclusive, commercially
available, off-the-shelf software license that provides for payments by any member of the Company Group of less than of $200,000 per annum or (y) non-exclusive licenses granted to customers or resellers or other distributors in the ordinary course of business; (B) for the acquisition, divestiture, or development of material Intellectual Property
(other than employee invention assignment agreements executed on the any member of the Company Groups standard form of agreement); or (C) affecting any member of the Company Groups ability to use or enforce any material Company
Owned Intellectual Property (including concurrent use agreements, settlement agreements, coexistence agreements, and covenant not to sue agreements);
41
(g) are contracts, agreements or instruments that includes any continuing earn-out or other similar contingent or deferred payment obligations on the part of any member of the Company Group in connection with acquisitions by any member of the Company Group of assets or capital
stock or other equity interests of any Person;
(h) are contracts, agreements or instruments that grants any rights of first refusal,
rights of first offer or other similar rights to any Person with respect to any equity interests or material asset of any member of the Company Group;
(i) require any capital commitment or capital expenditure (or series of capital expenditures) by the Company Group in an amount that,
individually or in the aggregate, is greater than $1,000,000, excluding any capital expenditure in connection with patient service equipment or in the ordinary course in accordance with the Companys capital budget;
(j) are contracts or agreements with Top Suppliers or Top Customers (excluding any immaterial addendums or schedules thereto);
(k) are Related Party Agreements;
(l) provide for the indemnification of any Person by the Company or any of its Subsidiaries, other than indemnification provisions arising in
the ordinary course;
(m) are current Government Contracts including all material options and anticipated orders;
(n) are current mentor-protégé agreements, joint venture agreements, strategic alliance, partnership, or any current contracts
awarded in connection with such agreements (including, for the avoidance of doubt, any prime contracts or subcontracts awarded to such a joint venture in which the Company or any Company Subsidiary holds interests);
(o) are not otherwise included in clauses (j), (m) or (n) above, that are contracts, agreements or instruments under which any member of
the Company Group has made payments under of more than $7,500,000 in the twelve (12) calendar months ended the date hereof, or any member of the Company Group has received payments pursuant to, of more than $7,500,000 in the twelve
(12) calendar months ended the date hereof;
(p) are collective bargaining agreements or other labor-related Contracts with a labor
union, works council, labor organization, or other employee representative (each, a Labor Agreement);
42
(q) are settlements, conciliations or similar agreements or pursuant to which the Company
or any Company Subsidiary will have any material outstanding obligation after the date of this Agreement; and
(r) that contain
most favored nation obligations, minimum purchase requirements or commitments or similar restrictions binding on any member of the Company Group.
With respect to all Material Contracts, as of the date of this Agreement, neither the Company, any Company Subsidiary nor, to the knowledge of the Company,
any other party to any such contract is in breach thereof or default thereunder and, to the knowledge of the Company, there does not exist under any Material Contract any event which, with the giving of notice or the lapse of time, would constitute
such a breach or default by the Company, any Company Subsidiary or, to the knowledge of the Company, any other party to such Material Contract, in each case, except for such breaches, defaults and events as to which requisite waivers or consents
have been obtained or which would not, individually or in the aggregate, reasonably be expected to be material to the operation of the business of the Company Group, taken as a whole. Each Material Contract is legal, valid and binding on the
applicable member of the Company Group, is in full force and effect and is enforceable against the applicable member of the Company Group, and, to the knowledge of the Company, against the other parties thereto in accordance with its terms (except
as such enforceability may be limited by the Equitable Exceptions).
With respect to Government Contracts, for the past three
(3) years, except as would not, individually or in the aggregate, reasonably be expected to be material to the operation of the business of the Company Group, taken as a whole: (a) the Company and its Subsidiaries have been in compliance
with applicable legal and contractual requirements, and all invoices and certifications were accurate in all material respects when made; (b) no Government Contract was awarded on the basis of any Small Business status or other
preferred bidder designation, or was awarded or is payable based on incurred costs or a disclosure of pricing offered to other customers or a pricing guarantee, or includes a duty to accumulate, allocate or report costs of performance, or requires
or involves access to classified information or facilities, or provides a Governmental Authority or customer with rights to Intellectual Property other than pursuant to the same standard license offered to commercial customers; (c) neither the
Company nor any of its Subsidiaries nor any of their respective principals, officers, directors, owners or managers have been suspended, debarred or excluded by a Governmental Authority nor been in violation of any applicable requirement regarding
lobbying, political activity or the offering or giving anything of value to a representative of a Governmental Authority; and (d) all Government Contracts were properly awarded and the applicable member of the Company Group has not violated the
federal False Claims Act or other Laws applicable to the formation or performance of Government Contracts, nor have the Company or any of its Subsidiaries received any written notice from a Governmental Authority asserting a claim or regarding an
investigation, audit or legal or administrative proceeding involving the Company or any of its Subsidiaries or their respective principals, officers, directors, owners or managers, or any written assertion of inaccurate certification, improper
billing, false claim, or violation of Law, default termination or material breach related to a Government Contract. Except
43
as would not, individually or in the aggregate, reasonably be expected to be material to the operation of the business of the Company Group, taken as a whole, with respect to contracts awarded by
a Governmental Authority to a joint venture (or any affiliated entity) of which any member of the Company Group is a party (including, for the avoidance of doubt, any contracts awarded in connection with a mentor-protégé agreement),
(i) such contracts are legal, valid and binding on the parties thereto, (ii) representations, certifications and reports made in connection with such contracts and associate procurements conducted by a Governmental Authority were accurate when
made, (iii) the parties to such contracts and associated subcontracts have complied with applicable laws, regulations and restrictions concerning participation of such joint ventures in procurements conducted by a Governmental Authority, and
(iv) neither such contracts nor such joint ventures have been the subject of a Small Business Administration (SBA) certificate of competency, size determination, size protest, size appeal or a review of eligibility of any
status under the administration of the SBA, nor any revocation of or challenge to eligibility under programs of the Department of Veterans Affairs (VA) promoting the participation of small businesses and/or veteran-owned
businesses in procurements conducted by a Governmental Authority; nor have there been any bid protests or administrative or court proceedings challenging the eligibility of such a joint venture or award of such a contract under a procurement
conducted by a Governmental Authority.
4.11 Litigation. Except as set forth on Schedule 4.11, there are
no, and for the past three (3) years there have not been, any Actions pending, settled, threatened in writing by or against the Company or any Company Subsidiary, by or before any Governmental Authority that, individually or in the aggregate,
would reasonably be expected to be material to the operation of the business of the Company Group, taken as a whole, or would or would reasonably be expected to affect the Companys ability to consummate the transactions contemplated hereby.
Except as set forth on Schedule 4.11, neither the Company nor any Company Subsidiary is subject to any material unsatisfied order, judgment, injunction, ruling, decision, award, writ or decree of any Governmental Authority.
4.12 Taxes. Except as set forth on Schedule 4.12:
(a) All IRS Form 1120s and other material Tax Returns required to be filed by or with respect to the Company or any Company Subsidiary have
been timely (within any applicable extension periods) filed, and all such Tax Returns are complete and correct in all material respects.
(b) The Company Group has fully and timely paid all U.S. federal Income Tax and other material Taxes due and owing by any member of the
Company Group (whether or not shown as due and owing on a Tax Return).
(c) All U.S. federal Income Tax and other material deficiencies
for Taxes asserted or assessed in writing against the Company or the Company Subsidiaries have been fully and timely (within any applicable extension periods) paid or settled.
44
(d) No Action with respect to U.S. federal Income Tax and other material Taxes or Tax
Returns of the Company or a Company Subsidiary is pending or, threatened in writing (and not finally resolved). There are no requests for rulings or determinations in respect of any U.S. federal Income Tax and other material Tax pending between a
member of the Company Group, on the one hand, and any Governmental Authority, on the other hand.
(e) There are no outstanding agreements
extending or waiving the statutory period of limitations applicable to any U.S. federal Income Tax and other material claim for, or the period for the collection or assessment or reassessment of, any U.S. federal Income Tax and other material Taxes
due from the Company or any Company Subsidiary for any taxable period and no written request for any such waiver or extension is currently pending, and there is not in force any extension of time with respect to the date for the filing of any Income
Tax and other material Tax Return by the Company or any Company Subsidiary (other than extensions obtained in the ordinary course of business).
(f) Neither the Company nor any Company Subsidiary will be required to include any material item of income in, or exclude any material item
of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (A) change in method of accounting (and associated adjustment pursuant to Code Section 481 or any corresponding
or similar provision of state, local or non-U.S. Law)made prior to Closing in respect of a taxable period (or portion thereof) ending on or prior to the Closing Date; (B) the use of an improper method of
accounting prior to Closing, (C) closing agreement as described in Section 7121 of the Code (or any corresponding or similar provision of state, local or non-U.S. Tax Law) executed prior to
the Closing; (C) installment sale or open transaction disposition made prior to Closing; or (D) prepaid amount received or deferred revenue accrued prior to the Closing (other than prepaid amounts or deferred revenue arising in the
ordinary course of business).
(g) There are no liens for Taxes (other than liens for Taxes not yet due and payable) on any assets of the
Company or any Company Subsidiary.
(h) Neither the Company nor any Company Subsidiary has been a member of an Affiliated Group as
defined in Section 1504 of the Code (or any analogous combined, consolidated, unitary or similar group under state, local or non-U.S. Law), other than any such group the common parent of which is the
Company or a Company Subsidiary. Neither the Company nor any Company Subsidiary is liable for material Taxes of any Person (other than a member of the Company Group) under Treasury Regulations
Section 1.1502-6 (or the corresponding provision of state, local or non-U.S. Law), as a transferee or successor, by contract or operation of Law, or otherwise.
(i) Within the last two years, neither the Company nor any Company Subsidiary has been a party to a transaction that was purported or
intended to be governed by Section 355 or Section 361 of the Code.
45
(j) Neither the Company nor any Company Subsidiary is or has been a party to any
reportable transaction within the meaning of Treasury Regulations Section 1.6011-4(b).
(k) The Company and each of its Subsidiaries is in material compliance with applicable Laws relating to the withholding of any Taxes required
to be withheld and paid to an applicable Governmental Authority in connection with any amounts paid or owing to any employee, independent contractor, creditor, stockholder or other third party.
(l) With respect to a member of the Company Group, no unresolved written claim has been made by a taxing authority in a jurisdiction where
such member of the Company Group does not file Tax Returns claiming that such member of the Company Group is or may be required to file a Tax Return in such jurisdiction.
(m) Neither the Company nor any Company Subsidiary is a party to any written Tax sharing, allocation, indemnification, apportionment or
similar agreement (other than any contract the principal purpose of which is not related to Taxes (such as a loan or a lease)).
(n) No
private letter rulings, technical advance memoranda or similar agreements or rulings have been entered into or issued by any taxing authority to the Company or any Company Subsidiary that could have any effect after Closing.
(o) All material sales and use and value added Taxes required to be collected and remitted by the Company Group have been timely collected
and to the extent required, have been remitted to the relevant Governmental Authority.
(p) The Company Group has complied in all
material respects with all escheat and abandoned or unclaimed property Laws and does not have any material liability under any escheat, abandoned or unclaimed property Laws.
(q) No member of the Company Group is a resident, or has a permanent establishment (within the meaning of an applicable Tax treaty) or
otherwise has an office or fixed place of business, in a country other than the United States.
(r) Neither the Company nor any of its
Subsidiaries is or has been in the last five years a United States shareholder (within the meaning of Section 951(b) of the Code) with respect to a controlled foreign corporation (within the meaning of
Section 957(a) of the Code).
4.13 Permits. Schedule 4.13 lists each material license, permit, registration, emergency
authorization, approval, and other governmental authorization, that is held by the Company Group and is necessary for the lawful conduct of the Companys and each Company Subsidiarys businesses as presently conducted, or the lawful
ownership of properties and assets or the operation of their businesses as presently conducted (collectively, Permits). The Company Group has not received any notice or other written communication from any Governmental Authority
or any other Person regarding any actual, alleged, or potential violation of, failure to comply with, revocation, withdrawal, suspension, cancellation, termination or modification (excluding recurring renewal notifications) of any Permit. The
Company Group has, and for the past three (3) years has had, all material Permits. All such Permits are in full force and effect.
46
4.14 Employee Benefit Plans.
(a) Schedule 4.14(a) contains a true and complete list of each Company Plan. For purposes of this Agreement, a
Company Plan is a material written employee benefit plan (within the meaning of Section 3(3) of ERISA), stock purchase, stock option or other equity or equity-based, severance, employment, consulting, change-in-control, fringe benefit, collective bargaining, bonus, incentive, deferred compensation, profit sharing, pension, retirement, health, welfare benefit,
post-employment or post-termination welfare, leave, salary continuation, life or disability insurance, or other employee benefit or compensation, contract, arrangement plan, agreement, program or policy, whether or not subject to ERISA, sponsored,
maintained, contributed to or required to be contributed to by the Company or any Company Subsidiary or with respect to which the Company or any Company Subsidiary has or could reasonably be expected to have any current or contingent liability or
obligation.
(b) With respect to each Company Plan, the Company has made available to Parent, complete, accurate and current copies of,
to the extent applicable: (i) the plan documents, any related trust agreements and all amendments thereto (or, to the extent no document exists, a written description of all material terms thereof); (ii) the most recent IRS determination
letter; (iii) the most recent summary plan description; (iv) all related insurance contracts or other funding arrangements; and (v) for the most recent plan year (A) the Form 5500 and attached schedules and (B) audited
financial statements.
(c) (i) Each Company Plan has been established and administered in accordance with its terms, and in
compliance with the applicable provisions of ERISA, the Code and other applicable Laws, except as would not, individually or in the aggregate, reasonably be expected to be material to the operation of the business of the Company Group, taken as a
whole; (ii) each Company Plan that is intended to be qualified within the meaning of Code Section 401(a) has received a favorable determination letter from the IRS as to its qualification, and, to the knowledge of the Company, nothing has
occurred that could reasonably be expected to cause the loss of such qualification; and (iii) except as set forth on Schedule 4.14(c), neither the Company nor any Company Subsidiary has any liability or obligation, including under
any Company Plan, to provide medical, death or other welfare benefits to any Person beyond their termination of employment or service (other than coverage mandated by Law for which the covered individual pays the full cost of coverage).
(d) Except as set forth on Schedule 4.14(d), none of the Company Plans are, and neither the Company nor any Company Subsidiary
maintains sponsors, contributes to, has an obligation to contribute to or has any current or contingent liability or obligation (including on account of an ERISA Affiliate), under or with respect to: (i) any defined benefit plan (as
defined under Section 3(35) of ERISA) or any other
47
plan that is or was subject to Section 302 or Title IV of ERISA or Section 412 or 430 of the Code, (ii) a multiemployer plan (as defined under Section 3(37) of
ERISA), (iii) a multiple employer plan (within the meaning of Section 210 of ERISA or Section 413(c) of the Code), or (iv) a multiple employer welfare arrangement (within the meaning of Section 3(40) of
ERISA). Neither the Company nor any Company Subsidiary has any current or contingent liability or obligation as a consequence of at any time being considered a single employer under Section 414 of the Code with any other Person.
(e) With respect to any Company Plan, no Actions (other than routine claims for benefits in the ordinary course) are pending or, to the
knowledge of the Company, threatened, except, in each case, as would not, individually or in the aggregate, reasonably be expected to be material to the operation of the business of the Company Group, taken as a whole. There has been no
prohibited transaction within the meaning of Section 4975 of the Code or Section 406 or 407 of ERISA and no breach of fiduciary duty (as determined under ERISA) has occurred with respect to any Company Plan, except as would
not, individually or in the aggregate, reasonably be expected to be material to the operation of the business of the Company Group, taken as a whole.
(f) Neither the Company nor any Company Subsidiary has incurred (whether or not assessed) or could reasonably be expected to incur any
material Tax or penalty under Sections 4980B, 4980D, 4980H, 6721 or 6722 of the Code.
(g) Neither the execution and delivery of this
Agreement, nor the consummation of the transactions contemplated hereby, either alone or in combination with another event, could: (i) entitle any current or former employee, officer, director or other individual service provider of the Company
or any Company Subsidiary (or any dependent or beneficiary thereof) to any material payment of compensation or benefits (whether in cash, property or the vesting of property); (ii) materially increase the amount of compensation or benefits due
or payable to any such person set forth in the preceding clause (i); (iii) accelerate the vesting, funding or time of payment of any compensation, equity award or other benefit; (iv) require a contribution by the Company or any Company
Subsidiary to any Company Plan; (v) restrict the ability of the Company or any Company Subsidiary to merge, amend or terminate any Company Plan or (vi) result in the forgiveness of any employee or service provider loan.
(h) No payment or benefit, individually or together with any other payment or benefit, that could be received (whether in cash, property or
the vesting of property), as a result of the transactions contemplated by this Agreement, either alone or in combination with another event, by any current or former employee, officer, director or other individual service provider of the Company or
any Company Subsidiary would not be deductible by reason of Section 280G of the Code or would be subject to an excise tax under Section 4999 of the Code.
(i) Neither the Company nor any Company Subsidiary has any current or contingent obligation to indemnify,
gross-up, reimburse or otherwise make whole any Person for any Taxes, including those imposed under Section 4999 or Section 409A of the Code (or any corresponding provisions of state, local or
foreign Tax law).
48
4.15 Labor Relations.
(a) Except as disclosed on Schedule 4.15(a) or as would not, individually or in the aggregate, reasonably be expected to be material
to the operation of the business of the Company Group, taken as a whole, in the last three years: (i) neither the Company nor any of the Company Subsidiaries have experienced any work stoppage, labor strike, lockout, slowdown, material labor
grievance, material labor arbitration or other material labor dispute, (ii) there have been no labor organizing, certification or de-certification activities with respect to any employees of the Company
or any of the Company Subsidiaries, and (iii) there has been no unfair labor practice charge or complaint against the Company or any of the Company Subsidiaries pending before the National Labor Relations Board or any similar Governmental
Authority.
(b) Except as disclosed on Schedule 4.15(b), neither the Company nor any of the Company
Subsidiaries is a party to or bound by any Labor Agreement or relationship with any labor union, labor organization, works council, employee representative or group of employees and no employees of the Company or any of the Company Subsidiaries are
represented by any labor union, labor organization, works council, employee representative or group of employees with respect to their employment with the Company or any of the Company Subsidiaries.
(c) The Company and each of the Company Subsidiaries have reasonably and impartially investigated all sexual harassment, or other harassment,
discrimination or retaliation allegations (except those the Company or the applicable Company Subsidiary reasonably deemed to not have merit), against any officers, directors, executives or supervisory employees of the Company or any Company
Subsidiary that have been reported to the Company or any Company Subsidiary or of which the Company or any Company Subsidiary was otherwise aware in the past three years, except as would not, individually or in the aggregate, reasonably be expected
to be material to the operation of the business of the Company Group, taken as a whole. With respect to each such allegation (except those the Company or the applicable Company Subsidiary reasonably deemed to not have merit), the Company or the
applicable Company Subsidiary has taken prompt corrective action reasonably calculated to prevent further improper action, and does not expect any material liability with respect to any such matters.
(d) To the knowledge of the Company, as of the date of this Agreement, no current employee whose total annual compensation (i.e.,
annual base salary and target bonus) exceeds $150,000, intends to terminate his or her employment with the Company or any Company Subsidiary prior to the one-year anniversary of the Closing.
(e) To the knowledge of the Company, no current or former employee or independent contractor of the Company or any Company Subsidiary whose
total annual compensation (i.e., annual base salary and target bonus) exceeds $150,000 is in any material respect in violation of any term of any employment agreement, nondisclosure agreement, fiduciary duty, noncompetition agreement or
restrictive covenant obligation: (i) owed to the Company or any Company Subsidiary, or (ii) owed to any third party with respect to such persons right to be employed or engaged by the Company or any Company Subsidiary.
49
4.16 Environmental Compliance. Except as set forth on
Schedule 4.16, (i) the Company Group is, and for the past three (3) years has been, in compliance with all applicable Environmental Laws, except where the failure to be in compliance would not, individually or in the
aggregate, have a Material Adverse Effect; (ii) for the past three (3) years, the Company Group has obtained, maintained and complied with all Permits required under any applicable Environmental Laws for the operation of the business and
occupancy of the facilities of the Company Group as presently conducted, except where the failure to obtain, maintain and comply with such Permits would not, individually or in the aggregate, have a Material Adverse Effect; (iii) there are no
material pending or threatened Environmental Claims against (or, to the extent unresolved, that have been received by) the Company or any Company Subsidiary; and (iv) no treatment, storage, disposal, arrangement for disposal, transportation,
handling, sale, distribution or release of, contamination by or exposure of any person to any Hazardous Substance has occurred (including on, in, under or from the Real Property for which the Company has any material liability or obligation under
any Environmental Law), including to perform any investigation or remedial action. The Company has made available to Parent all material environmental assessments, audits and reports and all other material documents bearing on material unresolved
environmental, health or safety liabilities in the Companys custody or control relating to its current or former operations, properties or facilities, including any actual or potential conditions of contamination on the Real Property.
4.17 Insurance. All material insurance policies (the Insurance Policies) with respect to the properties, business
and material assets of the Company Group are in full force and effect in all material respects. No member of the Company Group is in breach or default with respect to its obligations under any such insurance policies, and all premiums due thereon
have been paid. As of the date of this Agreement, neither the Company nor any Company Subsidiary has received either a written notice of a material increase of premiums with respect to, or cancellation, default, termination or non-renewal of, any Insurance Policy. The Company has made available to Parent true, correct and complete copies of all of the Insurance Policies and loss runs thereunder for the last two (2) years in respect
of the Company Group.
4.18 Real Property; Title to Assets.
(a) Schedule 4.18(a) sets forth a complete and accurate list of all of the real property owned by the Company or
any of the Company Subsidiaries (such real property, the Owned Real Property). The Company Group has valid fee simple title to the Owned Real Property free and clear of any Encumbrances other than Permitted Encumbrances. Except as
set forth in Schedule 4.18(a), (i) the Company Group has not leased or otherwise granted to any Person the right to use or occupy such Owned Real Property or any portion thereof and there are no outstanding options, rights
of first offer or rights of first refusal to purchase such Owned Real Property or any portion thereof or interest therein. The Company Group is not a party to any agreement or option to purchase any real property.
50
(b) Schedule 4.18(b) contains a complete and accurate list as of
the date of this Agreement of (i) all real property leased or subleased by the Company Group as lessee or sublessee for which the annual rent exceeds $200,000 (the Leased Real Property, and together with the Owned Real
Property, the Real Property) and (ii) all leases or subleases of the Leased Real Property under which the Company or any of the Company Subsidiaries leases or subleases the Leased Real Property, as lessee or sublessee (as the
same may have been amended, supplemented or otherwise modified from time to time, the Leases). The Company has delivered to Parent a true and complete copy of each such Lease document. The Company or a Company Subsidiary, as
applicable, has valid, legal, binding and enforceable leasehold interests in full force and effect in the Leased Real Property. Except as would not, individually or in the aggregate, reasonably be expected to be material to the operation of the
business of the Company Group, taken as a whole, with respect to the Leases, (i) neither the Company nor any Company Subsidiary is in breach thereof or default thereunder in each case except for such breaches and defaults as to which requisite
waivers or consents have been obtained, and no event has occurred or circumstance exists which, with the delivery of notice, the passage of time or both, would constitute such a breach or default, or permit the termination, modification or
acceleration of rent under such Lease, in each case except for such breaches, defaults, events and circumstances as to which requisite waivers or consents have been obtained; (ii) the Company has not subleased, licensed or otherwise granted any
Person the right to use or occupy the Leased Real Property subject to such Lease or any portion thereof; and (iii) the Company Group has not collaterally assigned or granted any security interest in any Leased Real Property or any interest
therein, except for assignments or security interests (x) in favor of the lessor or sublessor under a Lease, or (y) securing liabilities set forth on Schedule 4.7(b) or the Financial Statements.
(c) Except as set forth on Schedule 4.18(c), the Company or a Company Subsidiary, as applicable, has good and valid title to all of
its material tangible and intangible assets, personal and mixed, used or held for use in, or which are necessary to conduct, the business of the Company Group as currently conducted, free and clear of any Encumbrances other than Permitted
Encumbrances.
4.19 Affiliate Transactions. Except (a) for compensation or indemnification of directors, employment
relationships and compensation, benefits, travel advances and employee loans in the ordinary course of business or (b) as otherwise disclosed on Schedule 4.19, neither the Company nor any Company Subsidiary is a party
to any agreement with, or involving the making of any payment or transfer of assets to, any Related Parties. No Related Party (i) owns any asset, property or right, tangible or intangible, used by any member of the Company Group or (ii) is
owed any payment or obligation by any member of the Company Group (other than payments and obligations under Contracts disclosed in Schedule 4.19 or as described in clause (a) of the first sentence of this
Section 4.19). Following the Closing, no Related Party will own, lease or have any economic or any other right, in or to any asset or property that is used in the operation of the business of the Company Group.
51
4.20 Absence of Certain Changes or Events. Except as set forth on
Schedule 4.20, or as otherwise contemplated by this Agreement, since the date of the Audited Balance Sheet for the year ended December 31, 2023 through the date of this Agreement (a) the Company and each Company
Subsidiary have conducted their respective businesses in the ordinary course of business and they have not engaged in any of the activities prohibited by Sections 6.1(e), (h), (i), (j), (k) (with respect to
termination of Material Contracts), (l), (m), (n), (o), (q), (s), or (v) (to the extent related to the foregoing subsections) of this Agreement and (b) there has been no Material Adverse Effect.
4.21 Suppliers and Customers.
(a) Schedule 4.21(a) sets forth a complete and accurate list of the names of the ten largest suppliers of the
Company measured by dollar value for the twelve (12) calendar months ended on June 30, 2024 (Top Suppliers). As of the date of this Agreement, none of the suppliers listed on Schedule 4.21(a)
has notified in writing the Company or any Company Subsidiary that it is canceling, terminating or substantially reducing its relationship with the Company or any Company Subsidiary.
(b) Schedule 4.21(b) sets forth a complete and accurate list of the names of the ten largest customers of the
Company measured by dollar value for the twelve (12) calendar months ended on June 30, 2024 (Top Customers). As of the date of this Agreement, none of the customers listed on Schedule 4.21(b)
has notified in writing the Company or any Company Subsidiary that it is canceling, terminating or substantially reducing its relationship with the Company or any Company Subsidiary.
(c) There has been no material dispute or controversy or, to the knowledge of the Company Group, any threatened material dispute or
controversy, between the Company or any Company Subsidiary, on the one hand, and any Top Customer or Top Supplier on the other hand.
4.22
Healthcare Regulatory Matters.
(a) The Company and the Company Subsidiaries are, and for the past three (3) years have been,
in material compliance with all applicable Healthcare Laws. Since January 1, 2021, the Company and the Company Subsidiaries have not received any written notice, including any healthcare related Action from any Governmental Authority or any
other Person regarding any material noncompliance of any applicable Healthcare Law. No such notice or Action has been filed, commenced, or to the knowledge of the Company, threatened, against the Company or the Company Subsidiaries alleging that the
Company or any Company Subsidiary is not in material compliance with Healthcare Laws.
(b) Neither the Company nor the Company
Subsidiaries nor any of their respective officers, directors, employees, or managing employees (as such term is defined in 42 U.S.C. § 1320a-5(b)), or, to the knowledge of the Company, contractors,
vendors, or agents is or has been: (i) convicted of or pled nolo contendere to sufficient facts regarding, any violation of a Healthcare Law, including any Law applicable to a Governmental Health Program or any other criminal offense that would
result in mandatory exclusion from Governmental Health Programs; (ii) are or have been excluded, suspended,
52
disqualified or debarred from participation in, or are otherwise ineligible to participate in, any Governmental Health Program or listed on the General Services Administration-published list of
parties excluded from procurement programs and non-procurement programs; (iii) have entered into any corporate integrity agreement, deferred prosecution agreement,
non-prosecution agreement, or similar agreement or settlement with any Governmental Authority with respect to any actual or alleged violation of any Healthcare Law; or (iv) have made, or are in the
process of making, or are considering making a voluntary self-disclosure as may be required or permitted under any Healthcare Law.
(c)
The Company and the Company Subsidiaries maintain, and have at all times maintained, a compliance program having the elements of an effective corporate compliance and ethics program identified in U.S.S.G. § 8B2.1. There are no material
compliance complaints or reports outstanding, ongoing internal compliance investigations or compliance corrective actions outstanding.
(d) The Company and the Company Subsidiaries are and for the past three (3) years have been, in compliance in all material respects with
HIPAA. The Company and the Company Subsidiaries have not received written notice of, and there is no Action or, to the Companys Knowledge, pending or threatened with respect to any alleged breach (as defined in HIPAA) by the
Company or other members of the Company Group or their respective workforce. Except as set forth on Schedule 4.22, for the past three (3) years, no breach by the Company or the Company Subsidiaries or, to the
knowledge of the Company, their respective workforce or successful security incident has occurred with respect to protected health information (as such terms are defined by HIPAA) in the possession or under the
control of the Company and the Company Subsidiaries. The Company and the Company Subsidiaries have conducted a risk analysis as required by HIPAA and have implemented corrective actions to address all high-risk vulnerabilities identified through
such analysis. The Company and the Company Subsidiaries have written, signed and HIPAA-compliant business associate agreements with each Person that is a covered entity or business associate (as such terms are defined in
HIPAA) where required by HIPAA, and have materially complied with such agreements. The Company and the Company Subsidiaries have maintained a HIPAA compliance program, including written policies and procedures that address its HIPAA compliance
efforts.
(e) Except as set forth on Schedule 4.22(e), prior to the date hereof, the Company has provided to Parent a true,
complete, and correct (i) listing of active or suspended, but still ongoing (x) Targeted Probe and Educate (TPE) audits and (y) Unified Program Integrity Contractor (UPIC) audits, and
(ii) letters of commencement and closure of the same, in each case, in existence as of the date hereof.
4.23 FDA Regulatory
Matters.
(a) Except as set forth on Schedule 4.23(a), for the past three (3) years, there have been no recalls, field
actions, corrections, or removals ordered by any Governmental Authority, including the FDA, or any seizures or adverse regulatory actions taken (or, to the knowledge of the Company, threatened), by the FDA or any other Governmental Authority with
respect to any of the Company Products or, to the knowledge of the Company, any facilities where any Company Products are manufactured, packaged or stored.
53
(b) For the past three (3) years, none of the members of the Company Group has
voluntarily initiated or participated in any recalls, field actions, corrections, or removals (other than for commercial business reasons) of any of the Company Products.
(c) For the past three (3) years, all material reports, documents, claims, permits, notices, and other filings required to be filed,
maintained or furnished to the FDA or any other Governmental Authority by the Company or the Company Subsidiaries under FDA Regulatory Laws have been so filed, maintained or furnished in accordance with FDA Regulatory Laws. All such material
reports, documents, claims, permits, notices, and filings were true and complete in all material respects on the date filed (or were corrected in or supplemented by a subsequent filing).
(d) For the past three (3) years, the Company and the Company Subsidiaries have not, nor to the knowledge of the Company, has any
officer, employee, or agent of the Company or the Company Subsidiaries, made an untrue statement of a material fact or a fraudulent statement to the FDA or any other Governmental Authority, failed to disclose a material fact required to be disclosed
to the FDA or any other Governmental Authority, or committed an act, made a statement, or failed to make a statement, in each such case related to the business of the Company or Company Subsidiaries, that, at the time such disclosure was made, would
reasonably be expected to provide a basis for the FDA to invoke its policy respecting Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities, set forth in 56 Fed. Reg. 46191 (September 10, 1991) or for any other
Governmental Authority to invoke any similar policy.
(e) Each Company Product is being, and for the past three (3) years has been,
manufactured, labeled, stored, distributed, and marketed, as applicable, by each member of the Company Group in compliance with all applicable FDA Regulatory Laws. There is no Action pending or, to the knowledge of Company, threatened in writing,
including any prosecution, injunction, seizure, civil fine, debarment, suspension or recall, against any member of the Company Group in each case alleging any material violation applicable to any Company Product by a Governmental Authority of any
applicable FDA Regulatory Law.
4.24 Brokers. Except for Jefferies, LLC, no broker, finder or similar intermediary has acted for or
on behalf of the Company or any Company Subsidiary in connection with this Agreement or the transactions contemplated hereby, and no broker, finder, agent or similar intermediary is entitled to any brokers, finders or similar fee or
other commission in connection therewith based on any agreement with the Company or any Company Subsidiary or any action taken by them.
54
4.25 Exclusivity of Representations. Except for the representations and warranties
made by the Company in this Article 4 (as qualified by the Disclosure Schedules) or in the certificate delivered by the Company pursuant to Section 7.4, neither the Company nor any other Person
makes or has made any representation or warranty, express or implied, at law or in equity, with respect or on behalf of the Company or the Company Subsidiaries, their businesses, operations, assets, liabilities, financial condition, results of
operation, future operating or financial results, estimates, projections, forecasts, plans or prospects (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, plans or prospects) or the accuracy or
completeness of any information regarding the Company or the Company Subsidiaries or to any other matter furnished or provided to Parent, Merger Sub or any of their respective Affiliates or Agents or made available to Parent, Merger Sub or any of
their respective Affiliates or Agents in any data rooms, management presentations or in any other form in the expectation of, or in connection with, this Agreement or the transactions contemplated hereby. Each of the Company and the
Company Subsidiaries disclaim any other representations or warranties, whether made by the Company or any Company Subsidiaries or any of their respective Affiliates or Agents.
ARTICLE 5
REPRESENTATIONS
AND WARRANTIES OF PARENT AND MERGER SUB
Parent and Merger Sub, jointly and severally, represent and warrant to the Company and the
Representative (on behalf of the Equityholders) as of the date of this Agreement and as of the Closing Date (except for such representations and warranties expressly stated to relate to an earlier date, in which case, as of such earlier date) as
follows:
5.1 Organization. Parent is a corporation duly organized, validly existing and in good standing under the Laws of the
State of Virginia. Merger Sub is a corporation duly organized, validly incorporated, and in good standing under the Laws of its state of incorporation. Each of Parent and Merger Sub has all requisite corporate power and authority to own its
properties and carry on its business in all material respects as presently owned or conducted, except where the failure to be so organized, existing and in good standing or to have such power or authority would not reasonably be expected,
individually or in the aggregate, to materially impair or delay such Persons ability to effect the transactions contemplated hereby.
5.2 Ownership of Merger Sub; No Prior Activities. Merger Sub is a wholly-owned subsidiary of
Parent, was formed solely for the purpose of engaging in the transactions contemplated by this Agreement and has engaged in no business activity other than as contemplated by this Agreement. Except for obligations or liabilities incurred in
connection with the transactions contemplated by this Agreement, Merger Sub has not and will not have incurred, directly or indirectly, through any subsidiary or Affiliate, any obligations or liabilities or engaged in any business activities of any
type or kind whatsoever or entered into any agreements or arrangements with any Person.
55
5.3 Authority; Binding Obligation. Each of Parent and Merger Sub has all requisite
corporate authority and power to execute, deliver and perform this Agreement and the Ancillary Documents to which Parent and/or Merger Sub is a party, as applicable , and to consummate the transactions contemplated hereby. This Agreement and the
Ancillary Documents to which Parent and/or Merger Sub is a party, as applicable, and the consummation of the transactions contemplated hereby have been duly and validly authorized by all necessary corporate action on the part of each of Parent and
Merger Sub, and no other proceedings on the part of Parent or Merger Sub are necessary to authorize the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby by such Person. This Agreement
and the Ancillary Documents to which Parent and/or Merger Sub is a party, as applicable, have been duly executed and delivered by each of Parent and Merger Sub and, assuming that this Agreement constitutes the legal, valid and binding obligations of
the Company, constitute the legal, valid and binding obligations of such Person, enforceable against it in accordance with its terms, except to the extent that the enforceability thereof may be limited by the Equitable Exceptions.
5.4 No Defaults or Conflicts. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby
by Parent and Merger Sub and the performance by such Person of its respective obligations hereunder (a) do not result in any violation of the Organizational Documents of such Person, (b) except as set forth on
Schedule 5.4, do not conflict with, or result in a breach of any of the terms or provisions of, or constitute a default under any indenture, mortgage or loan or any other agreement or instrument to which Parent or Merger
Sub is a party or by which it is bound or to which its properties may be subject, and (c) do not violate any existing applicable Law, judgment, order or decree of any Governmental Authority having jurisdiction over Parent, Merger Sub or any of
their respective properties; provided, however, that no representation or warranty is made in the foregoing clauses (b) or (c) with respect to matters that would not reasonably be expected, individually or in the aggregate,
to materially impair or delay the ability of Parent or Merger Sub to effect the transactions contemplated hereby.
5.5 No Authorization
or Consents Required. Other than as listed on Schedule 4.6, no authorization or approval or other action by, and no notice to or filing with, any Governmental Authority or any other Person will be required to be
obtained or made by Parent or Merger Sub in connection with the due execution, delivery and performance by Parent or Merger Sub of this Agreement and the consummation by either such Person of the transactions contemplated hereby; provided,
however, that no representation and warranty is made with respect to authorizations, approvals, notices or filings with any Governmental Authority that, if not obtained or made, would not reasonably be expected, individually or in the
aggregate, to materially impair or delay the ability of Parent or Merger Sub to effect the transactions contemplated hereby.
5.6
Brokers. Except for Citigroup Global Markets, Inc., no broker, finder or similar intermediary has acted for or on behalf of Parent or Merger Sub in connection with this Agreement or the transactions contemplated hereby, and no broker, finder,
agent or similar intermediary is entitled to any brokers, finders or similar fee or other commission in connection therewith based on any agreement with Parent, Merger Sub or any action taken by Parent or Merger Sub.
56
5.7 Financing.
(a) As of the Closing, assuming the Debt Financing is funded in accordance with the terms of the Debt Commitment Letter, Parent will have,
sufficient unrestricted cash on hand or other sources of immediately available funds (including taking into account existing bank borrowing commitments) to enable Parent to complete the transactions contemplated by this Agreement, and to satisfy all
of the obligations of the Parent under this Agreement, including (A) paying all of the obligations of Parent under Section 3.4(a) (including the Closing Merger Consideration, the Credit Facilities Payoff Amount and the
Company Expenses, each at Closing and any adjustment payments to the Aggregate Closing Merger Consideration in accordance with Section 3.5), and (B) paying all related fees and expenses (the amount sufficient for the
purposes described in the foregoing, the Required Amount). Notwithstanding anything to the contrary in this Agreement, Parent understands and acknowledges that receipt or availability of any funds or any financing by Parent or any
of its Affiliates (including the Debt Financing) is not, and shall not be, a condition to Parents and/or Merger Subs obligations hereunder.
(b) Parent has delivered to the Company true, correct and complete copies of (i) the executed Debt Commitment Letter to Parent from
Citigroup Global Markets Inc. (Citigroup Global Markets Inc. and each Person that has not executed the Debt Commitment Letter as of the date hereof but becomes a party thereto after the date hereof and has committed to provide the Debt Financing
under the Debt Commitment Letter, collectively, the Debt Financing Sources) pursuant to which the Debt Financing Sources have committed to provide debt financing to Parent in the amount set forth therein, the proceeds of which
shall be available on the Closing Date for the purposes of funding the transactions contemplated by this Agreement (the Debt Financing) and (ii) each fee letter entered into in connection with the Debt Financing
(collectively, the Fee Letter), subject, in the case of the Fee Letter, to redaction solely of fee amounts, pricing, other economic provisions and market flex terms that are customarily redacted in connection with
transactions of this type, and that could not in any event (x) impose or permit the imposition of additional conditions or modify or permit the modification of any existing conditions, in each case, to the funding of the full amount of the Debt
Financing at the Closing or (y) could reasonably be expected to reduce the aggregate amount of the Debt Financing available to Parent at the Closing below the amount necessary to fund the Required Amount or prevent, delay or impede the Closing.
(c) The execution, delivery and performance of the Debt Commitment Letter and Fee Letter by Parent and, to the knowledge of Parent, each
other Person party thereto, and the consummation of the transactions contemplated thereby, have been duly and validly authorized by all requisite action by Parent and, to the knowledge of Parent, each other Person party thereto, and no other action
on the part of Parent or any other Person party thereto is necessary to authorize the execution, delivery or performance of the Debt Commitment Letter and Fee Letter by Parent or, to the knowledge of Parent, any other Person party thereto.
57
(d) The Debt Commitment Letter and Fee Letter have been duly and validly executed and
delivered by Parent and, to the knowledge of Parent, each other Person party thereto, and each of the Debt Commitment Letter and Fee Letter constitutes the valid and binding obligation of Parent and, to the knowledge of Parent, each other Person
party thereto, enforceable against Parent and each such other Person party thereto in accordance with its terms, except to the extent that the enforceability thereof may be limited by the Equitable Exceptions. Parent is not aware of any fact, event
or other occurrence that makes any of the representations or warranties of Parent in the Debt Commitment Letter misleading or inaccurate in any material respect. The Debt Commitment Letter has not been amended or modified prior to the date hereof,
and no such amendment or modification is contemplated as of the date hereof (and the commitment contained in the Debt Commitment Letter has not been withdrawn or rescinded in any respect (and no such withdrawal or rescission is contemplated as of
the date hereof)).
(e) Assuming the satisfaction of the conditions precedent set forth in Article 7, no event
has occurred that, with or without notice, lapse of time or both, would, or would reasonably be expected to, constitute a default or breach on the part of Parent under the Debt Commitment Letter or Fee Letter.
(f) As of the date of this Agreement, the Debt Commitment Letter, together with the Fee Letter, constitute the entire and complete agreement
among the parties thereto with respect to the transactions contemplated thereby and the financing for the transactions contemplated by this Agreement, and, except as expressly set forth in the Debt Commitment Letter, (i) there are
no conditions to the obligations of the Debt Financing Sources to fund the Debt Financing on the Closing Date, and (ii) there are no contractual contingencies or other provisions under any agreement (including any side letters,
arrangements, understandings or other agreements (written or oral)) relating to the transactions contemplated by this Agreement that would or would reasonably be expected to permit the Debt Financing Sources to reduce, restrict or limit the
total amount of the Debt Financing to an amount that is less than the Required Amount or impose any additional conditions or modify any existing conditions, in each case, to the funding of the full amount of the Debt Financing on the Closing Date or
otherwise adversely affect or delay the ability of Parent to consummate the transactions contemplated by this Agreement on a timely basis. Any commitments and other fees required to be paid under the Debt Commitment Letter and the Fee Letter prior
to the date hereof have been paid in full. As of the date hereof, the Parent does not have any reason to believe that any of the conditions to the Debt Financing will not be satisfied on a timely basis or that the full amount of the Debt Financing
will not be made available to Parent on a timely basis in order to consummate the transactions contemplated by this Agreement on the Closing Date.
58
5.8 Litigation. There is no Action pending or, to the knowledge of Parent, threatened
against Parent, Merger Sub or any material portion of any of their respective properties or assets before any Governmental Authority which would reasonably be expected, individually or in the aggregate, to materially impair or delay the ability of
Parent or Merger Sub to effect the transactions contemplated hereby.
5.9 Solvency. Assuming (i) the accuracy of the
representations and warranties set forth in Article 4 in all material respects, (ii) the conditions to Closing set forth in Article VIII are satisfied and (iii) the performance by the Company of its obligations
hereunder in all material respects, immediately after giving effect to the Merger and the other transactions contemplated by this Agreement (including any financing in connection with the Closing), Parent, the Surviving Corporation and the Company
Subsidiaries will be Solvent. No transfer of property is being made and no obligation is being incurred in connection with the transactions contemplated by this Agreement with the intent to hinder, delay or defraud either present or future creditors
of Parent, the Surviving Corporation or the Company Subsidiaries.
5.10 Parents Reliance. Each of Parent and
Merger Sub acknowledges that it and its Agents have been permitted full and complete access to the books and records, facilities, equipment, Tax Returns, Contracts, insurance policies (or summaries thereof) and other properties and assets of the
Company Group that it and its Agents have desired or requested to see or review, and that it and its Agents have had a full opportunity to meet with the officers and employees of the Company Group to discuss the business of the Company Group. Each
of Parent and Merger Sub acknowledges that neither the Company nor any other Person has made any representation or warranty, expressed or implied, as to the accuracy or completeness of any information regarding the Common Stock, the Company or the
Company Subsidiaries furnished or made available to Parent, Merger Sub and their respective Agents, except as expressly set forth in Article 4 of this Agreement or in the certificate delivered by the Company pursuant to
Section 7.4, and neither the Company nor any other Person (including any officer, director, member, partner or equityholder of the Company or any Equityholder) shall have or be subject to any liability to Parent, Merger
Sub, or any other Person, resulting from Parents or Merger Subs use of any information, documents or material made available to Parent or Merger Sub in any data rooms, management presentations, due diligence or in any other
form in expectation of the transactions contemplated hereby. Each of Parent and Merger Sub acknowledges that, should the Closing occur, Parent shall acquire the Company Group without any representation or warranty as to merchantability or fitness
for any particular purpose of their respective assets, in an as is condition and on a where is basis, except as otherwise expressly represented or warranted in Article 4 of this Agreement; provided,
however, that nothing in this Section 5.10 is intended to limit or modify the representations and warranties contained in Article 4 of this Agreement or any Ancillary Document to which the Company is a party.
Each of Parent and Merger Sub acknowledges that, except for the representations and warranties contained in Article 4 of this Agreement or in the certificate delivered by the Company pursuant to Section 7.4, neither
the Company nor any other Person has made, and neither Parent nor Merger Sub has relied on any other express or implied representation or warranty by or on behalf of the Company or any other Person. Each of Parent and Merger Sub acknowledges that
neither the Company nor any other Person, directly or indirectly, has made, and neither Parent nor Merger Sub has relied on, any representation or warranty regarding the pro-forma financial information,
financial projections or other forward-looking statements of the Company or any Company Subsidiary, and none of Parent, Merger Sub or any other Person acting on their behalf will make any claim with respect thereto. Notwithstanding anything to the
contrary herein, the provisions of this Section 5.10 shall not prevent or limit in any way a claim or cause of action (or recovery in connection therewith) by Parent or Merger Sub with respect to Fraud.
59
5.11 Investment Purpose. Parent will be purchasing the Common Stock for the purpose
of investment and not with a view to, or for resale in connection with, the distribution thereof in violation of applicable federal, state or provincial securities Laws. Each of Parent and Merger Sub acknowledges that the sale of the Common Stock
hereunder has not been registered under the Securities Act of 1933 (the Securities Act) or any state securities Laws, and that the Common Stock may not be sold, transferred, offered for sale, pledged, hypothecated, or otherwise
disposed of without registration under the Securities Act, pursuant to an exemption from the Securities Act or in a transaction not subject thereto. Each of Parent and Merger Sub represents that it is an Accredited Investor as that term
is defined in Rule 501 of Regulation D of the Securities Act.
ARTICLE 6
COVENANTS
6.1 Conduct
of Business of the Company. Except (w) as expressly contemplated by this Agreement, (x) as otherwise set forth on Schedule 6.1, (y) as required by applicable Law or (z) in connection with any Emergency
Measures subject to the last paragraph of this Section 6.1, during the period from the date of this Agreement to the earlier of the Closing Date and the termination of this Agreement pursuant to, and in accordance with,
Article 9, the Company (1) shall, and shall cause the Company Subsidiaries to, conduct their respective business and operations in the ordinary course in all material respects and (2), without the prior written consent
of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), shall not undertake any of the following actions:
(a) issue, transfer, grant, sell, or pledge or authorize the issuance, transfer, grant, sale or pledge of (i) shares of stock or other
equity interests of the Company (including the Common Stock) or any Company Subsidiary, or securities convertible into or exchangeable for any such equity interests, or any rights, warrants or options to acquire any such equity interests or other
convertible securities of the Company or any Company Subsidiary or (ii) any other securities in respect of, in lieu of, or in substitution for equity interests of the Company (including the Common Stock) or equity interests of any Company
Subsidiary outstanding on the date of this Agreement, in each case except to another member of the Company Group or any Stockholder as of the date of this Agreement;
(b) split, combine, subdivide or reclassify, or redeem, purchase or otherwise acquire, directly or indirectly, any outstanding shares of
stock of the Company or any outstanding equity interests of any Company Subsidiary (except for the repurchase of equity interests from directors, officers, employees, consultants or independent contractors of the Company or any Company Subsidiary in
connection with the termination of their services in the ordinary course of business and in accordance with the applicable Company Plans as in effect as of the date of this Agreement); provided that nothing in this Agreement shall restrict the
Company or any Company Subsidiary from declaring or paying any cash dividend or making any other cash distribution to the Stockholders prior to the Reference Time;
60
(c) adopt any amendment to the Organizational Documents of the Company or any Company
Subsidiary;
(d) incur, assume or guarantee any Indebtedness for borrowed money, individually or in the aggregate, in excess of
$1,000,000 (other than ordinary course borrowings under the Credit Facilities and other performance bonds or letters of credit entered into in the ordinary course of business);
(e) (i) increase in any material manner the salary or other compensation or benefits of any of its current or former directors,
officers, employees, or other individual service providers whose total annual compensation (i.e., annual base salary and target bonus) exceeds $150,000, except (x) as may be required under existing Company Plans or (y) for increases
in the ordinary course of business consistent with past practice; (ii) accelerate or commit to accelerate the funding, payment or vesting of any compensation or benefits provided to any of its current or former directors, officers, employees or
other individual service providers except (x) as required under existing Company Plans or (y) in connection with the termination of employment or service, consistent with past practice, of any director, officer, employee or other
individual service provider whose total annual compensation (i.e., annual base salary and target bonus) exceeds $150,000, where such termination of employment or service is other than for cause; (iii) pay or agree to pay any material
pension, retirement allowance or other employee benefit not contemplated by any Company Plan to any director or officer, whether past or present, other than in the ordinary course of business consistent with past practice or as required by Law;
(iv) enter into, adopt or amend any Company Plan or any other plan or arrangement that would be a Company Plan if in effect on the date hereof, in each case, except (w) in the ordinary course of business consistent with past practice,
(x) with respect to payments made or benefits provided that are to be treated as a Company Expense, (y) as required by Law or (z) as would not reasonably be expected to materially increase the expense or cost to the Company and the
Company Subsidiaries, taken as a whole, of providing the benefits under such Company Plan; or (v) hire, promote, engage, terminate (other than for cause) any of its director, officers, employees or other individual service providers with total
annual compensation (i.e., annual base salary and target bonus) in excess of $150,000; in each case other than as required by Law or any existing Company Plan in effect as of the date of this Agreement;
(f) (i) modify, extend, amend, negotiate, terminate or enter into any Labor Agreement or (ii) recognize or certify any labor union,
labor organization, works council or group of employees as the bargaining representative for any employees of the Company or any of the Company Subsidiaries;
(g) implement or announce any employee layoffs, furloughs, reductions in force, plant closings, reductions in compensation or other similar
actions that trigger notice obligations under the Worker Adjustment and Retraining Notification Act of 1988, or any similar Laws (the WARN Act);
61
(h) except in the ordinary course of business, (i) sell, lease, transfer or otherwise
dispose of, any of its material property or assets or (ii) create any Encumbrance (other than a Permitted Encumbrance) on any material property or assets; provided, for the avoidance of doubt, that the Company Group shall be permitted to
abandon, permit to lapse or otherwise dispose of any immaterial Intellectual Property in the ordinary course of business;
(i) disclose
any material trade secret or confidential information of the Company Group to any Person, other than in the ordinary course of business pursuant to a written confidentiality agreement;
(j) make any loans, advances or capital contributions to any Person, except advances for travel and other normal business expenses to
officers and employees in the ordinary course of business;
(k) materially amend, become subject to, or terminate any Material Contract
or Lease (other than (x) bidding for and entering into Contracts with customers or suppliers in the ordinary course of business, (y) terminations of Contracts as a result of the expiration of the term of such Contracts or breach by any
counterparty to such Contracts and (z) renewals of Contracts in the ordinary course of business);
(l) acquire any business or
Person, by merger or consolidation, purchase of assets or equity interests, or by any other manner, in a single transaction or a series of related transactions, except for any acquisition of assets in a single transaction or series of related
transactions for which (x) the purchase price does not exceed $1,000,000; or (y) the purchase price exceeds $1,000,000 but does not exceed $2,500,000 and prior to the Companys entry into such acquisition, the Company consults in good
faith with Parent; provided, that, the purchase price for any such acquisition of assets that is entered into without the prior written consent of Parent shall be treated as Indebtedness hereunder solely to the extent not consummated or closed by
the Closing;
(m) adopt a complete or partial plan of liquidation, dissolution, restructuring, recapitalization, bankruptcy, suspension
of payments or other reorganization;
(n) declare, set aside, make or pay any non-cash dividend
or other non-cash distribution in respect of the capital stock or other equity interests of any member of the Company Group;
(o) make, or commitment to make any, capital expenditures by the Company or any of its Subsidiaries in excess of $2,500,000 individually or
$5,000,000 in the aggregate, other than in the ordinary course of business or otherwise consistent in all material respects with the capital budget which has been provided to Parent prior to the date of this Agreement;
(p) make any material change in the lines of business in which the Company Group is engaged;
62
(q) settle any Action by or against the Company or any Company Subsidiary that would
reasonably be expected to involve payment by the Company Group in excess of $500,000 or the imposition of any equitable relief on the Company Group;
(r) enter into any Contract with a Related Party of the Company Group;
(s) make any change in any practice, policy or method of accounting or auditing practice other than those required by GAAP or applicable Law;
(t) make (other than in the ordinary course of business, consistent with past practice, and supported at a more likely than
not (or higher) level of confidence), change, or revoke any material Tax election, file an IRS Form 1120X or any other material amended Tax Return, change any Tax accounting period, settle any U.S. federal Income Tax claim or assessment or
other material Tax claim or assessment, enter into any closing agreement, consent to any waiver or extension of any applicable statute of limitations with respect to material Taxes (other than in the ordinary course of business), or fail to pay any
U.S. federal Income Tax or other material Tax that becomes due and payable (including estimated U.S. federal Income Tax or other material Tax payments); provided, that, solely for purposes of this Section 6.1(t),
Tax shall be deemed to include escheat, abandoned, and unclaimed property;
(u) cancel or reduce any material insurance
coverage other than with respect to any Company Plan in the ordinary course of business; or
(v) agree in writing to take any of the
foregoing actions.
Notwithstanding anything to the contrary contained herein, (i) nothing contained in this Agreement (A) will
give Parent, directly or indirectly, rights to control or direct the business or operations of the Company and the Company Subsidiaries prior to the Closing, (B) shall operate to prevent or restrict any act or omission by the Company or the
Company Subsidiaries the taking of which is required by applicable Law or any Contract or Company Plan by which the Company or any Company Subsidiary is bound as of the date of this Agreement, or (C) shall prevent the Company or any Company
Subsidiary from taking or failing to take any action in response to any Emergency or in connection with any Emergency Measures; provided, that, except as required by applicable Law, the Company shall be required to obtain Parents prior
written consent, such consent not to be unreasonably withheld, conditioned or delayed (provided, that Parent shall respond as soon as reasonably practicable), prior to taking any such action and (ii) the Parties expressly acknowledge and agree
that the Company and the Company Subsidiaries may repay any Indebtedness, pay any Company Expenses or make any distribution or dividend of Cash and Cash Equivalents at any time prior to the Reference Time.
63
6.2 Access to Information; Confidentiality; Public Announcements.
(a) During the period from the date of this Agreement to the earlier of the Closing Date and the termination of the Agreement pursuant to,
and in accordance with, Article 9, the Company shall give Parent and its authorized Agents reasonable access during normal business hours to all books, records, key personnel, offices and other facilities and properties of
the Company Group as Parent, or its authorized Agents may from time to time reasonably request; provided, however, that (i) any such access shall be conducted in a manner not to interfere with the businesses or operations of the
Company Group, (ii) any such access shall not result in the waiver of any attorney client privilege, (iii) any such access shall not include conducting any invasive sampling or testing with respect to the Real Property and (iv) such
access may be limited to the extent the Company reasonably determines, in light of any Emergency or any Emergency Measures, that such access would jeopardize the health and safety of any employees (provided, however, that the Company
shall use commercially reasonable efforts to allow for such access, or as much of such access as is reasonably practicable, in a manner that does not jeopardize the health and safety of such employees). Notwithstanding anything to the contrary in
this Agreement, neither the Company nor any Company Subsidiary shall be required to disclose any information to Parent, or its authorized Agents, if doing so could (A) violate (x) any Contract or confidentiality obligation or (y) any Law,
in each case, to which the Company or any Company Subsidiary is a party or to which the Company or any Company Subsidiary are subject or (B) compromise or waive any privilege; provided, that the Company shall use commercially reasonable efforts
to provide reasonable access to such information to Parent and its Agents in a manner that does not result in any of the foregoing.
(b)
Any information provided to or obtained by Parent or its authorized Agents pursuant to Section 6.2(a) above shall be Confidential Information (herein referred to as Confidential Information)
as defined in the Non-Disclosure Agreement, dated as of March 7, 2024, by and between the Company and Parent (the Confidentiality Agreement), and shall be held by Parent and Merger Sub
in accordance with and be subject to the terms of the Confidentiality Agreement. Notwithstanding anything to the contrary herein, the terms and provisions of the Confidentiality Agreement shall survive the termination of this Agreement in accordance
with the terms therein. In the event of the termination of this Agreement for any reason, Parent shall comply with the terms and provisions of the Confidentiality Agreement, including with respect to returning or destroying all Confidential
Information and the non-soliciting of employees of the Company Group.
(c) No Party will issue or
cause the publication of any press release or other public announcement with respect to this Agreement or the transactions contemplated hereby without the prior written consent of the other Parties (such consent not to be unreasonably withheld,
conditioned or delayed); provided, however, that nothing herein will prohibit any Party from issuing or causing publication of any such press release or public announcement to the extent that such disclosure is, upon advice of counsel,
required by Law, in which case the Party making such determination will, if practicable in the circumstances, use its reasonable best efforts to allow the other Parties reasonable time to comment on such release or announcement in advance of its
issuance; and provided, further, that nothing herein shall prohibit the Equityholders or any of their direct and indirect parent entities and Affiliates from disclosing the terms and status of this Agreement or the transactions
contemplated hereby to their respective Affiliates, Agents, shareholders, limited partners, members or prospective limited partners or members. Notwithstanding the foregoing or anything in this Agreement to the contrary, following Closing and after
the public announcement of the Merger, the Representative shall be permitted to announce that it has been engaged to serve as the Representative in connection herewith as long as such announcement does not disclose any of the other terms hereof.
64
6.3 Filings and Authorizations; Consummation.
(a) Each of the Parties shall within ten (10) Business Days following the date of this Agreement, file or supply, or cause to be filed
or supplied, in connection with the transactions contemplated herein, all notifications and information required to be filed or supplied pursuant to the HSR Act (it being understood that if there are changes in the applicable
regulations under the HSR Act between the date hereof and the date of filing pursuant to the HSR Act, the Company and Parent shall file or cause to be filed all required notification and report forms under the HSR Act as promptly as reasonably
practicable thereafter). Parent acknowledges and agrees that it shall pay and shall be solely responsible for the payment of all filing fees and other charges for the filing under the HSR Act.
(b) Each of the Parties, as promptly as practicable, shall make, or cause to be made, all other filings and submissions under applicable
Law, including Antitrust Laws and Healthcare Notification Laws, applicable to it, or to its Subsidiaries and Affiliates, as may be required for it to consummate the transactions contemplated herein and use its commercially reasonable efforts
(which, except as set forth in Section 6.3(d), shall not require either Party to make any payment or concession to any Person in connection with obtaining such Persons consent) to obtain, or cause to be obtained, all
other authorizations, approvals, consents and waivers from all Persons and Governmental Authorities necessary to be obtained by it, or its Subsidiaries or Affiliates, in order for it to consummate such transactions. Prior to the Closing Date, the
Company shall use commercially reasonable efforts to obtain third party consents and waivers pursuant to any Material Contracts and shall coordinate with Parent with respect to such efforts and keep Parent reasonably informed of the results of such
efforts; provided, that the Companys receipt of any such third party consent or waiver shall not be a condition to Parents or Merger Subs obligation to close the transactions contemplated under this Agreement;
provided, further, that such commercially reasonable efforts shall not include any requirement to make any payment or agree to any other material action in connection with seeking any such consents or waivers.
(c) The Parties shall coordinate and cooperate with one another in exchanging and providing such information to each other and in making the
filings and requests referred to in Sections 6.3(a) and (b) above, including any additional information, documentary material, or subsequent filings as may be requested. The Parties shall supply such reasonable assistance as may
be reasonably requested by any other Party in connection with the foregoing.
65
(d) Notwithstanding anything to the contrary in this Agreement, if any order is made by any
Governmental Authority or any suit is threatened or instituted challenging any of the transactions contemplated by this Agreement as violating any Antitrust Law or Healthcare Notification Law, Parent shall, and shall cause its controlled Affiliates
to, use reasonable best efforts to avoid or eliminate each and every impediment under any Antitrust Laws or Healthcare Notification Laws, as applicable, so as to enable the Closing to occur as soon as reasonably possible (and in any event no later
than the Termination Date); provided, however, that neither Parent nor any of its Affiliates shall have any obligation to (i) propose, negotiate, commit to or effect, by consent decree, hold separate order, or otherwise, the sale,
divestiture or disposition of any businesses, product lines or assets of Parent or its Affiliates, including, after the Closing Date, of the Company, any Company Subsidiary or their respective Affiliates, or (ii) otherwise take or commit to
take actions that after the Closing Date would limit Parents or its Affiliates freedom of action with respect to, or its or their ability to retain, one or more of the businesses, product lines or assets of Parent or its Affiliates,
including, after the Closing Date, of the Company, any Company Subsidiary or their respective Affiliates, in order to avoid the entry of, or to effect the dissolution of, any preliminary or permanent injunction, in any Action under any Antitrust
Laws or Healthcare Notification Laws.
(e) Each Party shall promptly inform the other Parties of any material communication from the
Federal Trade Commission, the Department of Justice, or any other Governmental Authority regarding any of the transactions contemplated by this Agreement. If any Party or any Affiliate thereof receives a request for additional information or
documentary material from any such Governmental Authority with respect to the transactions contemplated by this Agreement, then such Party will endeavor in good faith to make, or cause to be made, as soon as reasonably practicable and after
consultation with the other Party, an appropriate response in compliance with such request. Notwithstanding anything to the contrary in this Agreement, Parent shall have responsibility for directing, devising, and implementing the strategy for, and
advise the Company promptly in respect of any understandings, undertakings or agreements (oral or written) which Parent proposes to make or enter into for, obtaining authorizations, consents and approvals of or the expiration or termination of any
waiting periods from the Federal Trade Commission, the Department of Justice or any other Governmental Authority in connection with the transactions contemplated by this Agreement, and give the Company the opportunity to attend and participate at
any meetings with respect thereto.
(f) Until the earlier to occur of the termination of this Agreement pursuant to
Article 9 and the Effective Time, without the prior written consent of the other Party, neither Parent and Merger Sub, on the one hand, nor the Company, on the other hand, shall, and each shall cause its Subsidiaries and
Affiliates not to, enter into, agree to enter into, permit or agree to permit any Person (other than its Affiliates) to enter into, or consummate any Contracts or arrangements for an acquisition (including by way of acquiring or agreeing to acquire
by merger or consolidating with, or by purchasing a substantial portion of the assets of or equity in or otherwise making any investment in, or by any other manner, any Person or portion thereof, or otherwise acquiring or agreeing to acquire or make
any investment in any assets, or agreeing to a commercial or strategic relationship with any Person) of any ownership interest, equity interests, assets or rights in or of any Person, that would reasonably be expected to, individually or in the
aggregate, prevent, materially delay or materially impede the consummation of the transactions contemplated hereby including by (i) imposing any material delay in the obtaining of, or materially increase the risk of not obtaining, any
clearance, consent, approval,
66
authorization, declaration, waiver, license, franchise, permit, certificate, order, action or non-action of any Governmental Authority necessary to
consummate the transactions contemplated hereby or the expiration or termination of any applicable waiting period, (ii) materially increasing the risk of any Governmental Authority entering an order, ruling, judgment or injunction prohibiting
the consummation of the transactions contemplated hereby, or (iii) causing Parent, Merger Sub or the Company to be required to obtain any additional clearances, consents, approvals, authorizations, declarations, waivers, licenses, franchises,
permits, certificates, orders, actions, waiting period expirations or terminations, non-actions or other authorizations under any Antitrust Laws with respect to the transactions contemplated hereby.
6.4 Resignations. The Company shall cause to be delivered to Parent on the Closing Date such resignations of members of the board of
directors (or similar governing body) and officers of the Company and each Company Subsidiary which have been requested in writing by Parent at least five (5) Business Days prior to the Closing, such resignations to be effective concurrently
with the Closing.
6.5 Employee Matters.
(a) From and after the Closing Date until the first (1st) anniversary thereof, (or until
the date of termination of employment of the relevant Continuing Employee, if earlier), Parent shall, or shall cause the Surviving Corporation and each Company Subsidiary to, provide to each individual who is an employee of the Company or any
Company Subsidiary immediately prior to the Closing (each, a Continuing Employee), (i) an annual base salary or hourly wage rate, as applicable, that is no less favorable than the annual base salary or hourly wage rate
applicable to such Continuing Employee immediately prior to the Closing, (ii) target annual cash incentive, bonus, commission or similar cash compensation opportunities, whether paid annually, quarterly, monthly, or otherwise (excluding any
retention-, change in control- or transaction-related arrangements and equity or equity-based opportunities) that are no less favorable than the opportunities provided to such Continuing Employee immediately prior to the Closing Date, and
(iii) employee benefits that are substantially comparable in the aggregate to the employee benefits provided to such Continuing Employee immediately prior to the Closing Date under the Company Plans set forth on Schedule 4.14(a)
(excluding any equity or equity-based compensation, nonqualified deferred compensation, retention, change in control, transaction, defined benefit pension and post-employment welfare benefits (collectively, the Excluded
Benefits)). For purposes of the preceding sentence, an individual shall be deemed to be employed by the Company or any Company Subsidiary immediately prior to the Closing even if such employee is absent from active employment due to jury
duty, medical leave, military leave, bereavement leave, vacation, sick or any other permitted leave of absence but remains employed by the Company or a Company Subsidiary.
67
(b) Parent shall take, and shall cause to be taken, into account service rendered by
Continuing Employees prior to the Closing for purposes of eligibility to participate, vesting (other than vesting of future equity awards) and future vacation accruals, as applicable, under all employee benefit plans, programs, policies and
arrangements of Parent and its Subsidiaries (including the Surviving Corporation and the Company Subsidiaries), other than for the Excluded Benefits, in which such Continuing Employees participate following the Closing (the New Plan), to
the same extent as such service was taken into account under corresponding plans of the Company Group for such purposes prior to the Closing; provided, however, that nothing herein shall result in the duplication of any benefits for
the same period of service. Parent shall (or shall cause the Surviving Corporation to) use commercially reasonable efforts to, for the plan year in which the Closing Date occurs, provide Continuing Employees with credit for any co-payments made, and deductibles satisfied, prior to the Closing, in satisfying the corresponding deductible or co-payment requirements under any New Plans that are group
health plans.
(c) Notwithstanding anything to the contrary herein, nothing contained in this Section 6.5 shall
(i) confer any rights, remedies or claims upon any Person, other than the signatories of this Agreement, (ii) be considered to be an amendment, establishment, modification or creation of any Company Plan or any other employee benefit plan,
program, policy, contracts, practice, agreement or arrangement of the Company, the Surviving Corporation, any Company Subsidiary, Parent or any other Person, (iii) guarantee employment of any employee for any period of time after the Closing or
preclude the ability of Parent or any of its Affiliates (including, for the avoidance of doubt, the Company and each of its Subsidiaries) to terminate the employment of any employee, (iv) create a binding employment agreement with any employee,
or (v) prevent, limit or restrict Parent, the Company Group or any of their respective Affiliates from establishing, amending, terminating or otherwise modifying any Company Plan or other benefit or compensation plan, program, contract,
practice or agreement at any time.
6.6 Further Assurances. From the date of this Agreement until the earlier of the Closing Date
and the termination of this Agreement pursuant to, and in accordance with, Article 9, subject to the parenthetical in the first sentence of Section 6.3(b), each of the Parties shall execute such
documents and perform such further acts as may be reasonably required to carry out the provisions hereof and the actions contemplated hereby. Each Party shall, on or prior to the Closing Date, use its reasonable best efforts to fulfill or obtain the
fulfillment of the conditions precedent to the consummation of the transactions contemplated hereby, including the execution and delivery of any documents, certificates, instruments or other papers that are reasonably required for the consummation
of the transactions contemplated hereby.
6.7 Officer and Director Indemnification and Insurance.
(a) Parent agrees that all rights to indemnification and exculpation from liability for acts or omissions occurring on or prior to the
Closing Date now existing in favor of any of the current or former directors, managers, officers or employees of the Company Group (each a D&O Indemnified Party and collectively the D&O Indemnified
Parties), as provided in the respective Organizational Documents or in indemnification agreements provided to Parent prior to the date hereof, shall survive the Closing Date and shall continue in full force and effect in accordance with
their respective terms for a period of not less than six (6) years after the Closing Date.
68
(b) On the Closing Date, Parent shall pay (in full) for a
non-cancelable run-off insurance policy (the D&O Tail Policy) of not less than the existing coverage amount, for a period of
six (6) years after the Closing Date to provide insurance coverage for events, acts or omissions occurring on or prior to the Closing Date for all D&O Indemnified Parties and other persons who were covered under the directors and
officers insurance policy currently maintained by the Company and/or one or more of the Company Subsidiaries, which policy shall contain terms and conditions no less favorable to the insured persons than such coverage currently maintained by
the Company and/or one or more of the Company Subsidiaries (the Company D&O Tail Policy); provided, that, in no event shall Parent be required to expend for the D&O Tail Policy an aggregate premium amount in excess
of 250% of the premium amount per annum for the Company D&O Tail Policy and, if the aggregate premium amount for the D&O Tail Policy exceeds such amount, Parent shall be obligated to obtain a D&O Tail Policy with the greatest coverage
available, with respect to matters occurring prior to the Closing, for a cost not exceeding such amount.
(c) Parent hereby acknowledges
that the D&O Indemnified Parties may have certain rights to indemnification, advancement of expenses and/or insurance provided by other Persons. Parent hereby agrees that, following the Effective Time, (i) the Surviving Corporation is the
indemnitor of first resort (i.e., its obligations to the D&O Indemnified Parties are primary and any obligation of such other Persons to advance expenses or to provide indemnification for the same expenses or liabilities incurred by any such
D&O Indemnified Party are secondary), (ii) the Surviving Corporation shall, as applicable, be required to advance the full amount of expenses incurred by any such D&O Indemnified Party and shall be liable for the full indemnifiable
amounts (in each case, to the extent set forth in Section 6.7(a)), without regard to any rights any such D&O Indemnified Party may have against any such other Persons and (iii) Parent and the Surviving Corporation
irrevocably waive, relinquish and release such other Persons from any and all claims against any such other Persons for contribution, subrogation or any other recovery of any kind in respect thereof. Each of Parent and the Surviving Corporation
further agrees that no advancement or payment by any of such other Persons on behalf of any such D&O Indemnified Party with respect to any claim for which such D&O Indemnified Party has sought indemnification from the Surviving Corporation
shall affect the foregoing and such other Persons shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such D&O Indemnified Party against the Surviving
Corporation.
(d) The covenants contained in this Section 6.7 are intended to be for the benefit of, and shall
be enforceable by, each of the D&O Indemnified Parties and their respective heirs and legal representatives and shall not be deemed exclusive of any other rights to which a D&O Indemnified Party is entitled, whether pursuant to Law, Contract
or otherwise. In the event that Parent or the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of
such consolidation or merger or (ii) transfers or conveys all or substantially all of its properties and assets to any Person, then, and in each such case, Parent shall take all necessary action so that the successors or assigns of Parent or
the Surviving Corporation, as the case may be, shall succeed to the obligations set forth in this Section 6.7.
69
6.8 Exclusivity. Until the earlier of the Closing and such time as this Agreement is
terminated pursuant to, and in accordance with, Article 9, except for the transactions contemplated by this Agreement, the Company shall, and shall cause the Company Subsidiaries and their respective Affiliates and Agents
not to, directly or indirectly, solicit, encourage or enter into any negotiation, discussion, Contract or instrument, with any Person other than Parent, Merger Sub and their respective Affiliates, with respect to the sale of the Common Stock or all
or substantially all the assets of the Company and the Company Subsidiaries, or any merger, recapitalization or similar transaction with respect to the Company and the Company Subsidiaries or their business. The Company shall and shall cause the
Company Subsidiaries, their Affiliates and Agents to cease any discussions or negotiations with any Person conducted prior to the date of this Agreement, promptly deliver written notice to each such Person that it is ending all activities,
discussions and negotiations with such Person, promptly request the return or destruction of all confidential information concerning the Company Group provided to such Person and promptly terminate any physical electronic data or other diligence
access previously granted to such Person.
6.9 FIRPTA Certificate. On or prior to the Closing Date, the Company shall deliver to
Parent a certificate or certificates in compliance with Treasury Regulation Section 1.1445-2, together with a draft notice, prepared in accordance with Treasury Regulation
Section 1.897-2(h)(2), to be mailed promptly (together with copies of such certificate) to the IRS in accordance with Treasury Regulation
Section 1.897-2(h)(2), in the forms attached hereto as Exhibit D, certifying that the transactions contemplated by this Agreement are exempt from withholding under Section 1445 of the Code;
provided, that, notwithstanding anything in this Agreement to the contrary, Parents sole right if the Company fails to provide such certificate shall be to make an appropriate withholding under Sections 897 and 1445 of the Code.
6.10 Payoff Letters. (A) At least two (2) Business Days prior to the Closing Date, the Company shall have delivered to Parent
(i) an unexecuted Payoff Letter from the lenders under the Credit Facilities that authorize the release of all Encumbrances securing such Credit Facilities upon payment in full and (ii) with respect to any other Indebtedness for borrowed
money intended to be repaid as of the Closing, unexecuted payoff letters relating to such Indebtedness, which payoff letters shall be in customary form and shall (x) indicate the total amount required to be paid to fully satisfy all principal,
interest, prepayment premiums or other outstanding and unpaid obligations related to such Indebtedness as of the Closing Date and (y) state that all obligations (including guarantees) in respect thereof and Encumbrances in connection therewith
on the equity interests in and assets of the Company shall be, substantially concurrently with the receipt of the applicable payoff amount on the Closing Date by the Persons holding such Indebtedness or other obligations, be released and terminated,
or arrangements reasonably satisfactory to Parent for such release shall have been made by such time, subject, as applicable, to the replacement (or cash collateralization or backstopping) of any then outstanding letters of credit thereunder and
(B) immediately prior to Closing, the Company shall have delivered to Parent an executed and released Payoff Letter and executed and released additional payoff letters as described in clause (A) above.
70
6.11 Written Consent. Within 24 hours after the execution and delivery of this
Agreement, the Company shall deliver to Parent the Written Consent.
6.12 Company Obligations in Respect of the Financing.
(a) Prior to the Closing (or earlier termination pursuant to, and in accordance with, Article 9), subject to
the limitations set forth below, the Company shall use reasonable best efforts at Parents sole expense, to provide to Parent and shall use its reasonable best efforts to cause its Subsidiaries to use their reasonable best efforts, and shall
direct its and their officers, employees and advisors to use their reasonable best efforts to provide to Parent, such cooperation as is customary for debt financings of the type contemplated by the Debt Commitment Letter or as is reasonably
requested by Parent and that is necessary in connection with arranging the Debt Financing (including any Alternative Financing), including (i) upon reasonable notice and at reasonable times and at locations mutually agreed, and solely to the
extent contemplated by the Debt Commitment Letter, participation, with appropriate seniority and expertise, in a reasonable number of meetings, conference calls, presentations, drafting sessions and due diligence sessions with any Debt Financing
Sources, other prospective financing sources, or rating agencies that are customary for financings of a type similar to the Debt Financing (including any Alternative Financing), (ii) furnishing Parent, its Affiliates and its financing sources
with (x) historical financial information regarding the Company as necessary to satisfy the conditions required by paragraph 9 of Exhibit D to the Debt Commitment Letter (or the analogous provision in any amendment, modification, supplement,
restatement or replacement thereof permitted or required hereunder), and (y) such other customary financial and other pertinent information regarding the Company, its Subsidiaries and their respective businesses within the Companys
possession as may be reasonably requested by Parent and necessary to satisfy the conditions set forth in paragraph 8 of Exhibit D to the Debt Commitment Letter, including in the event the Debt Financing includes an offering of debt securities,
financial statements, financial data, audit reports and other information regarding the Company and its Subsidiaries of the type required by Regulation S-X or Regulation
S-K under the 1933 Act, in each case to the extent the same is of the type and form customarily included in, and subject to exceptions that are customary for, an offering memorandum for private placements of non-convertible high-yield bonds under Rule 144A promulgated under the Securities Act, or otherwise necessary to receive from the independent auditors of the Company (and any other auditor to the extent financial
statements audited or reviewed by such auditor are or would be included in such offering memorandum) customary (for high yield unsecured debt securities issued in a private placement pursuant to Rule 144A) comfort (including
negative assurance comfort and change period comfort) with respect to the financial information of the Company to be included in such offering memorandum, and any other financial statements and financial data reasonably requested by
Parent to assist Parent in preparing the pro forma financial statements required by paragraph 11 of Exhibit D to the Debt Commitment Letter (provided that the Company and its Subsidiaries shall not be responsible for the preparation of any pro forma
financial statements or pro forma adjustments thereto and shall not be obligated
71
to provide any Excluded Information) (such information in this clause (ii), the Required Information), (iii) in the event the Debt Financing includes an offer of debt
securities, request its independent auditors to provide customary accountants comfort letters (with customary bring-down comfort letters delivered on the closing date of any such Debt Financing) and audit reports from the independent auditors
of the Company (and any other auditor to the extent financial statements audited or reviewed by such auditor are or would be included in such offering memorandum), (iv) assisting Parent in a commercially reasonable manner with the preparation
of customary offering documents and materials in connection with the Debt Financing, including private placement memoranda, information memoranda and packages, lender and investor presentations, rating agency presentations, and similar documents and
materials customary for use in a debt financing similar to the Debt Financing, (v) assisting Parent in its preparation of customary definitive financing documentation and the schedules and exhibits thereto, including reasonably facilitating the
pledging of collateral or granting of security interests and liens on such collateral reasonably requested by Parent (it being understood that the effectiveness of such documents and pledges shall be conditioned upon the occurrence of the Closing),
(vi) to the extent requested at least nine (9) Business Days prior to the Closing Date, providing to Parent and the Debt Financing Sources all documentation and other information relating to the Company and its Subsidiaries required by
regulatory authorities under applicable know your customer and anti-money laundering rules and regulations, including the PATRIOT Act, (vii) taking reasonable actions necessary to permit the Debt Financing Sources to evaluate the
Companys current assets, cash management and accounting systems, policies and procedures relating thereto for the purposes of Parent establishing collateral arrangements at the Closing, and provide customary assistance with due diligence
examinations customary for a debt financing of the type consistent with the Debt Financing (including documentary due diligence), as mutually agreed, (viii) delivering notices of prepayment within the time periods required by the relevant
agreements governing indebtedness (unless otherwise waived), (ix) executing customary authorization letters with respect to offering documents relating to the bank financing and customary management representation letters required by the
Companys auditors in connection with their delivery of comfort letters, and (x) as soon as reasonably practicable after obtaining actual knowledge thereof, supplementing the written Required Information to the extent that any such
Required Information that is included in any offering document for the Debt Financing contains any untrue statement of a material fact or omits to state a material fact necessary in order to make the statements contained therein, in light of the
circumstances under which such statements were made, not misleading; provided, however, that nothing herein shall require the Company or any Company Subsidiary to (x) take any action that would be effective prior to the Closing to
the extent it would, in the Companys reasonable judgment, interfere with the business or operations of the Company or (y) furnish any information (A) which is not regularly prepared by the Company and the Subsidiaries in the ordinary
course of business or which is not capable of being prepared from financial information prepared in the ordinary course of business without undue burden or (B) not customarily required for completion of debt financings similar to the Debt
Financing.
72
(b) Notwithstanding anything in this Agreement to the contrary, neither the Company nor any
of the Company Subsidiaries shall be required to pay any commitment or other similar fee or make any other payment or incur any other expense or liability or provide or agree to provide any indemnity in connection with the Financings or any of the
foregoing that would be effective prior to the Closing or would be treated as a Company Expense. None of the Company, the Company Subsidiaries or their respective officers, directors or employees shall be required to execute or enter into or perform
any agreement with respect to the financings contemplated by the Commitment Letters that is not contingent upon the Closing or that would be effective prior to the Closing (other than customary authorization letters and customary management
representation letters required to be delivered pursuant to Section 6.12(a)(ix)). Notwithstanding anything in this Agreement to the contrary, nothing in this Section 6.12 shall require any
cooperation or assistance to the extent it would: (i) require the Company or any of its Subsidiaries or any of their respective Agents to amend or waive any terms of this Agreement; (ii) require the Company or any of its Affiliates to take
any action that would (A) subject any director, manager, officer or employee of the Company or any of its Affiliates to any actual or potential personal liability; (B) conflict with, violate or result in a breach of or a default under any
Organizational Documents of the Company or any of its Affiliates, any Contract or any Law; (C) require providing access to or disclosing information that the Company determines would jeopardize any privilege of, or conflict with any
confidentiality obligations applicable to, the Company or any of its Affiliates (but the Company shall take reasonable best efforts to provide such information or cooperation in a manner that does not violate any such privilege or confidentiality
obligations); (D) require any such entity to change any fiscal period; (iii) require any director or manager of the Company or any Company Subsidiary to pass resolutions or consents to approve or authorize the execution of the Debt
Financing (other than persons who will continue as officers or directors of the Company or Company Subsidiary or otherwise be appointed to such a position at Closing and will not be removed or replaced in connection therewith); (iv) require any
of the Company and its Subsidiaries or any of their respective Agents (A) to pay or incur any commitment or other similar fee in connection with the Debt Financing or (B) to incur any liability or bear any cost or expense in connection
with the Debt Financing that is not simultaneously reimbursed by Parent; (v) require any of the Company and its Subsidiaries or any of their respective Agents to execute, deliver or perform any agreement, instrument, certificate or other
document with respect to the Debt Financing (other than those pursuant to clause (vi), (viii) or (ix) of Section 6.12(a)), or any board of directors, manager, member or other governing body of any of the Company and
its Subsidiaries to adopt resolutions approving or ratifying any agreement, instrument, certificate or other document with respect to the Debt Financing, that is not contingent on the Closing or that would be effective prior to the Closing;
(vi) require the Company or any of its Subsidiaries to provide any legal opinion or other opinion of counsel at or prior to the Closing Date; (vii) require the Company or any of its Subsidiaries or any of their respective Agents to deliver
any certificate that it reasonably believes in good faith, contains any untrue certifications; or (viii) require the Company or its Affiliates and representatives to provide Excluded Information. The Company and its Agents shall be given a
reasonable opportunity to review and comment on any marketing, offering or other similar materials that are to be presented during any meetings conducted or otherwise used in connection with the Debt Financing. Parent shall promptly, upon request by
the Company, reimburse the Company for all costs and expenses (including reasonable attorneys fees) incurred by the Company or any of its Affiliates in connection with the cooperation of the Company and its Affiliates
73
contemplated by this Section 6.12 and shall indemnify and hold harmless the Company, its Affiliates and their respective Agents from and against any and all losses
suffered or incurred by any of them of any type in connection with the arrangement of any Financing and any information used in connection therewith (collectively, the Financing Cooperation Indemnity). Whether or not the Closing
occurs, Parent shall, promptly upon request by the Company, reimburse the Company (for the benefit of the Stockholders) for all costs and expenses incurred by the Stockholders, the Company or any Company Subsidiaries in connection with this
Section 6.12, including legal fees, accounting fees and other fees and expenses (collectively, the Financing Cooperation Expenses, and together with the Financing Cooperation Indemnity, the
Financing Cooperation Obligations). Notwithstanding anything to the contrary set forth in this Agreement, Parent shall not be required to pay or reimburse the Company or any of its Affiliates pursuant to this
Section 6.12(b) for any cost of any of the foregoing in connection with the preparation of its regular annual or periodical financial statements or in connection with the performance of its obligations pursuant to
provisions of this Agreement other than this Section 6.12. All information provided by the Company or any of its Affiliates or any of their respective Agents pursuant to this Section 6.12 shall be
kept confidential in accordance with the Confidentiality Agreement, except that Parent shall be permitted to disclose such information to the Debt Financing Related Parties, rating agencies and prospective lenders during syndication, and prospective
investors during marketing, of the Debt Financing, subject to the Debt Financing Related Parties, rating agencies and prospective lenders and investors entering into customary confidentiality undertakings with respect to information (including
through a notice and undertaking in a form customarily used in confidential information memoranda for senior credit facilities) in each case subject to the Companys review of such materials and undertakings (with reasonable opportunity to
comment) prior to such disclosure; provided, that such undertakings shall not be required with respect to customary disclosure of (i) any Required Information or (ii) any other information in any prospectuses, private placement memoranda,
offering memoranda, or investor presentations used in connection with any debt securities offering (in the case of this clause (ii) subject to the Companys review of such other information contained in any such prospectuses, memoranda and
presentations (with reasonable opportunity to comment) prior to disclosure of such information).
(c) Notwithstanding anything to the
contrary in this Agreement or in any agreement contemplated by or delivered in connection herewith, the condition set forth in Section 7.2 of this Agreement, as it applies to the Companys obligations under this
Section 6.12, shall be deemed satisfied unless the Debt Financing (or any Alternative Financing) has not been obtained primarily as a result of the Companys Willful Breach of its obligations under this
Section 6.12. Parent acknowledges and agrees that it shall have no condition to Closing that its Debt Financing is actually obtained.
(d) The Company consents to the customary and reasonable use of the Companys logos solely in connection with any Debt Financing;
provided, that such logos are used solely in a manner that is not intended, or reasonably likely, to harm or disparage the Company or any of its Subsidiaries or Affiliates or the reputation or goodwill of the Company or any of its
Subsidiaries or Affiliates.
74
6.13 Parent Obligations in Respect of Financing.
(a) Parent shall use its (and shall cause each of its Affiliates to use their) reasonable best efforts to take, or cause to be taken, all
actions and to do, or cause to be done, all things necessary, advisable or desirable to arrange, obtain and consummate the Debt Financing on the Closing Date on the terms and subject only to the conditions set forth in the Debt Commitment Letter,
including using reasonable best efforts, to (i) satisfy, or cause to be satisfied, on a timely basis all terms, conditions, representations and warranties applicable to Parent set forth in the Debt Commitment Letter that are within its control,
(ii) maintain in effect the Debt Commitment Letter in the form provided to the Company concurrently with the execution of this Agreement, subject to amendments, supplements and modifications thereto permitted by this Agreement,
(iii) promptly negotiate and enter into definitive agreements with respect thereto on the terms and subject only to the conditions expressly set forth in the Debt Commitment Letter and enforce its rights under the Debt Commitment Letter
(including in the event that all conditions to the Debt Commitment Letter have been satisfied, using its reasonable best efforts to cause the lenders and the other Persons providing such Debt Financing to fund on the Closing Date the Debt Financing
required to consummate the transactions contemplated herein), (iv) draw the full amount of the Debt Financing necessary to fund the Required Amount at or prior to the Closing Date and (v) consummate the Debt Financing at the Closing.
Parent shall not enter into, permit or consent to (x) any amendment, supplement or modification to, or waiver or consent under, the Debt Commitment Letter, that, individually or in the aggregate, would or would reasonably be expected to
directly or indirectly (A) impose or permit the imposition of any new or additional conditions to the funding of the Debt Financing on the Closing Date that are not expressly set forth in the Debt Commitment Letter as of the date hereof or
otherwise expands any condition to the funding of the Debt Financing on the Closing Date set forth in the Debt Commitment Letter as of the date hereof, (B) delay the timing of the funding of the Debt Financing thereunder or impair, delay or
prevent the availability of all or any portion of the Debt Financing necessary to fund the Required Amount or the consummation of the transactions contemplated by this Agreement on the Closing Date, (C) impair, delay or prevent the availability
of all or any portion of the Debt Financing necessary to fund the Required Amount or the consummation of the transactions contemplated by this Agreement on the Closing Date, (D) reduce the aggregate cash amount of the Debt Financing below the
Required Amount or (E) otherwise materially adversely affect or impair the ability of the Parent to consummate the transactions contemplated by this Agreement or prevent or delay the Closing; provided, that, subject to the limitations
set forth in this Section 6.13(a), Parent may amend the Debt Commitment Letter to add lenders, lead arrangers, bookrunners, syndication agents, managers or similar entities that have not executed the Debt Commitment Letter
as of the date hereof; provided further, that the replacement of any bridge facility with notes, as described in and in accordance with the Debt Commitment Letter, shall not violate any of the foregoing. Parent shall promptly deliver to the
Company copies of any amendment, supplement, waiver, consent, modification, assignment or replacement in respect of the Debt Commitment Letter. For purposes of this Agreement, references to the Debt Financing will include the financing
contemplated by the Debt Commitment Letter as amended, restated, supplemented, modified, waived or replaced in accordance with this Section 6.13(a) (including any Alternative Financing), references to the Debt
Financing
75
Sources shall include each Person that has not executed the Debt Commitment Letter as of the date hereof but becomes a party thereto after the date hereof in accordance with the terms
thereof and this Section 6.13(a) and each Person party to any replacement therefor obtained in accordance with this Section 6.13(a), references to the Debt Commitment Letter shall
include such agreement as amended, restated, supplemented, modified, waived or replaced in accordance with this Section 6.13(a) (including any Alternative Financing Commitment Letter), and references to the Fee
Letter shall include such agreement as amended, restated, supplemented, modified, waived or replaced in accordance with this Section 6.13(a) (including any Alternative Financing Fee Letter), in each case, unless the
context otherwise provides.
(b) Upon reasonable request of the Company, Parent shall keep the Company apprised of material developments
relating to the Debt Financing and shall give the Company prompt notice of any material adverse change with respect to such Debt Financing. Parent shall promptly notify the Company of (i) the expiration or termination (or attempted or purported
termination, whether or not valid) of the Debt Commitment Letter or any definitive with respect to the Debt Financing, (ii) any refusal by any Debt Financing Source to provide or any stated intent by any Debt Financing Source to refuse to
provide the Debt Financing in an amount at least equal to the Required Amount, (iii) any breach or default (or any event or circumstance that, with or without notice, lapse of time or both, could reasonably be expected to give rise to any
breach or default) by any party to the Debt Commitment Letter or definitive document related to the Debt Financing, (iv) Parents good faith belief, for any reason, that there is a material possibility that Parent will no longer be able to
obtain the Debt Financing in an amount at least equal to the Required Amount contemplated by the Debt Commitment Letter on the terms described therein or (v) receipt of any notice or other communication from any person with respect to any:
actual or potential breach, default, termination or repudiation by any party to the Debt Commitment Letter or any definitive document related to the Debt Financing (including any proposal by any Debt Financing Source to withdraw or terminate the
Debt Commitment Letter).
(c) If any portion of the Debt Financing becomes unavailable on the terms and conditions contemplated in the
Debt Commitment Letter, and such portion is required to fund the Required Amount, Parent shall (i) promptly notify the Company of such event and (ii) use its reasonable best efforts to take, or cause to be taken, all actions and to do, or
cause to be done, all things necessary, proper or advisable to arrange for and obtain as promptly as practicable following the occurrence of any such unavailability alternative debt financing (the Alternative Financing) from the
same or alternative financing sources, on terms and conditions not materially less favorable to Parent (including no obligation to (x) obtain equity financing and/or (y) pay fees or interest rates applicable to the Debt Financing in excess
of those contemplated by the Debt Commitment Letter or the Fee Letter as in effect on the date hereof (including the market flex provisions)) or the Company, taken as a whole, than those set forth in the Commitment Letters delivered to the Company
on the date of this Agreement and in an amount that, when taken together with the portion of the Financing that remains available to Parent is at least equal to the Required Amount. In the event that Alternative Financing is obtained, Parent shall
promptly provide the Company with true, correct and complete copies of each
76
commitment letter, engagement letter and fee letter (which fee letter may be redacted as permitted under Section 5.7) entered into in connection therewith (such
commitment letters, side letters and engagement letters, together with all exhibits, schedules and annexes, attached thereto, collectively, the Alternative Financing Commitment Letter, and the related fee letters, collectively,
the Alternative Financing Fee Letter).
(d) Parent acknowledges and agrees that neither the obtaining of the Debt
Financing or any Alternative Financing, nor the completion of any issuance of securities contemplated by the Debt Financing or any Alternative Financing, is a condition to the Closing.
6.14 Frustration of Closing Conditions. Notwithstanding anything to the contrary set forth in this Agreement, including in
Article 7 or Article 8, neither Parent nor Merger Sub may rely on the failure of any condition set forth in Article 7 to be satisfied if such failure was caused primarily
by the failure of Parent or Merger Sub to perform any of its obligations under this Agreement. Notwithstanding anything to the contrary set forth in this Agreement, including in Article 7 or
Article 8, the Company may not rely on the failure of any condition set forth in Article 8 to be satisfied if such failure was caused primarily by its failure to perform any of its obligations
under this Agreement.
6.15 280G. The Company shall, and shall cause the Company Subsidiaries to, use its commercially reasonable
efforts (which shall in no event require payment of additional consideration to any Person) as soon as practicable after the date hereof (but in no event later than the second (2nd) Business Day immediately prior to the Closing Date), obtain from
each Person to whom any payment or benefit is required or proposed to be made that could constitute a parachute payment (as defined in Section 280G(b)(2) of the Code) a written agreement waiving such Persons right to receive
some or all of such payment or benefit (the Waived Benefit) so that all remaining payment or benefit applicable to such Person shall not be deemed to be a parachute payment that would not be deductible under Section 280G of
the Code, and to accept in substitution for the Waived Benefit the right to receive such remaining payment or benefit only if approved by the Stockholders in a manner that complies with Section 280G(b)(5)(B) of the Code. Each such waiver shall
identify the specific Waived Benefit and shall provide that if such Stockholder approval is not obtained, such payments shall not be made and such Persons shall have no right or entitlement with respect thereto. As soon as practicable thereafter but
in any event prior to the Closing Date, to the extent such waivers are obtained, the Company shall seek Stockholder approval in a manner that complies with Section 280G(b)(5)(B) of the Code of all such payments that have been conditioned on the
receipt of such approval. At least two (2) business days prior to obtaining such waivers and seeking approval from the Stockholders, the determination of which payments may be deemed to constitute parachute payments, the form of each such
waiver, and the disclosure and other circumstances of any such Stockholder approval shall be provided to Parent for Parents review and comment, and the Company (and its advisors) shall reasonably consider such comments. To the extent that
Parent (or its Affiliates) wish to enter into, or cause the Company to enter into, additional arrangements with the Companys disqualified individuals (as defined in Section 280G of the Code) prior to the Closing Date with
respect to services to be provided prior to or following the Merger, such
77
arrangements shall be disclosed to the Company at least seven (7) business days prior to the Closing Date. Prior to the Closing Date, the Company shall deliver reasonably satisfactory
evidence to Parent that either (a) the requisite vote was obtained with respect to the Waived Benefit (the 280G Approval) or (b) the 280G Approval was not obtained and, as a consequence, the Waived Benefit shall not be
retained, made or provided.
6.16 Tax Matters.
(a) To the extent it is necessary for purposes of this Agreement to determine the allocation of Taxes among a Straddle Period, the portion of
such Taxes allocable to the Pre-Closing Tax Period shall: (i) in the case of Taxes that are either (x) based upon or related to income or receipts or withholding, or (y) imposed in connection
with any sale, transfer or assignment or any deemed sale, transfer or assignment of property (real or personal, tangible or intangible), be deemed equal to the amount that would be payable if the Tax year or period ended on the Closing Date (and for
such purpose, the taxable period of any controlled foreign corporation as defined in Section 957 of the Code and any partnership or other pass-through entity in which the Company or its Subsidiaries hold a beneficial interest shall
be deemed to terminate at such time); and (ii) in the case of Taxes other than those described in clause (i) above, be deemed to be the amount of such Taxes for the entire Straddle Period (or, in the case of such Taxes determined on an
arrears basis, the amount of such Taxes for the immediately preceding Tax period) multiplied by a fraction the numerator of which is the number of calendar days in the portion of the Straddle Period ending on the Closing Date and the denominator of
which is the number of calendar days in the entire Straddle Period. For purposes of clause (i) of the preceding sentence, any exemption, deduction, credit or other item (including, without limitation, the effect of any graduated rates of tax)
(other than for property placed in service after the Closing Date), that is calculated on an annual basis shall be allocated to the portion of the Straddle Period ending on the Closing Date on a pro rata basis determined by multiplying the total
amount of such item allocated to the Straddle Period times a fraction, the numerator of which is the number of calendar days in the portion of the Straddle Period ending on the Closing Date and the denominator of which is the number of calendar days
in the entire Straddle Period. All determinations necessary to give effect to the foregoing allocations shall be made in a manner consistent with past practice of the Company and the Company Subsidiaries to the extent supported at a more
likely than not (or higher) level of confidence. The Parties agree that for purposes of determining the amount of Taxes taken into account in Closing Indebtedness or Closing Working Capital (as finally determined), it shall be assumed that
Parent and its Affiliates (including the Company and its Subsidiaries) (i) do not make an election under Treasury Regulation Section 1.1502-76(b)(2)(ii)(D) to ratably allocate items (or any make any
similar election or ratably allocate items under any corresponding provision of state, local or non-U.S. Law) and (ii) do not apply the next day rule of Treasury Regulation Section 1.1502-76(b)(1)(ii)(B) with respect to any of the Transaction Tax Deductions.
(b) Parent
shall not make or cause the Company to make any election under Code Section 338 or Code Section 336 (or any similar provision under state, local or non-U.S. Law) with respect to the acquisition of
the Company pursuant to this Agreement.
78
(c) The parties hereto agree that the taxable period of the Company and the Company
Subsidiaries shall end at the close of business on the Closing Date for U.S. federal income Tax purposes (and Parent shall make any election to include the Company and applicable Company Subsidiaries in an affiliated group filing a consolidated U.S.
federal income Tax Return) and, to the extent permissible under applicable Laws, state and local income Tax purposes.
(d) All written
Tax sharing agreements or similar agreements to which any member of the Company Group is a party (other than any contract the principal purpose of which is not related to Taxes (such as a loan or a lease)) shall be terminated as of the Closing Date
and, after the Closing Date, no member of the Company Group shall be bound thereby or have any liability thereunder.
(e) Prior to the
Closing, the Company shall use commercially reasonable efforts to complete and make available to Parent the Code Section 382 study that the Company has engaged BDO USA, P.C. to perform. The Company shall also use commercially reasonable
efforts, upon the request of Parent, to reasonably cooperate with Parent to answer questions with respect to the study.
(f) After the
Closing, the Parties shall use commercially reasonable efforts, upon the request of a Party, to reasonably cooperate with one another with respect to Tax matters relating to the Company Group and a Pre-Closing
Tax Period, including the filing of Tax Returns and the prosecution of Actions with respect to Taxes or Tax Returns, and including making available to one another, during normal business hours, all books and records, information and employees
(without substantial disruption of employment) retained and remaining in existence after the Closing that are necessary or useful in connection with the preparation of any Tax Returns and any Tax inquiry, audit, investigation or any other matter
requiring any such books and records, information or employees for any reasonable business purpose.
6.17 R&W Insurance Policy.
Prior to the Closing, the Company shall, and shall cause the Company Subsidiaries to, use commercially reasonable efforts to provide to Parent such cooperation as is reasonably requested by Parent in connection with the R&W Insurance
Policy. All premiums, underwriting fees, brokers commissions and other costs and expenses incurred by or on behalf of Parent related to the procurement of such R&W Insurance Policy shall be paid by Parent. During the term of the
R&W Insurance Policy, Parent shall not, and shall not permit any member of the Company Group to, amend, restate, supplement, repeal or modify any subrogation provision of the R&W Insurance Policy (or waive any associated terms or provisions)
in a manner adverse to the Equityholders, in their capacities as such, without the Representatives prior express written consent.
6.18 Termination of Certain Agreements. Prior to the Effective Time, the Company shall take all actions necessary to terminate, and
shall cause to be terminated, in its entirety each Contract specified on Schedule 6.18 with no further liability of the Company, the Surviving Corporation or any other member of the Company Group in respect thereof, in each case pursuant to
written agreements in form and substance reasonably satisfactory to Parent.
79
6.19 Termination of Derivative Contract. Prior to the Effective Time, the Company
shall take all actions necessary to terminate and close out, and shall cause to be terminated and closed-out, in its entirety all hedges, interest rates, currency swaps (as such terms as defined under the
Commodity Exchange Act) or other derivative arrangements, regardless of valuation to which any member of the Company Group is a party or otherwise has any obligations on an arms-length basis. The Company shall deliver to Parent evidence reasonably
satisfactory to Parent of all such termination, unwinding or other closeout of all hedges, interest rate swaps, currency swaps or other derivative arrangements in accordance with this Section 6.19.
ARTICLE 7
CONDITIONS
PRECEDENT TO OBLIGATIONS OF PARENT AND MERGER SUB
The obligations of Parent and Merger Sub under this Agreement shall be subject to
the satisfaction, at or prior to the Closing Date, of all of the following conditions, any one or more of which may be waived by Parent:
7.1 Representations and Warranties. Each of the (a) Company Fundamental Representations (other than Sections 4.2(a) and
Section 4.20(b)) shall be true and correct in all material respects, in each case, on and as of the date hereof and as of the Closing Date as though made on and as of the Closing Date (except for such representations and
warranties expressly stated to relate to an earlier date, in which case, as of such earlier date), (b) the representations and warranties of the Company contained in Section 4.2(a) shall be true and correct in all respects
as of the date hereof and as of the Closing Date, as though then made on and as of the Closing Date except for de minimis inaccuracies, (c) the representations and warranties of the Company contained in
Section 4.20(b) shall be true and correct in all respects and (d) remaining representations and warranties of the Company contained in Article 4 shall be true and correct in all respects, in
each case, as of the date hereof and on and as of the Closing Date as though made on and as of the Closing Date (except for such representations and warranties expressly stated to relate to an earlier date, in which case, as of such earlier date);
provided, however, (i) that clause (c) of this condition shall be considered satisfied so long as all such brokers, finders or similar fee or other commission are treated as a Company Expense hereunder and
(ii) that clause (d) of this condition shall be considered satisfied unless the failure of such representations or warranties to be true and correct (ignoring for the purposes of this Section 7.1 any
qualifications as to Material Adverse Effect or materiality contained in such representations or warranties), has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
7.2 Performance. The Company shall have performed and complied in all material respects with all agreements and covenants required by
this Agreement to be performed and complied with by it prior to or on the Closing Date.
80
7.3 No MAE. Since the date of this Agreement, there shall not have occurred a
Material Adverse Effect.
7.4 Officers Certificate. The Company shall have delivered to Parent a certificate,
signed by an executive officer of the Company, dated as of the Closing Date, certifying the matters set forth in Sections 7.1, 7.2 and 7.3 with respect to such Person.
7.5 Legal Prohibition. On the Closing Date, there shall exist no injunction, action or other order (whether temporary, preliminary or
permanent) issued by any Governmental Authority or court of competent jurisdiction which prohibits or makes illegal the consummation of the transactions contemplated under this Agreement.
7.6 HSR Act. All required filings under the HSR Act shall have been completed and all applicable time limitations thereunder shall have
expired without a request for further information by the relevant federal authorities under the HSR Act, or in the event of such a request for further information, the expiration of all applicable time limitations under the HSR Act shall have
occurred without the objection of such federal authorities.
7.7 Healthcare Notification Laws. All filings under Healthcare
Notification Laws set forth on Schedule 7.7 (the Pre-Closing Healthcare Notifications) shall have been completed and, as applicable under such Healthcare Notification Laws and the
rules promulgated thereunder, all notice or waiting periods will have been expired or terminated without a request for further information or objection of the applicable Governmental Authority and any consents or approvals required shall have been
obtained.
ARTICLE 8
CONDITIONS PRECEDENT TO OBLIGATIONS OF THE COMPANY
The obligation of the Company to effect the transactions contemplated by this Agreement shall be subject to the satisfaction, at or prior to
the Closing Date, of all of the following conditions, any one or more of which may be waived by the Company:
8.1 Representations and
Warranties. Each of the (a) Parent Fundamental Representations shall be true and correct in all material respects, in each case, on and as of the date hereof and as of the Closing Date as though made on and as of the Closing Date (except
for such representations and warranties expressly stated to relate to an earlier date, in which case, as of such earlier date) and (b) remaining representations and warranties of Parent and Merger Sub contained in
Article 5 shall be true and correct in all respects, in each case, as of the date hereof and on and as of the Closing Date as though made on and as of the Closing Date (except for such representations and warranties
expressly stated to relate to an earlier date, in which case, as of such earlier date); provided, however, that clause (b) of this condition shall be considered satisfied unless the failure of such representations or warranties to
be true and correct (ignoring for the purposes of this Section 8.1 any qualifications as to materiality contained in such representations or warranties), individually or in the aggregate, would not reasonably be
expected to prevent or delay the ability of Parent or Merger Sub to consummate the transactions contemplated hereby.
81
8.2 Performance. Each of Parent and Merger Sub shall have performed and complied in
all material respects with all agreements and covenants required by this Agreement to be performed and complied with by it prior to or on the Closing Date.
8.3 Officer Certificate. Parent shall have delivered to the Company a certificate, signed by an executive officer of Parent, dated as
of the Closing Date, certifying the matters set forth in Sections 8.1 and 8.2 with respect to Parent and Merger Sub.
8.4
Legal Prohibition. On the Closing Date, there shall exist no injunction, action or other order (whether temporary, preliminary or permanent) issued by any Governmental Authority or court of competent jurisdiction which prohibits or makes
illegal the consummation of the transactions contemplated under this Agreement.
8.5 HSR Act. All required filings under the HSR
Act shall have been completed and all applicable time limitations thereunder shall have expired without a request for further information by the relevant federal authorities under the HSR Act, or in the event of such a request for further
information, the expiration of all applicable time limitations under the HSR Act shall have occurred without the objection of such federal authorities.
8.6 Healthcare Notification Laws. All filings under the Pre-Closing Healthcare Notifications
shall have been completed and, as applicable under such Healthcare Notification Laws and the rules promulgated thereunder, all notice or waiting periods will have been expired or terminated without a request for further information or objection of
the applicable Governmental Authority and any consents or approvals required shall have been obtained.
ARTICLE 9
TERMINATION
9.1
Termination. This Agreement may be terminated prior to the Closing as follows:
(a) Parent and the Company may terminate this
Agreement by mutual written consent at any time prior to the Closing;
(b) Parent may terminate this Agreement (if neither Parent nor
Merger Sub is then in material breach of its representations, warranties, covenants or agreements under this Agreement so as to cause any of the conditions set forth in Sections 8.1 or 8.2 not to be satisfied), upon
written notice to the Company, if there has been a material violation, breach or inaccuracy of any representation, warranty, covenant or agreement of the Company contained in this Agreement, which violation, breach or inaccuracy would cause any of
the conditions set forth in Sections 7.1 or 7.2 not to be satisfied, and such violation, breach or inaccuracy has not been waived by Parent or cured by the Company, as applicable, within the earlier of (x) the
Termination Date and (y) twenty (20) Business Days after receipt by the Company of written notice thereof from Parent or is not reasonably capable of being cured prior to the Termination Date;
82
(c) the Company may terminate this Agreement (if the Company is not then in material breach
of its representations, warranties, covenants or agreements under this Agreement so as to cause any of the conditions set forth in Sections 7.1 or 7.2 not to be satisfied), upon written notice to Parent, if there has been a material
violation, breach or inaccuracy of any representation, warranty, agreement or covenant of Parent contained in this Agreement, which violation, breach or inaccuracy would cause any of the conditions set forth in Sections 8.1
or 8.2 not to be satisfied, and such violation, breach or inaccuracy has not been waived by the Company or cured by Parent within the earlier of (x) the Termination Date and (y) twenty (20) Business Days after receipt by Parent
of written notice thereof from the Company or is not reasonably capable of being cured prior to the Termination Date;
(d) either Parent
or the Company may terminate this Agreement if the Closing Date shall not have occurred on or before July 22, 2025 (the Termination Date); provided, however that the terminating party under this
Section 9.1(d) is not in material breach of any representation, warranty, covenant or other agreement contained herein at the time of such termination so as to primarily cause (x) in the case that Parent is the
terminating party, any of the conditions set forth in Sections 8.1 or 8.2 not to be satisfied and (y) in the case that the Company is the terminating party, any of the conditions set forth in
Sections 7.1 or 7.2 not to be satisfied; provided, that (A) if the Marketing Period shall have commenced on or prior to the Termination Date but not been completed by the date that is three (3) Business
Days prior to the Termination Date (including, without limitation, as result of clause (ii) or (iii) of the definition of Marketing Period), but all other conditions to the Closing (other than those conditions that by their nature are to be
satisfied at the Closing) have been satisfied or, to the extent permitted by law, waived, then the Termination Date shall be extended to the third (3rd) Business Day following the final day of the Marketing Period, and such date shall become the
Termination Date for purposes of this Agreement and (B) if the Marketing Period shall have commenced on or prior to the Termination Date but not been completed by the date that is three (3) Business Days prior to the Termination Date
solely as a result of clause (v) of the definition of Marketing Period and would subsequently be deemed not to have commenced under clause (v) of the definition of Marketing Period, the Termination Date may be extended by the
Company or Parent for a period of up to 45 days by written notice to the other party at least one Business Day prior to the Termination Date;
(e) either Parent or the Company may terminate this Agreement, upon prior written notice to the other Party, if a Governmental Authority of
competent jurisdiction has issued an injunction or order permanently enjoining or otherwise prohibiting the consummation of the transactions contemplated by this Agreement, and such injunction or order has become final and non-appealable; provided, however, that the right to terminate this Agreement pursuant to this Section 9.1(e) is not available to any Party hereto whose material breach of any provision of
this Agreement primarily results in or primarily causes such injunction or order;
83
(f) Parent may terminate this Agreement if the Company has not obtained and delivered to
Parent the Written Consent within 24 hours after the execution of this Agreement;
(g) the Company may terminate this Agreement upon
prior written notice to Parent, if (i) the Closing shall not have occurred on or before the date required by Section 2.2, (ii) all of the conditions to Closing set forth in Article 7 have
been satisfied at the time of such termination if the Closing were held at the time of such termination (other than conditions that, either (A) by their nature, are to be satisfied at the Closing (and which are, at the time of termination of
this Agreement, capable of being satisfied if the Closing were to occur at such time) or (B) the failure of which to be satisfied is attributable to a breach by Parent or Merger Sub of their respective representations, warranties, covenants or
agreements contained in this Agreement), (iii) the Company has notified Parent in writing that the Company is ready, willing and able to effect the Closing at the time of termination and (iv) Parent fails to consummate the Closing on the
earlier of the Termination Date or the second (2nd) Business Day following the date of delivery of such written notification by the Company.
9.2 Effect of Termination. If this Agreement is terminated by the Parties in accordance with Section 9.1
hereof, this Agreement shall become void and of no further force and effect and there shall be no liability on the part of any Party to any other Party, except that (i) the provisions of this Section 9.2,
Section 6.2(b), Section 6.2(c), Section 6.12 (with respect to Parents Financing Cooperation Obligations), Section 9.3 and
Article 10 shall remain in full force and effect and (ii) except as provided in Section 9.3, termination shall not preclude any Party from recovering damages from any other Party for any
Willful Breach of this Agreement. The Confidentiality Agreement shall survive any termination of this Agreement in accordance with its terms and, subject to Section 9.3, nothing in this Section 9.2
shall be construed to discharge or relieve any party to the Confidentiality Agreement of its obligations thereunder.
9.3 Reverse
Termination Fee.
(a) In the event that this Agreement is validly terminated by Parent or the Company (i) pursuant to
Section 9.1(d) and at the time of such termination, one or more of the conditions to Closing set forth in Section 7.5 (to the extent related to any applicable Antitrust Law),
Section 7.6, Section 8.4 (to the extent related to any applicable Antitrust Law) or Section 8.5 have not been satisfied or waived, but all other conditions to Closing set
forth in Article 7 and Article 8 have been satisfied or waived (except for those conditions that by their nature are to be satisfied at the Closing (so long as such conditions are capable of being
satisfied if the Closing were to occur on such date)) or (ii) pursuant to Section 9.1(d) (to the extent related to any applicable Antitrust Law), then promptly, but in any event within two (2) Business Days after
the date of such termination, Parent shall pay or cause to be paid to the Company (or, if instructed by the Company in writing, its designee) an amount in cash equal to $70,000,000 (the Termination Fee) by wire transfer of
immediately available funds to one or more accounts designated in writing by the Company (or its designee), so long as a material breach by the Company of its obligations under this Agreement was not the primary cause of the failure of the
transactions to be consummated by the Termination Date or of the entry of such injunction or other order, as applicable. The Company shall have the right to assign its right to receive the Termination Fee to one or more Persons in its sole
discretion.
84
(b) The Parties acknowledge and agree that the agreements contained in this
Section 9.3 are an integral part of the transactions contemplated by this Agreement, and that, without these agreements, the Parties would not otherwise enter into this Agreement; accordingly, if Parent fails to pay the
Termination Fee pursuant to Section 9.3(a) on or prior to the date such amounts are due hereunder, and, in order to obtain such payment, the Company commences an Action that results in a final, nonappealable judgment
against Parent for the payment of the Termination Fee pursuant to Section 9.3(a), Parent shall pay, or cause to be paid, to the Company interest on such amount at an annual rate equal to the prime rate as published in the
Wall Street Journal, Eastern Edition, in effect on the date such amounts were originally due hereunder which shall accrue from such date through the date such payment is actually delivered to the Company or its designee, and the costs and
expenses (including reasonable attorneys fees and expenses incurred by the Company in connection with such action or proceeding) (collectively, Interest).
(c) Other than in connection with the enforcement of the Confidentiality Agreement, following any termination of this Agreement in accordance
with its terms, in the event that Parent is required to pay the Termination Fee pursuant to Section 9.3(a) and Parent timely pays the full Termination Fee together with any Interest, if applicable, payment of such fee and
the Companys right to enforce its rights under the Financing Cooperation Obligations shall be the sole and exclusive remedy of the Company and its Affiliates against Parent, Merger Sub and any of their respective former, current and future
Affiliates, representatives, shareholders, members, managers, partners, successors and assigns and the Debt Financing Related Parties for any losses, damages or liabilities suffered or incurred as a result of or under this Agreement or the
transactions contemplated by this Agreement, including the failure of the Closing to occur.
(d) The Parties acknowledge and agree that
(i) in no event shall Parent be required to pay, or cause to be paid, the Termination Fee on more than one occasion and (ii) any payment of the Termination Fee (together with Interest, if applicable), as applicable, described in this
Section 9.3 is not a penalty but is liquidated damages in a reasonable amount that will compensate the Company in the circumstances in which such fees are payable for the efforts and resources expended and the opportunities
foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation of the transactions contemplated by this Agreement, which amount would otherwise be impossible to calculate with precision.
85
ARTICLE 10
MISCELLANEOUS
10.1 No
Survival. The Parties, intending to modify any applicable statute of limitations, hereby agree that none of the representations, warranties, covenants or agreements (subject to the following sentence) in this Agreement or in any instrument
delivered pursuant to this Agreement (other than Sections 4.25, 5.10 and 5.11) shall survive the Closing and all rights, claims and causes of action (whether in contract or in tort or otherwise, or whether at
law or in equity) with respect thereto shall terminate at the Closing (other than in the case of Fraud). Notwithstanding the foregoing, neither this Section 10.1 nor anything else in this Agreement to the contrary
shall limit the survival of any covenant or agreement of any Party hereto which by its terms is required to be performed or complied with in whole or in part after the Closing, which covenants and agreements shall survive the Closing in accordance
with their respective terms. Parent acknowledges and agrees that, other than in the case of Fraud and except, solely with respect to the Company, to the extent set forth in Section 9.2, none of the Equityholders, the
Company or any other Person shall have any obligation or liability for any costs or expenses (including legal fees and disbursements), judgments, fines, losses, damages or liabilities incurred by Parent or any of its Affiliates, successors or
assigns for any inaccuracy or breach of any of the Companys representations, warranties, covenants or agreements in this Agreement other than to terminate this Agreement pursuant to, and in accordance with, Article 9
or to enforce this Agreement to the extent permitted in accordance with Section 10.19.
10.2 Reserved.
10.3 Expenses. Except as expressly provided herein, all costs and expenses incurred in connection with this Agreement and the
transactions contemplated hereby shall be borne and paid by the Party incurring such costs and expenses; provided that all Company Expenses shall be paid by Parent on behalf of the Company Group on the Closing Date.
10.4 Amendment. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Parties.
10.5 Entire Agreement. This Agreement, including the Disclosure Schedules and Exhibits attached hereto, which are deemed for all
purposes to be part of this Agreement, the other documents delivered pursuant to this Agreement and the Confidentiality Agreement contain all of the terms, conditions and representations and warranties agreed upon or made by the Parties relating to
the subject matter of this Agreement and the businesses and operations of the Company and supersede all prior and contemporaneous agreements, negotiations, correspondence, undertakings and communications of the Parties or their Agents, oral or
written, respecting such subject matter.
10.6 Headings. The headings contained in this Agreement are intended solely for
convenience and shall not affect the rights of the Parties.
10.7 Notices. Any notice or other communication required or permitted
under this Agreement shall be deemed to have been duly given and made if (i) in writing and served by personal delivery upon the Party for whom it is intended, (ii) if delivered by electronic mail (with receipt confirmed (including by
receipt of confirmatory electronic mail from recipient) or if no failure to send message is generated) or (iii) if delivered by certified mail, registered mail, courier service, return-receipt received to the Party at the address set forth
below, with copies sent to the Persons indicated:
86
If, prior to the Closing, to the Company or the Company Subsidiaries:
Rotech Healthcare Holdings Inc.
3600 Vineland Road, Suite 114
Orlando, Florida 32811-6460
Attention: General Counsel
E-mail: Steven.burres@rotech.com; legal@rotech.com
With a copy to (which shall not constitute notice):
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, New York 10019-6064
Attention: Jeffrey D. Marell; Matthew Benedetto
Email: jmarell@paulweiss.com;
mbenedetto@paulweiss.com
If to the Representative:
Shareholder Representative Services LLC
950 17th Street, Suite 1400
Denver, CO 80202
Attention:
Managing Director
Email: deals@srsacquiom.com
With a copy to (which shall not constitute notice):
Paul, Weiss, Rifkind, Wharton & Garrison LLP
1285 Avenue of the Americas
New York, New York 10019-6064
Attention: Jeffrey D. Marell; Matthew Benedetto
Email: jmarell@paulweiss.com;
mbenedetto@paulweiss.com
If to Parent or Merger Sub or, after the Closing, to the Surviving Corporation or the Company Subsidiaries:
Owens & Minor, Inc.
9120 Lockwood Boulevard
Mechanicsville, Virginia 23116
Attention: General Counsel
E-mail: Heath.Galloway@owens-minor.com
87
With a copy to (which shall not constitute notice):
Kirkland & Ellis LLP
601 Lexington Avenue
New York,
NY 10022
Attention: Eric L. Schiele
Allison M. Wein
E-mail: eric.schiele@kirkland.com
allie.wein@kirkland.com
Such addresses may be changed, from time to time, by means of a notice given in the manner provided in this Section 10.7.
10.8 Exhibits and Schedules.
(a) Any matter, information or item disclosed in the Disclosure Schedules delivered under any specific representation, warranty or
covenant or Schedule number hereof, shall be deemed to have been disclosed for all purposes of this Agreement in response to every representation, warranty or covenant in this Agreement in respect of which the relevance of such disclosure is
readily apparent on its face. The inclusion of any matter, information or item in any Schedule to this Agreement shall not be deemed to constitute an admission of any liability by the Company to any third party or otherwise imply that any such
matter, information or item is material or creates a measure for materiality for the purposes of this Agreement. Matters reflected in the Disclosure Schedules are not necessarily limited to matters required by this Agreement to be reflected in the
Disclosure Schedules. Such additional matters are set forth for informational purposes and do not necessarily include other matters of a similar nature. All references in the Disclosure Schedules to the enforceability of agreements with
third parties, the existence or non-existence of third-party rights, the absence of breaches or defaults by third parties, or similar matters or statements, are intended only to allocate rights and risks
between Parent and Merger Sub, on the one hand, and the Company, on the other hand, and are not intended to be admissions against interests, give rise to any inference or proof of accuracy, be admissible against any Party by any Person who is not a
Party, or give rise to any claim or benefit to any Person who is not a Party. In addition, the disclosure of any matter in the Disclosure Schedules is not to be deemed an admission that such matter actually constitutes noncompliance with, or a
violation of, applicable Law, Contract or other topic to which such disclosure is applicable. In no event shall the disclosure of matters disclosed in the Disclosure Schedules be deemed or interpreted to broaden the Companys
representations and warranties, obligations, covenants, conditions or agreements contained in the Agreement. The headings contained in the Disclosure Schedules are for convenience of reference only and shall not be deemed to modify or influence
the interpretation of the information contained in the Disclosure Schedules or this Agreement.
(b) The Disclosure Schedules and
Exhibits hereto are hereby incorporated into this Agreement and are hereby made a part hereof as if set out in full in this Agreement.
88
10.9 Waiver. Waiver of any term or condition of this Agreement by any Party shall
only be effective if in writing and shall not be construed as a waiver of any subsequent breach or failure of the same term or condition, or a waiver of any other term or condition of this Agreement.
10.10 Binding Effect; Assignment. This Agreement shall be binding upon and shall inure to the benefit of the Parties and their
permitted successors and assigns. No Party may assign or delegate all or any portion of its rights, obligations or liabilities under this Agreement without the prior written consent of the other Parties, which any such Party may withhold in its
absolute discretion; provided, that Parent may assign all of its rights, interests or obligations under this Agreement or any related documents to any Affiliate of Parent; and provided further, that any such assignment shall not
relieve Parent of any of its obligations hereunder. Any purported assignment without such prior written consent shall be void.
10.11
No Third Party Beneficiary. Nothing in this Agreement shall confer any rights, remedies or claims upon any Person or entity not a Party or a permitted assignee of a Party, except as set forth in Section 6.7,
Section 10.13, Section 10.14 and Section 10.21.
10.12
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together will constitute one and the same instrument. Delivery of an executed counterpart of a signature page
to this Agreement or any other agreements or certificates contemplated hereby (including any of the closing deliverables contemplated hereby) by facsimile, e-mail, scanned pages, pdf or by DocuSign shall be
effective as delivery of a manually executed counterpart to this Agreement or any such other agreement or certificate. No party hereto or to any other agreement or certificate contemplated hereby shall raise the use of facsimile, e-mail, scanned pages, pdf or by DocuSign to deliver a signature or the fact that any signature or contract was transmitted or communicated through the use of facsimile,
e-mail, scanned pages, pdf or by DocuSign as a defense to the formation of a contract and each such party forever waives any such defense.
10.13 Non-Recourse. Notwithstanding anything to the contrary herein, except as set forth in the
Confidentiality Agreement, the Fee Letter and the Debt Commitment Letter, (i) this Agreement may be enforced only against, and any Action based upon, arising out of, or related to this Agreement or the transactions contemplated hereby may be
brought only against, the entities that are expressly named as parties and then only with respect to the specific obligations set forth herein with respect to such party and (ii) with respect to each Party, no past, present or future director,
officer, employee, incorporator, member, partner, shareholder, agent, attorney, advisor, lender or Agent or Affiliate of such named party (the Related Parties), shall have any liability (whether in contract or tort, at Law or in
equity or otherwise, or based upon any theory that seeks to impose liability of an entity party against its owners or Affiliates) for any one or more of the representations, warranties, covenants, agreements or other obligations or liabilities of
such named party or for any claim based on, arising out of, or related to this Agreement or the transactions contemplated hereby. The provisions of this Section 10.13 are intended to
89
be for the benefit of, and enforceable by, the Related Parties and each such Person shall be a third-party beneficiary of this Section 10.13. This
Section 10.13 shall be binding on all successors and assigns of the Company. Notwithstanding the foregoing, this Section 10.13 shall not apply to Section 10.20, which shall be binding upon, and enforceable by the
Representative against, the Equityholders in its entirety.
10.14 Release. Parent agrees (and, from and after the Closing, shall
cause the Surviving Corporation and each Company Subsidiary to agree) that, other than in the case of Fraud, none of the Equityholders, the Representative or any of their respective Affiliates, current or former officers and directors, members,
managers or Agents of the Company or any Company Subsidiary or any of their respective Affiliates as of or prior to the Closing Date shall have any liability or responsibility to Parent or the Surviving Corporation or any Company Subsidiary for (and
Parent hereby unconditionally releases (and from and after the Closing shall cause the Surviving Corporation and each Company Subsidiary to unconditionally release) such Persons from) any obligations or liability:
(a) arising out of, or relating to, the organization, management or operation of the businesses of the Company or any Company Subsidiary
relating to any matter, occurrence, action or activity on or prior to the Closing Date; or
(b) relating to this Agreement and the
transactions contemplated hereby.
10.15 Governing Law and Jurisdiction. This Agreement and any claim or controversy hereunder
shall be governed by and construed in accordance with the Laws of the State of Delaware, without giving effect to the principles of conflict of laws thereof.
10.16 Consent to Jurisdiction and Service of Process. Each of the Parties (i) irrevocably agrees that all Actions (whether in
contract or tort, at law or in equity or otherwise) that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of
or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement) shall be exclusively resolved in the Delaware Court of Chancery, or, if such court shall not have
jurisdiction, any federal or state court sitting in Delaware, (ii) irrevocably agrees service of process, summons, notice or document by registered mail addressed to them at their respective addresses provided in
Section 10.7 shall be effective service of process against it for any such Action brought in any such court, and (iii) waives, to the fullest extent permitted by applicable Law, any objection which it may now or
hereafter have to the laying of venue of, and the defense of an inconvenient forum to the maintenance of, any such Action in any such court. Each of the Parties hereby agrees that a final judgment in any Actions shall be conclusive and may be
enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law.
90
10.17 WAIVER OF JURY TRIAL. EACH PARTY HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH
PARTY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND
(B) ACKNOWLEDGES AND AGREES THAT IT AND THE OTHER PARTIES HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.
10.18 Transfer Taxes. Parent agrees to pay all sales, use, transfer, stamp, registration, documentary, excise, real property transfer
or gains, or similar Taxes (Transfer Taxes) incurred as a result of the Merger described in Section 2.1 of this Agreement. Parent shall prepare and file any Tax Returns with respect to such Transfer
Taxes.
10.19 Specific Performance.
(a) The Parties agree that (i) irreparable damage would occur in the event that the provisions of this Agreement or obligations,
undertakings, covenants or agreements of the Parties were not performed in accordance with their specific terms or were otherwise breached and (ii) money damages, even if available, would not be an adequate remedy for any such failure to
perform or any breach of this Agreement. Accordingly, it is agreed that the Parties shall be entitled to an injunction or injunctions to enforce specifically the terms and provisions hereof in any court specified in
Section 10.15 without proof of actual damages or any requirement to post a bond, this being in addition to any other remedy to which they are entitled at law or in equity, and each Party agrees that it shall not oppose (and
hereby waives any defense in any action for) the granting of an injunction, specific performance or other equitable relief on the basis that any other Party has an adequate remedy at law or that any award of specific performance or other equitable
remedy is not an appropriate remedy for any reason at law, in equity or otherwise. Without limitation of the foregoing, the Parties hereby further acknowledge and agree that prior to the Closing, the Company shall be entitled to seek specific
performance to enforce specifically the terms and provisions of, and to prevent or cure breaches of the covenants required to be performed by Parent and Merger Sub under this Agreement (including Section 6.3 and
Section 6.13, and including to cause Parent and Merger Sub to consummate the Merger and the Closing and to make the payments contemplated by this Agreement, including Article 3) in addition to any
other remedy to which the Company is entitled at law or in equity, including the Companys right to terminate this Agreement pursuant to, and in accordance with, Article 9 and, subject to
Article 9, seek money damages (including damages based on loss of the economic benefits of the Merger to the Equityholders).
91
10.20 Representative.
(a) By virtue of the adoption of this Agreement and as set forth in the Letters of Transmittal, as applicable, the Representative is hereby
irrevocably appointed as of the Closing as the representative, agent, proxy, and attorney-in-fact for all the Equityholders for all purposes under this Agreement,
including the full power and authority on the Equityholders behalf (i) to consummate the transactions contemplated under this Agreement and the other agreements, instruments, and documents contemplated hereby or executed in connection
herewith, (ii) to negotiate and settle disputes arising under, or relating to, this Agreement and the other agreements, instruments, and documents contemplated hereby or executed in connection herewith, (iii) to receive and disburse to the
Equityholders any funds received on behalf of the Equityholders under this Agreement or otherwise, (iv) to withhold any amounts received on behalf of the Equityholders pursuant to this Agreement, including the Reserve Amount, or otherwise to
satisfy any and all obligations or liabilities incurred by the Equityholders or the Representative in the performance of their duties hereunder, (v) to direct the distribution of funds, designate or engage a paying agent to distribute funds
(including, the Aggregate Closing Merger Consideration, positive adjustment to Aggregate Closing Merger Consideration payable in accordance with Section 3.6 and funds from the Escrow Account and the Reserve Amount), make or
direct payments of funds from the Reserve Amount, give receipts for funds, authorize deliveries to Parent of cash from the Escrow Account in satisfaction of claims asserted by Parent, and object to any claims by any Person against the Escrow
Account, (vi) to execute and deliver any amendment or waiver to this Agreement and the other agreements, instruments, and documents contemplated hereby or executed in connection herewith (without the prior approval of the Equityholders) and
(vii) to take all other actions to be taken by or on behalf of the Equityholders in connection with this Agreement and the other agreements, instruments, and documents contemplated hereby or executed in connection herewith. The Stockholders, by
execution of a Letter of Transmittal, further agree that such agency and proxy are coupled with an interest, are therefore irrevocable without the consent of the Representative and shall survive the death, incapacity, bankruptcy, dissolution or
liquidation of any Stockholder. All decisions and actions by the Representative shall be binding upon all of the Equityholders and no Equityholder shall have the right to object, dissent, protest or otherwise contest the same. Parent may
conclusively rely, without independent verification or investigation, upon any such decision or action of the Representative as being the binding decision or action of every Equityholder, and Parent shall not be liable to any Stockholder or any
other Persons for any actions taken or omitted from being taken by them or by Parent in accordance with or reliance upon any such decision or action of the Representative. The Representative shall have no duties or obligations to the Equityholders
hereunder, except as expressly set forth in this Agreement.
(b) The Representative will incur no liability in connection with its
services pursuant to this Agreement and any related agreements, except to the extent resulting from its fraud, bad faith, gross negligence or willful misconduct. The Representative shall not be liable for any action or omission taken in good faith
pursuant to the advice of counsel. The Equityholders shall indemnify the Representative against any reasonable, documented, and out-of-pocket losses, liabilities and
expenses
92
(Representative Losses) arising out of or in connection with this Agreement and any related agreements, in each case as such Representative Loss is suffered or incurred;
provided, that in the event that any such Representative Loss is finally adjudicated to have been caused by fraud, bad faith, gross negligence or willful misconduct of the Representative, the Representative will reimburse the Equityholders
the amount of such indemnified Representative Loss to the extent attributable to such fraud, bad faith, gross negligence or willful misconduct. Representative Losses may be recovered by the Representative from (i) the Reserve Amount and
(ii) any other funds that become payable to the Equityholders under this Agreement at such time as such amounts would otherwise be distributable to the Equityholders; provided, that while the Representative may be paid from the
aforementioned sources of funds, this does not relieve the Equityholders from their obligation to promptly pay such Representative Losses as they are suffered or incurred. In no event will the Representative be required to advance its own funds on
behalf of the Equityholders or otherwise. Notwithstanding anything in this Agreement to the contrary, any restrictions or limitations on liability or indemnification obligations of, or provisions limiting the recourse against non-parties otherwise applicable to, the Equityholders set forth elsewhere in this Agreement are not intended to be applicable to the indemnities provided to the Representative hereunder. The foregoing indemnities
will survive the Closing, the resignation or removal of the Representative or the termination of this Agreement.
(c) In furtherance of,
and without limiting any rights of the Representative set forth in this Section 10.20, the Representative shall have the right and the Equityholders hereby authorize the Representative, to withhold from the Closing Merger
Consideration the Reserve Amount (in connection with the allocation and distribution of the Closing Merger Consideration in accordance with Article 3) to satisfy potential future obligations of the Equityholders and
expenses incurred by the Representative in connection with performing its obligations under this Agreement and the Escrow Agreement. The Reserve Amount shall be retained by the Representative until such time as the Representative shall determine,
and, subject to the terms of this Agreement, the balance of the Reserve Amount, if any, shall be delivered by the Representative to the Paying Agent for further distribution to the Equityholders as if such amounts were being distributed pursuant to
Section 3.6. The Equityholders will not receive any interest or earnings on the Reserve Amount and irrevocably transfer and assign to the Representative any ownership right that they may otherwise have had in any such
interest or earnings. The Representative will not be liable for any loss of principal of the Reserve Amount other than as a result of its bad faith or willful misconduct. Notwithstanding the foregoing, each Equityholder acknowledges and agrees that
there can be no assurances that any of the Reserve Amount will be paid or disbursed to the Equityholders. For U.S. federal and applicable state and local income tax purposes, the Reserve Amount shall be treated as received by the Equityholders at
Closing and voluntarily set aside by the Equityholders for the Representative, such that no withholding is required upon any subsequent transfer or disbursement of the Reserve Amount (or any portion thereof).
93
(d) If the Representative becomes unable or unwilling to continue in its capacity as
Representative, or if the Representative resigns as the Representative, a majority-in-interest of the Stockholders may by written consent appoint a new representative as
the Representative. Notice and a copy of the written consent appointing such new representative and bearing the signatures of a majority-in-interest of the Stockholders
must be delivered to Parent. Such appointment will be effective upon the later of the date indicated in the consent or the date such consent is received by Parent.
10.21 Waiver of Conflicts Regarding Representation. Recognizing that Paul, Weiss, Rifkind, Wharton & Garrison LLP
(Paul, Weiss) has acted as legal counsel to Representative and its Affiliates, and may be deemed to have acted as legal counsel to the Company Group prior to the Closing, and that Paul, Weiss intends to act as legal counsel to the
Representative and its Affiliates after the Closing, effective upon and conditioned upon the completion of the Closing, (i) the Company hereby waives, on its own behalf and agrees to cause its Affiliates to waive, any conflicts that may arise
in connection with Paul, Weiss representing the Representative and its Affiliates after the Closing and (ii) the Company hereby agrees that, in the event that a dispute arises between or among any of Parent or any of its respective Affiliates
(including, after the Closing, the Company Group) and the Representative or any of its Affiliates (including, prior to the Closing, the Company Group) each of the Parties agree that Paul, Weiss may represent the Representative or any of its
Affiliates in such dispute even though the interests of the Representative or such Affiliate may be directly adverse to Parent or any of its respective Affiliates (including, after the Closing, the Company or the Company Subsidiaries), and even
though Paul, Weiss may have represented the Company or the Company Subsidiaries in a matter substantially related to such dispute, or may be handling ongoing matters for the Representative, Parent and the Company hereby waive, on behalf of
themselves and each of their respective Affiliates, any conflict of interest in connection with such representation by Paul, Weiss. Parent and the Company further agree that, as to all communications among Paul, Weiss, the Company and/or the Company
Subsidiaries, and all attorney work product that relate in any way to the transactions contemplated by this Agreement (the Privileged Communications), the attorney-client privilege, the expectation of client confidence and all
other rights to any evidentiary privilege belong to the Representative and may be controlled by the Representative and shall not pass to or be claimed by Parent, Merger Sub, the Company or any of the Company Subsidiaries. The Parties agree to take,
and to cause their respective Affiliates to take, all steps necessary to implement the intent of this Section 10.21. Parent acknowledges that it and the Company have had the opportunity to discuss and obtain adequate
information concerning the significance and material risks of, and reasonable available alternatives to, the waivers, permissions and other provisions of this Agreement, including the opportunity to consult with counsel other than Paul, Weiss.
Notwithstanding the foregoing, in the event that a dispute arises between Parent or the Company, on the one hand, and a third party other than Representative or any of its Affiliates, on the other hand, Parent or the Company may assert the
attorney-client privilege to prevent the disclosure of the Privileged Communications to such third party. This Section 10.21 is for the benefit of the Representative, its Affiliates, and Paul, Weiss (including its partners
and employees), each of which are intended third-party beneficiaries of this Section 10.21.
94
10.22 Severability. If any term, provision, agreement, covenant or restriction of
this Agreement is held by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, agreements, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no
way be affected, impaired or invalidated so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any Party. Upon such a determination, the Parties shall negotiate in good
faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in a reasonably acceptable manner so that the transactions contemplated hereby may be consummated as originally contemplated to the fullest
extent possible.
10.23 Financing Sources. Notwithstanding anything in this Agreement to the contrary, the Company on behalf of
itself, its Subsidiaries and each of its Affiliates hereby: (a) agrees that any proceeding, whether in law or in equity, whether in contract or in tort or otherwise, involving the Debt Financing Related Parties, arising out of or relating to,
this Agreement, the Debt Commitment Letter or any of the agreements entered into in connection with the Debt Commitment Letter or any of the transactions contemplated hereby or thereby or the performance of any services thereunder shall be subject
to the exclusive jurisdiction of any federal or state court in the Borough of Manhattan, New York, New York, so long as such forum is and remains available, and any appellate court thereof and each party hereto irrevocably submits itself
and its property with respect to any such proceeding to the exclusive jurisdiction of such court, (b) agrees that any such proceeding shall be governed by the laws of the State of New York (without giving effect to any conflicts of law
principles that would result in the application of the laws of another state), except as otherwise provided in the Debt Commitment Letter or other applicable definitive document relating to the Debt Commitment Letter, (c) agrees not to bring or
support or permit any of its controlled Affiliates to bring or support any proceeding of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against any Debt Financing Related Party in any way arising
out of or relating to, this Agreement, the Debt Financing or any of the transactions contemplated hereby or thereby or the performance of any services thereunder in any forum other than any federal or state court in the Borough of Manhattan,
New York, New York, (d) agrees that service of process upon the Company, its Subsidiaries or its Affiliates in any such proceeding shall be effective if notice is given by registered or certified mail in accordance with
Section 10.6, (e) irrevocably waives, to the fullest extent that it may effectively do so, the defense of an inconvenient forum to the maintenance of such proceeding in any such court, (f) knowingly, intentionally
and voluntarily waives to the fullest extent permitted by applicable law trial by jury in any proceeding brought against the Debt Financing Related Parties in any way arising out of or relating to, this Agreement, the Financing or any of the
transactions contemplated hereby or thereby or the performance of any services thereunder, (g) agrees that none of the Debt Financing Related Parties will have any liability to any of the Company Related Parties (for the avoidance of doubt, in
each case, other than (x) the Parent and its permitted assigns in connection with the commitment letters governing the Debt Financing or the definitive agreements governing the Debt Financing and (y) the Parent and its subsidiaries
following the Closing) relating to or arising out of this Agreement, the Debt Financing or any of the transactions contemplated hereby or thereby or the performance of any services thereunder, whether in law or in equity, whether in contract or in
tort or otherwise (except, after giving effect to the Closing Date, to the Company and its Subsidiaries party to the definitive agreements entered into with respect to the Debt Financing in accordance with the terms thereof) and (h) agrees that
the Debt
95
Financing Sources are express third party beneficiaries of, and may enforce, any of the provisions of Section 9.3(c) and this Section 10.23, and that such
provisions of Section 9.3(c) and this Section 10.23 and the definitions of Debt Financing Sources and Debt Financing Related Parties (and any other provisions of this Agreement to the extent a
modification thereof would directly affect the substance of any of the foregoing) shall not be amended in any way adverse to the Debt Financing Related Parties without the prior written consent of the Debt Financing Sources party to the Debt
Commitment Letter. This Section 10.23 shall, with respect to the matters referenced herein, supersede any provision of this Agreement to the contrary. Notwithstanding the foregoing, nothing in this
Section 10.23 shall in any way limit or modify (i) the rights and obligations of the Parent and its Affiliates under this Agreement or (ii) any Debt Financing Related Parties obligations to, and the
corresponding rights in connection therewith of, the Parent or any of their Affiliates (following the Closing Date, including the Company and its Subsidiaries) under the commitment letters governing the Debt Financing (including the Debt Commitment
Letter) or the definitive agreements governing the Debt Financing.
10.24 Currency. All payments made by Parent pursuant to this
Agreement shall be made in United States dollars.
10.25 Time of the Essence. With regard to all dates and time periods set forth
or referred to in this Agreement, time is of the essence.
[Remainder of page intentionally left blank]
96
IN WITNESS WHEREOF, the Parties have executed and delivered this Agreement as of the date
first above written.
|
|
|
COMPANY: |
|
ROTECH HEALTHCARE HOLDINGS INC. |
|
|
By: |
|
/s/ Robin Menchen |
Name: |
|
Robin L. Menchen |
Title: |
|
President and Chief Executive Officer |
|
REPRESENTATIVE: |
|
SHAREHOLDER REPRESENTATIVE SERVICES LLC |
|
|
By: |
|
/s/ Sam Riffe |
Name: Title: |
|
Sam Riffe Managing Director |
|
PARENT: |
|
OWENS & MINOR, INC. |
|
|
By: |
|
/s/ Heath Galloway |
Name: |
|
Heath H. Galloway |
Title: |
|
EVP, General Counsel and Corporate Secretary |
|
MERGER SUB: |
|
HITCHCOCK MERGER SUB INC. |
|
|
By: |
|
/s/ Jonathan Leon |
Name: |
|
Jonathan Leon |
Title: |
|
SVP, Corporate Treasurer and Interim CFO |
Signature Page
Merger Agreement
Exhibit 99.1
Owens & Minor, Inc. Signs Definitive Agreement to Acquire Rotech Healthcare Holdings, Inc. for
$1.36 Billion in Cash
Strategy Articulated at Investor Day is Advanced by Strengthening Our Patient Directs Position as a
Premier Growth Platform in Home-Based Care
Combined Capabilities Support Improved Service to Patients, Providers, and Payors
Adjusted EPS Neutral in First Full Year and Approximately $0.15 Accretion in Second Year
Company Reports Preliminary Second Quarter Results and Reaffirms 2024 Full Year Guidance in Separate Press Release
RICHMOND, Va. (BUSINESS WIRE) July 23, 2024 Owens & Minor, Inc. (Owens & Minor) (NYSE:
OMI), today announced that it has entered into a definitive agreement to acquire Rotech Healthcare Holdings, Inc. (Rotech), a privately held home based care business headquartered in Orlando, Florida, for $1.36 billion in cash.
Given anticipated tax benefits of approximately $40 million from the transaction, the net purchase price is approximately $1.32 billion, which represents approximately a 6.3x multiple of LTM EBITDA, excluding synergies.
Rotech is a national leader in providing home medical equipment in the United States. The company has over 4,200 employees and provides products and services
in 46 states through approximately 325 operating locations. Rotech generated approximately $750 million of revenue and an EBITDA margin of nearly 30% in 2023.
Rotech squarely fits into our existing Patient Direct segment and directly aligns with the strategy we outlined last December during our Investor Day,
supporting our expansion in the very large and fast-growing home-based care space. We are excited to acquire a high-quality company like Rotech, an opportunity that doesnt come along very often, and I look forward to welcoming the Rotech
teammates into the Owens & Minor family, said Edward A. Pesicka, President & Chief Executive Officer of Owens & Minor.
Pesicka added, This transaction highlights our disciplined approach toward inorganic growth, with a focus on strategic fit, value creation for
shareholders, prudent capital allocation and most importantly, providing improved service and experience to patients, providers, and payors. Furthermore, we are committed to deleveraging the balance sheet to below 3.0x in approximately 24 months
after closing.
The team and I look forward to being part of Owens & Minor due to their commitment to providing best-in-class products and services to patients in their homes. Owens & Minor is a natural home for the Rotech team, and we believe the combination will benefit
patients, providers, payors, and employees, said Robin Menchen, President & Chief Executive Officer of Rotech.
Strategic Rationale
|
|
|
Strengthens Patient Direct product offerings through expansion across a complementary portfolio including
Respiratory, Sleep Apnea, Diabetes, Wound Care, and provides access to the Durable Medical Equipment (DME) market. |
|
|
|
Supports combined customer base allowing Owens & Minor to better serve providers and payors
across an integrated national network. |
|
|
|
Enables Owens & Minor to more comprehensively serve patients through the combined
suite of complementary product offerings and improved service for patients with chronic conditions in large and fragmented markets. |
|
|
|
Provides significant synergy opportunity of approximately $50 million by the end of year
three, with further upside potential, as well as prospect for additional revenue synergies in both the near and long term. |
|
|
|
Accelerates the growth path for the Patient Direct segment as outlined at the December 2023
Investor Day to achieve $5 billion in revenue by 2028. |
Transaction Details
Under the terms of the agreement, which was unanimously approved by the Board of Directors of each company, Owens & Minor will acquire Rotech for
$1.36 billion in an all-cash transaction. Given anticipated tax benefits of approximately $40 million from the transaction, the net purchase price is approximately $1.32 billion.
Owens & Minor has fully committed financing in place and expects to use a combination of cash and incremental borrowings to fund the purchase price. At closing, Owens & Minor is expected to have book leverage of approximately 4.2x
and expects to de-lever below 3.0x book leverage in approximately 24 months of closing.
The transaction is
subject to customary closing conditions, including the Hart Scott Rodino Act, and is expected to close by the end of 2024.
Advisors
Citi acted as exclusive financial advisor to Owens & Minor in connection with this acquisition. Owens & Minors legal advisor is
Kirkland & Ellis LLP.
Jefferies LLC acted as exclusive financial advisor to Rotech in connection with the acquisition. Rotechs legal
advisor is Paul, Weiss, Rifkind, Wharton & Garrison LLP.
Conference Call Information
Owens & Minor will host a conference call at 8:30 a.m. EDT today to discuss the transaction. Participants may access the call at 877-407-8037. The international dial-in number is 1-201-689-8037. A webcast of the event will be available at investors.owens-minor.com/events-and-presentations/. A
replay of the webcast can be accessed following the presentation at the link provided above.
Safe Harbor
This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary
distribution to the public in compliance with the SECs Fair Disclosure Regulation. This release contains certain forward-looking statements made pursuant to the Safe Harbor provisions of the Private Securities
Litigation Reform Act of 1995. Some of these statements can be identified by terms and phrases such as outlook, believes, expects, potential, continues, may, will,
should, could, seeks, predicts, intends, trends, plans, estimates, anticipates or the negative version of these words or other comparable
words. These statements include, but are not limited to, the statements in this release regarding the proposed transaction and opportunities related thereto, Owens & Minors expectations with respect to its financial performance and
expectations of its business. Forward-looking statements involve known and unknown risks and uncertainties that may cause Owens & Minors actual results in future periods to differ materially from those projected or contemplated in the
forward-looking statements, including the occurrence of any event, change or other circumstances that could give rise to the termination of the agreement relating to the proposed transaction; risks related to disruption of managements
attention from Owens & Minors ongoing business operations due to the proposed transaction; the effect of the announcement of the proposed transaction on Owens & Minors or Rotechs relationships with its customers,
suppliers and other third parties, as well as it operating results and business generally; the risk that the proposed transaction will not be consummated in a timely manner; exceeding the expected costs of the transaction; and the risk that problems
may arise in successfully integrating the businesses of the companies, which may result in the combined company not operating as effectively and efficiently as expected and the risk that the combined company may be unable to achieve synergies or it
may take longer than expected to achieve those synergies. Investors should refer to Owens & Minors Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities
and Exchange Commission (the SEC) including the sections captioned Cautionary Note Regarding Forward-Looking Statements and Item 1A. Risk Factors, and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause Owens & Minors actual
results to differ materially from its current estimates. These filings are available at www.owens-minor.com. Given these risks and uncertainties, Owens & Minor cannot give any assurance that any forward-looking statements will, in fact,
transpire and, therefore, cautions investors not to place undue reliance on them. Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future
developments or otherwise.
About Owens & Minor
Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from
the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have
helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront.
Owens & Minor exists because every day, everywhere, Life Takes Care. For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us
on LinkedIn and Instagram.
*Registered Trademark or Trademark of O&M Halyard or its affiliates.
About Rotech
Rotech is one of the largest providers of
home medical equipment and related products and services (collectively referred to as HME products and services) in the United States, with a comprehensive offering of oxygen, other respiratory therapy equipment, wound care equipment and
supplies, and diabetes devices and supplies. The Company provides HME products and services in 46 states through approximately 325 operating locations.
Investor Contact for Owens & Minor:
Alpha IR
Group
Jackie Marcus or Nick Teves
OMI@alpha-ir.com
Jonathan Leon
Interim CFO, SVP Finance & Treasurer
Investor.Relations@owens-minor.com
Media Contact for
Owens & Minor:
Stacy Law
media@owens-minor.com
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p1g1.jpg)
Exhibit 99.2 Rotech – Investor Presentation July 23,
2024
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p2g1.jpg)
Disclaimer This presentation is intended to be disclosure through
methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This presentation contains certain “forward-looking” statements made pursuant to the Safe
Harbor provisions of the Private Securities Litigation Reform Act of 1995. Some of these statements can be identified by terms and phrases such as “outlook,” “believes,” “expects,” “potential,”
“continues,” “may,” “will,” “should,” “could,” “seeks,” “predicts,” “intends,” “trends,” “plans,” “estimates,”
“anticipates” or the negative version of these words or other comparable words. These statements include, but are not limited to, statements regarding the proposed transaction with Rotech Healthcare Holdings, Inc. (“Rotech”)
and opportunities related thereto, Owens & Minor’s (“Owens & Minor’s” or the “Company’s”) expectations with respect to its financial performance and expectations of its business. Forward-looking
statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected, targeted or contemplated in the forward-looking statements, including the occurrence of any
event, change or other circumstances that could give rise to the termination of the agreement relating to the proposed transaction; risks related to disruption of management’s attention from Owens & Minor’s ongoing business
operations due to the proposed transaction; the effect of the announcement of the proposed transaction on Owens & Minor’s or Rotech’s relationships with its customers, suppliers and other third parties, as well as operating results
and their businesses generally; the risk that the proposed transaction will not be consummated in a timely manner or at all; exceeding the expected costs of the transaction; the risk that problems may arise in successfully integrating the businesses
of the companies, which may result in the combined company not operating as effectively and efficiently as expected and the risk that the combined company may be unable to achieve synergies or it may take longer than expected to achieve those
synergies. Investors should refer to Owen & Minor’s Annual Report on Form 10-K for the year ended December 31, 2023, including the sections captioned ‘Cautionary Note Regarding Forward-Looking Statements’ and ‘Item 1A.
Risk Factors,’ and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause the actual results to differ materially from those
projected, targeted or contemplated in the forward-looking statements. Given these risks and uncertainties, Owens & Minor can give no assurance that any forward-looking statements will, in fact, transpire and, therefore, cautions investors not
to place undue reliance on them. Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, as a result of new information, future developments or otherwise. This presentation includes certain
combined financial information which reflects the sum of the relevant financial information for the Company and Rotech without any other adjustments and refer to such presentation as on a pro forma basis for the applicable period. This combination
does not comply with U.S. GAAP or with the rules for pro forma presentation. As a result, the combined financial information included in this presentation may differ from pro forma financial information prepared in accordance with U.S. GAAP and the
rules and regulations of the SEC, and any such differences could be material. Certain financial measures included herein are not made in accordance with U.S. GAAP, including Adjusted EBITDA and Adjusted EPS, and use of such terms varies from others
in the same industry. Management uses these non-GAAP financial measures internally to evaluate our performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation. Non-GAAP financial
measures should not be considered as alternatives to measures derived in accordance with U.S. GAAP. Non-GAAP financial measures have important limitations as analytical tools and you should not consider them in isolation or as substitutes for
results as reported in accordance with U.S. GAAP. Projected or targeted GAAP financial measures and reconciliations of projected or targeted non-GAAP financial measures are not provided herein because such GAAP financial measures are not available
on a forward-looking basis and such reconciliations could not be derived without unreasonable effort. Note: To be updated to reflect final presentation. Owens & Minor uses its web site, www.owens-minor.com, as a channel of distribution for
material Company information, including news releases, investor presentations and financial information. This information is routinely posted and accessible under the Investor Relations section. 2 2
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p3g1.jpg)
Transaction Overview Key Stats Strategic Rationale Financial
Implications 2024 Update § Purchase price of $1.36 § Improves Patient Direct § Accelerates top line and § Q2 2024 revenue of $2.65 – earnings growth $2.67 billion, net loss of billion in cash or $1.32 capabilities (1)
billion net of tax benefits $(35) - $(32) million, adjusted net income of $25 - $28 million, adjusted EBITDA of $123 - $127 § Adjusted EPS neutral in § Expands reach across an § 6.3x implied LTM EBITDA million, net loss per share year
1 and approximately (1) multiple integrated national of $(0.46) - $(0.42), and $0.15 accretion in year 2 network adjusted EPS of $0.32 - (4) $0.36 (2) § 5.1x implied synergized § Company reaffirms full year (1) LTM EBITDA multiple §
Expected book leverage at 2024 outlook for revenue of § Enables Owens & Minor to close of ~4.2x; Committed $10.5 - $10.9 billion, achieve improved service to deleveraging to below Adjusted EBITDA of $550 - to patients, providers, and 3.0x
in approximately 24 $590 million and Adjusted (3) § Expected close in 2024 payors (5) months after closing EPS of $1.40 - $1.70 (1) Includes estimated cash tax benefits to Owens & Minor of at least $40 million. (2) Assumed run-rate
synergies of $50 million. (3) Subject to customary approvals and closing conditions. 3 3 (4) Reconciliations of the differences between the non-GAAP financial measures presented herein and their most comparable GAAP financial measures are included
in the Appendix of this document. (5) Excludes the impact of Rotech transaction. 2
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p4g1.jpg)
Compelling Strategic Rationale and Value Creation Opportunity Strategic
Rationale Value Creation Strengthens Patient Direct by expanding product offerings through expansion Accelerates long-term across complementary portfolios and provides access to the Durable Medical Equipment revenue growth (DME) market, including
hospital beds, wheelchairs, and mobility aids Accretive to operating Supports combined customer base allowing Owens & Minor to better serve providers and EBITDA margins and payors across an integrated national network Enables Owens & Minor
to more comprehensively serve patients through the Improves free cash combined suite of product offerings and improved service for patients with chronic flow generation conditions in large and fragmented markets Provides significant synergy
opportunity of approximately $50 million by the end Accretive to Adjusted of year three, with further upside potential, as well as prospect for additional revenue EPS synergies in both the near and long term 4 4
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p5g1.jpg)
Rotech at-a-Glance Key Stats Proven Track Record § Best-in-class
Home Medical Equipment distributor ~$750mm § Partner of choice for many payors, providers, suppliers and patients 2023A Net Revenue § 40+ years in operation led by a seasoned management team with 100+ years of combined experience $200mm+
Compelling Geographic Footprint 2023A Adj. EBITDA § Robust and scalable national infrastructure Above Market § Reliable national delivery across approximately 325 locations in 46 states Organic Revenue CAGR Comprehensive Product Portfolio
4,200+ § Focused on high growth end markets for patients with chronic conditions Employees § Diversified mix across patients, suppliers, payors and geographic footprint 300+ § Extensive product offerings Account Executives 5
5
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p6g1.jpg)
Rotech Further Diversifies our Patient Direct Business 2023A Pro Forma
Patient Direct Business Mix 2023A Pro Forma Patient Direct Payor Mix VA & Other Medicaid 1% 4% Urology 3% (1) Other Ostomy 10% 5% Sleep 28% Wound Care Medicare 6% 27% Commercial (2) 68% Diabetes 23% Respiratory 24% Key Business Mix Takeaway Key
Payor Mix Takeaway Rotech shifts Patient Direct’s payor mix slightly away Rotech enhances Patient Direct’s from commercial payors toward government diversified product portfolio 6 6 (1) Includes Other Medical Supplies, Other Equipment
and Services, DME / Other and Capitated Arrangements. (2) Includes Patient Pay.
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p7g1.jpg)
Alignment with Our Patient Direct Vision Rotech Advances the Patient
Direct 2028 Vision Framing the 2028 Patient Direct Vision Presented at Investor Day Patient Direct Revenue of $5 billion or more Strong brand recognition with a national footprint and local presence Proven model is expected to continue to drive
organic growth Revenue CAGR of 8%+ Expansive opportunities to serve patients across core disease categories and numerous opportunities to enter adjacencies Adjusted Operating Income Target of $400 million+ Focus investments to drive organic growth 7
7
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p8g1.jpg)
Financial Implications • Further scales business and accelerates
company long-term growth rate Sales & Growth • Ability to leverage sizable combined network with ~625 locations • Accretive to operating and EBITDA margins • Improves Owens & Minor free cash flow generation Earnings &
Returns • Adjusted EPS neutral in year 1 and approximately $0.15 accretion in year 2 • Expected approximately $50 million synergy opportunity by the end of year three, with potential for further upside Synergies • Cost synergies
through procurement and DS&A and network consolidation • Expected book leverage at close of ~4.2x Deleveraging & Capital • Focused on deleveraging below 3.0x in approximately 24 months after close Allocation • Demonstrates
commitment to use balance sheet to effectively execute transformative M&A 8 8
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p9g1.jpg)
Maintain 2024 Company Outlook & Q2 Preliminary Results (1) $ in
million, except per share data 2024 Outlook Revenue $10,500 - $10,900 Adjusted EBITDA $550 - $590 Adjusted EPS $1.40 - $1.70 (2) $ in million, except per share data or when otherwise noted Selected Preliminary Financial Results for Q2 2024 Revenue
$2.65 - $2.67 billion Operating Income, GAAP $16 - $20 Adj. Operating Income, Non-GAAP $72 - $76 Net Loss, GAAP $(35) - $(32) Adj. Net Income, Non-GAAP $25 - $28 Adj. EBITDA, Non-GAAP $123 - $127 Net Loss per common share, GAAP $(0.46) - $(0.42)
Adj. Net Income per share, Non-GAAP $0.32 - $0.36 Operating Cash Flow $111 - $116 Total debt and net debt reduction $68 - $71 (1) Excludes the impact of Rotech transaction. (2) Reconciliation of the differences between the non-GAAP financial
measures presented in this release and their most directly comparable GAAP financial measures are in the tables 9 9 included herein.
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p10g1.jpg)
Summary of Key Investment Highlights Advances strategy articulated at
Investor Day by strengthening Patient Direct’s position as a premier growth platform in 1 home-based care Combined capabilities and reach to support improved service to patients, providers and payors 2 Enables Owens & Minor to more
comprehensively serve patients through the combined suite of product offerings and 3 improved service levels Adjusted EPS neutral in first year and approximately $0.15 accretion in second year 4 Accelerates Owens & Minor long-term revenue growth
5 Accretive to operating and EBITDA margins as well as improves free cash flow generation 6 Significant synergy opportunity with further upside potential 7 10 10
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p11g1.jpg)
• • • A P P E N D I X • •
•
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p12g1.jpg)
GAAP/Non-GAAP Reconciliations Three Months Ended June 30, 2024 $ in
millions Low High Operating income, as reported (GAAP) $ 16 $ 20 (1) Acquisition-related charges and intangible amortization 20 20 (2) Exit and realignment charges, net 29 29 (3) Litigation and related charges 7 7 Operating income, adjusted
(non-GAAP) (Adjusted Operating Income) $ 72 $ 76 Three Months Ended June 30, 2024 $ in millions Low High Net loss, as reported (GAAP) $ (35) $ (32) Pre-tax adjustments: (1) Acquisition-related charges and intangible amortization 20 20 (2) Exit and
realignment charges, net 29 29 (3) Litigation and related charges 7 7 (4) Income tax benefit on pre-tax adjustments (13) (13) (5) One-time income tax charge 17 17 Net income, adjusted (non-GAAP) (Adjusted Net Income) $ 25 $ 28 Note: See p.15,
“Definitions of Non-GAAP Reconciliation Items”, for footnotes. 12 12
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p13g1.jpg)
GAAP/Non-GAAP Reconciliations (Continued) Three Months Ended June 30,
2024 Low High Net loss per share, as reported (GAAP) $ (0.46) $ (0.42) After-tax adjustments: (1) Acquisition-related charges and intangible amortization 0.19 0.19 (2) Exit and realignment charges, net 0.29 0.29 (3) Litigation and related charges
0.08 0.08 (5) One-time income tax charge 0.22 0.22 Net income per share, adjusted (non-GAAP) (Adjusted EPS) $ 0.32 $ 0.36 Note: See p.15, “Definitions of Non-GAAP Reconciliation Items”, for footnotes. 13 13
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p14g1.jpg)
GAAP/Non-GAAP Reconciliations (Continued) Three Months Ended June 30,
2024 $ in millions Low High Net loss, as reported (GAAP) $ (35) $ (32) Income tax provision 15 16 Interest expense, net 36 36 (1) Acquisition-related charges and intangible amortization 20 20 (2) Exit and realignment charges, net 29 29 (6) Other
depreciation and amortization 46 46 (7) Stock compensation 6 6 (8) LIFO credits (1) (1) (3) Litigation and related charges 7 7 Adjusted EBITDA (non-GAAP) $ 123 $ 127 June 30, 2024 March 31, 2024 $ in millions Low High Total debt, as reported (GAAP)
$ 2,083 $ 2,085 $ 2,154 Cash and cash equivalents (244) (244) (245) Net debt (non-GAAP) $ 1,839 $ 1,841 $ 1,909 Note: See p.15, “Definitions of Non-GAAP Reconciliation Items”, for footnotes. 14 14
![](https://www.sec.gov/Archives/edgar/data/75252/000119312524182569/g861390ex99_2p15g1.jpg)
Definitions of Non-GAAP Reconciliation Items (1) Acquisition-related
charges and intangible amortization includes one-time costs related to the expected acquisition of Rotech, including legal and other professional fees, and amortization of intangible assets established during acquisition method of accounting for
business combinations. These amounts are highly dependent on the size and frequency of acquisitions and are being excluded to allow for a more consistent comparison with forecasted, current and historical results. (2) Exit and realignment charges,
net primarily related to our Operating Model Realignment Program, including professional fees, severance, and other costs to streamline functions and processes and costs related to IT strategic initiatives such as converting certain divisions to
common IT systems. These costs are not normal recurring, cash operating expenses necessary for the Company to operate its business on an ongoing basis. (3) Litigation and related charges includes settlement costs and related charges of legal matters
within our Apria division. These costs do not occur in the ordinary course of our business and are inherently unpredictable in timing and amount. (4) These charges have been tax effected by determining the income tax rate depending on the amount of
charges incurred in different tax jurisdictions and the deductibility of those charges for income tax purposes. (5) One-time income tax charge relates to a recent decision associated with Notices of Proposed Adjustments received in 2020 and 2021.
The matter at hand, as discussed in previously filed SEC documents, is related to past transfer pricing methodology. We believe the matter will be concluded without further impact to our financial results. (6) Other depreciation and amortization
relates to property and equipment and capitalized computer software, excluding such amounts captured within exit and realignment charges, net or acquisition-related charges. (7) Stock compensation includes share-based compensation expense related to
our share-based compensation plans, excluding such amounts captured within exit and realignment charges, net or acquisition-related charges. (8) LIFO credits includes non-cash adjustments to merchandise inventories valued at the lower of cost or
market, with the approximate cost determined by the last-in, first-out (LIFO) method for distribution inventories in the U.S. within our Products & Healthcare Services segment. 15 15
v3.24.2
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Owens and Minor (NYSE:OMI)
Historical Stock Chart
From Jul 2024 to Aug 2024
Owens and Minor (NYSE:OMI)
Historical Stock Chart
From Aug 2023 to Aug 2024